
<html lang="en"     class="pb-page"  data-request-id="19247444-a61c-4c83-a337-58f4ea204802"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b00794;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2017.60.issue-17;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer" /></meta><meta name="dc.Creator" content="Floriana  Morgillo" /></meta><meta name="dc.Creator" content="Giorgio  Amendola" /></meta><meta name="dc.Creator" content="Carminia Maria  Della Corte" /></meta><meta name="dc.Creator" content="Chiara  Giacomelli" /></meta><meta name="dc.Creator" content="Lorenzo  Botta" /></meta><meta name="dc.Creator" content="Salvatore  Di Maro" /></meta><meta name="dc.Creator" content="Anna  Messere" /></meta><meta name="dc.Creator" content="Vincenza  Ciaramella" /></meta><meta name="dc.Creator" content="Sabrina  Taliani" /></meta><meta name="dc.Creator" content="Luciana  Marinelli" /></meta><meta name="dc.Creator" content="Maria Letizia  Trincavelli" /></meta><meta name="dc.Creator" content="Claudia  Martini" /></meta><meta name="dc.Creator" content="Ettore  Novellino" /></meta><meta name="dc.Creator" content="Fortunato  Ciardiello" /></meta><meta name="dc.Creator" content="Sandro  Cosconati" /></meta><meta name="dc.Description" content="Tyrosine kinase inhibitors (TKIs) of the EGF receptor (EGFR) have provided a significant improvement in the disease outcome of nonsmall cell lung cancer (NSCLC). Unfortunately, resistance to these ..." /></meta><meta name="Description" content="Tyrosine kinase inhibitors (TKIs) of the EGF receptor (EGFR) have provided a significant improvement in the disease outcome of nonsmall cell lung cancer (NSCLC). Unfortunately, resistance to these ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 22, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00794" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00794" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00794" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00794" /></link>
        
    
    

<title>Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00794" /></meta><meta property="og:title" content="Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0008.jpeg" /></meta><meta property="og:description" content="Tyrosine kinase inhibitors (TKIs) of the EGF receptor (EGFR) have provided a significant improvement in the disease outcome of nonsmall cell lung cancer (NSCLC). Unfortunately, resistance to these agents frequently occurs, and it is often related to the activation of the Hedgehog (Hh) and MET signaling cascades driving the epithelial-to-mesenchymal transition (EMT). Because the concomitant inhibition of both Hh and MET pathways restores the sensitivity to anti-EGFR drugs, here we aimed at discovering the first compounds that block simultaneously MET and SMO. By using an “in silico drug repurposing” approach and by validating our predictions both in vitro and in vivo, we identified a set of compounds with the desired dual inhibitory activity and enhanced antiproliferative activity on EGFR TKI-resistant NSCLC. The identification of the known MET TKIs, glesatinib and foretinib, as negative modulators of the Hh pathway, widens their application in the context of NSCLC." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00794"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00794">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00794&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00794&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00794&amp;href=/doi/10.1021/acs.jmedchem.7b00794" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7447-7458</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00787" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00805" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Floriana++Morgillo">Floriana Morgillo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giorgio++Amendola">Giorgio Amendola</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-4271-5031" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carminia+Maria++Della+Corte">Carminia Maria Della Corte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chiara++Giacomelli">Chiara Giacomelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6244-602X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lorenzo++Botta">Lorenzo Botta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Salvatore++Di+Maro">Salvatore Di Maro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Messere">Anna Messere</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincenza++Ciaramella">Vincenza Ciaramella</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sabrina++Taliani">Sabrina Taliani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luciana++Marinelli">Luciana Marinelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Letizia++Trincavelli">Maria Letizia Trincavelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudia++Martini">Claudia Martini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-9379-3027" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ettore++Novellino">Ettore Novellino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2181-2142" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fortunato++Ciardiello">Fortunato Ciardiello</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandro++Cosconati">Sandro Cosconati</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-8900-0968" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale “F. Magrassi e A. Lanzara”, Università della Campania “Luigi Vanvitelli”, Via Pansini 6, 80131 Naples, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">DiSTABiF, Università della Campania “Luigi Vanvitelli”, Via Vivaldi 43, 81100 Caserta, Italy</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Dipartimento di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Dipartimento di Farmacia, Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Naples, Italy</span></div><div class="corresp-info"><strong>*</strong>For S.C.: phone, +39 0823 274789; E-mail, <a href="/cdn-cgi/l/email-protection#582b39363c2a37763b372b3b3736392c31182d36313b3935283936313976312c"><span class="__cf_email__" data-cfemail="d7a4b6b9b3a5b8f9b4b8a4b4b8b9b6a3be97a2b9beb4b6baa7b6b9beb6f9bea3">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For F.M.: phone, +39 081 5666732; E-mail, <a href="/cdn-cgi/l/email-protection#88eee4e7fae1e9e6e9e5e7faefe1e4e4e7c8f1e9e0e7e7a6ebe7e5"><span class="__cf_email__" data-cfemail="23454f4c514a424d424e4c51444a4f4f4c635a424b4c4c0d404c4e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00794&amp;href=/doi/10.1021%2Facs.jmedchem.7b00794" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7447–7458</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 8, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 May 2017</li><li><span class="item_label"><b>Published</b> online</span>22 August 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 September 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00794" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00794</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7447%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFloriana%2BMorgillo%252C%2BGiorgio%2BAmendola%252C%2BCarminia%2BMaria%2BDella%2BCorte%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D17%26contentID%3Dacs.jmedchem.7b00794%26title%3DDual%2BMET%2Band%2BSMO%2BNegative%2BModulators%2BOvercome%2BResistance%2Bto%2BEGFR%2BInhibitors%2Bin%2BHuman%2BNonsmall%2BCell%2BLung%2BCancer%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7458%26publicationDate%3DSeptember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00794"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1732</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00794" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Floriana&quot;,&quot;last_name&quot;:&quot;Morgillo&quot;},{&quot;first_name&quot;:&quot;Giorgio&quot;,&quot;last_name&quot;:&quot;Amendola&quot;},{&quot;first_name&quot;:&quot;Carminia&quot;,&quot;last_name&quot;:&quot;Maria Della Corte&quot;},{&quot;first_name&quot;:&quot;Chiara&quot;,&quot;last_name&quot;:&quot;Giacomelli&quot;},{&quot;first_name&quot;:&quot;Lorenzo&quot;,&quot;last_name&quot;:&quot;Botta&quot;},{&quot;first_name&quot;:&quot;Salvatore&quot;,&quot;last_name&quot;:&quot;Di Maro&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Messere&quot;},{&quot;first_name&quot;:&quot;Vincenza&quot;,&quot;last_name&quot;:&quot;Ciaramella&quot;},{&quot;first_name&quot;:&quot;Sabrina&quot;,&quot;last_name&quot;:&quot;Taliani&quot;},{&quot;first_name&quot;:&quot;Luciana&quot;,&quot;last_name&quot;:&quot;Marinelli&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Letizia Trincavelli&quot;},{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;Martini&quot;},{&quot;first_name&quot;:&quot;Ettore&quot;,&quot;last_name&quot;:&quot;Novellino&quot;},{&quot;first_name&quot;:&quot;Fortunato&quot;,&quot;last_name&quot;:&quot;Ciardiello&quot;},{&quot;first_name&quot;:&quot;Sandro&quot;,&quot;last_name&quot;:&quot;Cosconati&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;7447-7458&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00794&quot;},&quot;abstract&quot;:&quot;Tyrosine kinase inhibitors (TKIs) of the EGF receptor (EGFR) have provided a significant improvement in the disease outcome of nonsmall cell lung cancer (NSCLC). Unfortunately, resistance to these agents frequently occurs, and it is often related to the activation of the Hedgehog (Hh) and MET signaling cascades driving the epithelial-to-mesenchymal transition (EMT). Because the concomitant inhibition of both Hh and MET pathways restores the sensitivity to anti-EGFR drugs, here we aimed at discovering the first compounds that block simultaneously MET and SMO. By using an “in silico drug repurposing” approach and by validating our predictions both in vitro and in vivo, we identified a set of compounds with the desired dual inhibitory activity and enhanced antiproliferative activity on EGFR TKI-resistant NSCLC. The identification of the known MET TKIs, glesatinib and foretinib, as negative modulators of the Hh pathway, widens their application in the context of NSCLC.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00794&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00794" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00794&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00794" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00794&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00794" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00794&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00794&amp;href=/doi/10.1021/acs.jmedchem.7b00794" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00794" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00794" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00794%26sid%3Dliteratum%253Aachs%26pmid%3D28787156%26genre%3Darticle%26aulast%3DMorgillo%26date%3D2017%26atitle%3DDual%2BMET%2Band%2BSMO%2BNegative%2BModulators%2BOvercome%2BResistance%2Bto%2BEGFR%2BInhibitors%2Bin%2BHuman%2BNonsmall%2BCell%2BLung%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D17%26spage%3D7447%26epage%3D7458%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (11)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290951" title="Soil organic matter">Soil organic matter</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/jmcmar.2017.60.issue-17/20170914/jmcmar.2017.60.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Tyrosine kinase inhibitors (TKIs) of the EGF receptor (EGFR) have provided a significant improvement in the disease outcome of nonsmall cell lung cancer (NSCLC). Unfortunately, resistance to these agents frequently occurs, and it is often related to the activation of the Hedgehog (Hh) and MET signaling cascades driving the epithelial-to-mesenchymal transition (EMT). Because the concomitant inhibition of both Hh and MET pathways restores the sensitivity to anti-EGFR drugs, here we aimed at discovering the first compounds that block simultaneously MET and SMO. By using an “in silico drug repurposing” approach and by validating our predictions both in vitro and in vivo, we identified a set of compounds with the desired dual inhibitory activity and enhanced antiproliferative activity on EGFR TKI-resistant NSCLC. The identification of the known MET TKIs, glesatinib and foretinib, as negative modulators of the Hh pathway, widens their application in the context of NSCLC.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nonsmall cell lung cancer (NSCLC) is the major cause of cancer-related deaths worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The primary reason for this poor outcome is the presence of metastatic dissemination in a high proportion of patients at diagnosis. The critical step in the development of metastasis and acquisition of resistance to existing cytotoxic and targeted agents, including EGFR-TKIs, is the epithelial-to-mesenchymal transition (EMT) process. EMT is characterized by a switch from an epithelial phenotype of polarized cells, with the expression of epithelial markers such as E-cadherin, to a mesenchymal phenotype of cells that lack polarity, that are motile, and have E-cadherin down-regulation. This phenomenon has been extensively studied, and measures to reverse EMT are awaited to enhance the therapeutic efficacy of anticancer drugs against NSCLC.</div><div class="NLM_p">In this scenario, the Hedgehog (Hh) signaling cascade has recently emerged as an important mediator of cancer development and metastatic progression.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The Hh pathway regulates these processes through the induction of EMT. This pathway is comprised of the ligands Sonic, Indian, and Desert hedgehog (Shh, Ihh, Dhh, respectively), the cell surface protein Patched (PTCH) and the Frizzled G protein-coupled receptor (GPCR) Smoothened (SMO). In the absence of Hh ligands, PTCH inhibits SMO, while, upon ligand binding to PTCH, SMO is activated, triggering the GLI1 transcription factor, which in turn migrates into the nucleus, leading to the expression of Hh-induced genes. Hh has been demonstrated to be active in human embryogenesis and in tissue repair as well as in cancer stem cell renewal and survival. This pathway is also critical for lung development, while its aberrant reactivation is implicated in cellular response to injury and cancer growth.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Recently, alterations (mutation, amplification, mRNA overexpression) of the gene encoding for SMO have been investigated in The Cancer Genome Atlas (TCGA) lung adenocarcinomas by whole exome sequencing and were observed in 12.2% of lung tumors. The incidence of SMO mutations was 2.6% and SMO gene amplifications were found in 5% of cases.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Similarly, the overexpression of the receptor tyrosine kinase MET, also called hepatocyte growth factor receptor (HGFR), and/or its activation has been demonstrated to be a crucial mediator of the EMT process and has been implicated in resistance to chemotherapy and to anti-EGFR TKIs. Several MET TKIs inhibitors have been evaluated in phase II/III clinical studies in NSCLC patients, with controversial results.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Most probably, blocking MET alone is not sufficient to revert the resistant phenotype as this latter is implicated in several intracellular interactions and the best way to overcome resistance is a combined approach, where the concomitant inhibition of MET and Hh pathways is performed.</div><div class="NLM_p">In this respect, we have recently demonstrated the occurrence of SMO gene amplification, MET activation, and a functional interaction of these two signaling pathways in a model of EGFR-mutated TKI-resistant NSCLC cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In the same cell model, inhibition of SMO in combination with MET inhibition significantly reduced cancer cell proliferation, induced apoptosis, blocked the invasive and migratory behavior, and induced the complete regression of 100% of tumors xenografted in nude mice.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Moreover, blockade of Hh pathway reverted EMT and was also associated with enhanced tumor sensitivity to cytotoxic agents in EGFR-wild-type NSCLC models.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Consistently, recent data demonstrated that aberrant activation of the Hh pathway represented also a common feature, along with EMT, in an in vivo model of acquired resistance to EGFR-inhibitors obtained with a sequence of first-generation (erlotinib), second-generation (afatinib), and third-generation (osimertinib) EGFR TKIs.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">The synergistic interaction of Hh and MET pathways strongly supports the rationale for a combined therapy in order to overcome resistance to EGFR TKIs. On the other hand, despite the established pharmacological significance of combination therapies, several advantages can be envisaged with the employment of rationally discovered compounds that are able to simultaneously hit two different pharmacological targets<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> such as a better description of the pharmacokinetic profile compared to combination therapy, diminished risks of drug–drug interactions, and a simplified dosing scheduling. On the other hand, multitarget compounds might indeed display a degree of target promiscuity resulting in unexpected adverse effects that could lead to late attrition in the drug discovery pipeline. To this end, repurposing of known drugs, with an already described toxicological profile, might indeed offer an attractive opportunity in the search of multitarget ligands.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">In this context, the aim of the present study was to rationally discover a set of antiproliferative compounds able to simultaneously block MET and SMO receptors. To this end, we wanted to merge the advantages of the drug repurposing strategy,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> which searches for novel indications, mechanism of action, and/or pharmacological targets of already existing drugs, with the predictive power of theoretical docking-based virtual screening (VS). Through this “in silico drug repurposing approach”, we selected, among 1911 MET-inhibitors, a set of 12 promising compounds for their potential dual inhibitory activity against MET and SMO, which were validated in in vitro and in vivo models of resistance to anti-EGFR TKIs.</div><div class="NLM_p last">This strategy allowed us to identify two compounds that are currently in clinical trials, as new inhibitors of the Hh pathway, in addition to the already known AXL and MET inhibitory properties. The potent antitumor activity in vitro and in vivo in a NSCLC model of EGFR-acquired resistance potentially expands the indications for these two drugs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63385" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63385" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> In Silico Identification of Known MET Inhibitors as New SMO Binders</h3><div class="NLM_p">To identify MET inhibitors, which might show interesting affinities at the SMO receptor and vice versa, we took advantage of a public domain repository of compound structures and activity data, the BindingDB database.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Thus, a set of 1911 known selective, as well as unselective MET inhibitors, was virtually docked against the available SMO receptor X-ray structures by following a protocol that we recently devised to optimize the performances of structure-based VS against SMO receptor.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> By following this protocol, we were able to rank the inspected compounds for their predicted affinity against the SMO receptor.</div><div class="NLM_p">A critical step of a VS campaign is the postdocking selection of the compounds to experimentally test. To this end, we first decided to in silico characterize the theoretical interaction pattern established by known SMO antagonists and the published structures for this receptor. Therefore, as happened for the MET inhibitors, a collection of 412 SMO antagonists was also obtained by interrogating the BindingDB database.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Thus, by following the above-mentioned docking protocol for these latter compounds, the binding pose within the SMO receptor was calculated. These results were subsequently analyzed through an interaction fingerprints routine (see Materials and Methods), thereby allowing us to detect which SMO residues are predicted to be more frequently contacted by the known antagonists for this receptor. According to this inspection, the SMO D384, Y394, R400, and E518 residues are the most frequently contacted ones. Interestingly, also mutagenesis experiments outlined the importance of the above-mentioned residues for SMO antagonist binding.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The same interaction pattern was also observed for the docked MET inhibitors within the SMO receptor, thereby substantiating our initial design hypothesis. Parts a and b of <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> depict the interaction fingerprints obtained for the two docking experiments (SMO antagonists against SMO receptor and MET inhibitors against the same receptor, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a,b, respectively). In addition, analysis of the X-ray antagonist/SMO structures also outlined that N219, F484, and W281 receptor residues provide additional anchoring points for cocrystallized antagonists.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Interaction fingerprints calculated through docking experiments for SMO antagonists (a) and MET inhibitors (b) with the four SMO receptor structures. The most frequently contacted residues are labeled. (c) Structures of the MET inhibitors identified as potential SMO antagonists along with their IC<sub>50</sub> or <i>K</i><sub>d</sub> values. For each MET inhibitor, the reported IC<sub>50</sub> or <i>K</i><sub>d</sub> values correspond to the ones indicated in the paper where they were first published. For compound <b>1</b>, see ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>; for compounds <b>2</b>, <b>4</b>, and <b>9</b>, ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>; for compounds <b>3</b>, <b>5</b>, <b>6</b>, <b>7</b>, <b>8</b>, <b>10</b>, <b>11</b>, and <b>12</b>, see refs <a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20 ref21 ref22">16−22</a>, and <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Thus, in our theoretical model, we further filtered out the docked MET inhibitors for which no favorable contacts with the above-mentioned SMO residues were predicted. Of the remaining 421 compounds, 25 were commercially available and, of the latter, we decided to select only those whose MET inhibitory potency and or affinity were reported to be at least in the midmicromolar regimen. This additional filter allowed selecting 12 inhibitors that were finally purchased from different vendors and then checked for compound composition and purity (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">Supporting Information</a>). The selected inhibitors along with their reported inhibitory activity and/or affinity against MET are reported in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>c.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Selected MET Inhibitors Bind and Antagonize SMO Receptor</h3><div class="NLM_p">The affinity of the selected compounds toward SMO protein was evaluated by radioligand binding competition studies using [<sup>3</sup>H]-cyclopamine ((2′<i>R</i>,3<i>S</i>,3′<i>R</i>,3′a<i>S</i>,6′<i>S</i>,6a<i>S</i>,6b<i>S</i>,7′a<i>R</i>,11a<i>S</i>,11b<i>R</i>)-1,2,3,3′a,4,4′,5′,6,6′,6a,6b,7,7′,7′a,8,11,11a,11b-octadecahydro-3′,6′,10,11b-tetramethyl-spiro[9<i>H</i>-benzo[<i>a</i>]fluorene-9,2′(3′<i>H</i>)-furo[3,2-<i>b</i>]pyridin]-3-ol, <b>13</b>, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">Chart S1</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> For this purpose, we used the EGFR exon 19 deletion mutant (delE746-A750) HCC827-GR human NSCLC cell line made resistant to gefitinib in vitro, which we previously characterized for SMO and MET expression.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The HCC827-GR cell line presents <i>SMO</i> gene amplification and MET pathway overexpression and activation.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In particular, NGS analysis of this cell line showed a 47% allelic frequency of V404 M mutation in the <i>SMO</i> gene as compared to the parental HCC827, which showed an allelic frequency of 0.1%, indicating the selection of an SMO mutated resistant clone during acquisition of resistance to gefitinib. The affinity dissociation constant (<i>K</i><sub>d</sub>) of [<sup>3</sup>H]-<b>13</b> in HCC827-GR cells overexpressing the SMO receptor was 36.9 ± 8.9 nM and a <i>B</i><sub>max</sub> of 1567 ± 61 fmol/mg, as obtained by saturation binding studies (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SMO binding analysis. Saturation assay of [<sup>3</sup>H]-<b>13</b> binding to HCC827-GR cells. Cells were incubated 4 h at RT in binding buffer containing increasing concentrations of [<sup>3</sup>H]-<b>13</b>. Nonspecific binding was determined in the presence of 25 μM of compound <b>14</b>. Scatchard plot analysis of the specific binding. Data are means ± SEM (<i>n</i> = 3) of a representative experiment over three independent experiments. The ability of each of the 12 potential dual inhibitors to displace 25 nM [<sup>3</sup>H]-<b>13</b> specific binding is reported in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The SMO antagonist vismodegib (2-chloro-<i>N</i>-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide, <b>14</b>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">Chart S1</a>) showed a <i>K</i><sub>i</sub> value of 12.2 ± 1.7 nM in accordance with literature data.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Some of the compounds (compounds <b>1</b>, <b>2</b>, <b>4</b>, and <b>6</b>) were not able to completely displace the radiolabeled ligand when tested at a 10 μM concentration. On the contrary, compounds <b>3</b>, <b>5</b>, and <b>7</b>–<b>12</b> demonstrated the ability to compete with the [<sup>3</sup>H]-<b>13</b> for the SMO binding site with an affinity in the nanomolar range (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In particular, compounds <b>5</b> and <b>11</b> were demonstrated to be comparably efficient in inhibiting MET and binding SMO. For these latter inhibitors, we also demonstrated that a similar affinity was recorded for the wild-type SMO receptor (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b), indicating that the V404 M SMO mutation does not affect drug affinity. <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> reports the binding mode of compounds <b>3</b>, <b>5</b>, and <b>7</b>–<b>12</b> in the SMO receptor (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">Figures S1–S8</a> in Supporting Information for the 2D diagrams of the calculated complexes).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Experimental Binding Affinity of Compounds <b>1</b>–<b>14</b> towards V404M Mutant SMO Receptor in HCC827-GR Cells and of Compounds <b>5</b> and <b>11</b> on WT SMO Receptor in HEK293T Cells<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>i</sub> V404 M SMO (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> wt SMO (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">168.1 ± 21.9</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="±">53.1 ± 9.9</td><td class="colsep0 rowsep0" align="center">41.7 ± 8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="±">46.5 ± 6.3</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="±">187.8 ± 36.9</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char="±">50.4 ± 11.8</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char="±">46.2 ± 11.7</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">66.8 ± 7.0</td><td class="colsep0 rowsep0" align="center">59.7 ± 9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char="±">87.6 ± 12.4</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">51.0 ± 8.4</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">12.2 ± 1.7</td><td class="colsep0 rowsep0" align="center">nd</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">nd: not determined.</p></div></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Predicted binding pose of compound <b>3</b>, <b>5</b>, and <b>7</b>–<b>12</b> in the SMO X-ray structure. Compounds are represented as green sticks, while receptor as orange sticks and transparent white ribbons. H-bonds are represented as dashed yellow lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because GLI1 is a SMO regulated transcription factor,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> we tested the functional significance of treatment with MET inhibitors that demonstrated the highest ability to displace <b>13</b> from binding to the SMO receptor on GLI1 activity by using a GLI1-responsive promoter within a luciferase reporter expression vector. In particular, we performed a dose-dependent analysis of luciferase activity in HCC827-GR cell line (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Treatment with 2 μM (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a) or 60 μM (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b) of each compound resulted, respectively, in a 25–50% and in a 10–100% decrease in GLI1-responsive promoter compared with the HCC827-GR untreated cells (<i>p</i> < 0.001).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. GLI1-driven luciferase expression in HCC827-GR cells during treatment with compounds <b>3</b>, <b>5</b>, and <b>7</b>–<b>12</b> at 2 (a) and 60 μM (b) and in combination with SAG at a concentration of 100 nM. CTR bars represent the response obtained for HCC827-GR untreated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">These data demonstrate that the tested MET inhibitors have a SMO antagonist activity in a concentration-dependent manner. Furthermore, to test if the effect of the selected compounds on GLI1 activity was mediated by SMO antagonism, we analyzed the ability of the SMO agonist SAG (100 nM) [<i>N</i>-methyl-<i>N</i>′-(3-pyridinylbenzyl)-<i>N</i>′-(3-chlorobenzo[<i>b</i>]thiophene-2-carbonyl)-1,4 diaminocyclohexane]<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> to revert this effect. Interestingly, in the presence of SAG, the induced inhibition of GLI1 activity was completely reverted in almost all treatments at a 2 μM concentration of compounds <b>3</b>, <b>5</b>, and <b>7</b>–<b>12</b> (<i>p</i> < 0.01) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a) and partially reverted at a 60 μM concentration (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b), confirming that the selected MET inhibitors antagonize the SMO receptor function.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Dual MET/SMO Inhibitors Are Potent Antiproliferative Agents in EGFR-TKI Resistant Human NSCLC</h3><div class="NLM_p">We then selected, among the 12 potential dual inhibitors, compounds <b>5</b> and <b>11</b> as the most active MET inhibitors with the most potent activity also on SMO. Moreover, we also kept compounds <b>6</b> (significant inhibitory activity against MET and no binding at SMO receptor) and <b>9</b> (weak MET inhibitor and nanomolar affinity for SMO) as negative controls. Of interest, compound <b>5</b> was identified as glesatinib (<i>N</i>-[(3-fluoro-4-{[2-(5-{[(2-methoxyethyl)amino]methyl}pyridin-2-yl)thieno[3,2-<i>b</i>]pyridin-7-yl]oxy}phenyl)carbamothioyl]-2-(4-fluorophenyl)acetamide),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> MGCD265,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Mirati Therapeutics), a tyrosine kinase inhibitor of MET and AXL, and compound <b>11</b> as foretinib (<i>N</i>1′-[3-fluoro-4-[[6-methoxy-7-(3-morpholinopropoxy)-4-quinolyl]oxy]phenyl]-<i>N</i>1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, XL880, Exelixis, GSK1363089, GlaxoSmithKline),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> known as a MET and VEGFR2 inhibitor, with activity against AXL.</div><div class="NLM_p">We analyzed the activity of <b>5</b> and <b>11</b> in the <i>EGFR</i>-mutated HCC827-GR NSCLC cells with the already described amplification of SMO and overexpression of MET and displaying a typical mesenchymal behavior.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In this model, as already demonstrated, activation of AXL (phospho-AXL), which is a known pathway responsible for the acquisition of resistance to anti-EGFR TKIs and mediator of EMT,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and another signaling pathway potentially activated as a resistance mechanism, was not significantly high as compared to sensitive cell models.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">We first evaluated the antiproliferative effects at different concentrations of <b>5</b> and <b>11</b> by using an MTT assay. To compare the effects of each compound with those obtained with specific SMO and MET inhibitors, we also treated the same cancer cells with sonidegib (<i>N</i>-[6-[(2<i>S</i>,6<i>R</i>)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide, NVP-LDE225, SMO antagonist with no reported inhibitory activity against MET, Novartis, <b>15</b>, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">Chart S1</a>)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and PHA-665752 ((3<i>Z</i>)-5-[(2,6-dichlorophenyl)methylsulfonyl]-3-{[3,5-dimethyl-4-[(2<i>R</i>)-2-(pyrrolidin-1-ylmethyl)pyrrolidine-1-carbonyl]-1<i>H</i>-pyrrol-2-yl]methylidene}-1<i>H</i>-indol-2-one, MET inhibitor with no reported activity against SMO, Pfizer, <b>16</b>, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">Chart S1</a>)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> as single agents and in combination. In addition, down-regulation of MET and SMO mRNA levels was performed with silencing-RNA technology. By using drug concentrations ranging from 0.01 to 5 μM, treatment with <b>5</b> or <b>11</b> resulted in a dose-dependent inhibition of cancer cell growth and showed the lowest IC<sub>50</sub> values (0.08 and 0.5 μM, respectively, for <b>5</b> and <b>11</b>) (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Biological activity of experimental compounds on the HCC827-GR NSCLC cell line. (a) MTT proliferation assay performed on NSCLC HCC827-GR cells with the indicated treatments. The results are the average ± SD of three independent experiments, each done in triplicate. (b) Apoptosis was evaluated as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> with annexin V staining in HCC827-GR cancer cells, which were treated with the indicated concentration of drugs. Columns, mean of three identical wells of a single representative experiment; bars, top 95% confidence interval.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>6</b> and <b>9</b> resulted in higher IC<sub>50</sub> values, while the selective inhibition of MET or SMO, by pharmacological or mRNA silencing approaches, did not exert comparable effects. Of interest, <b>5</b> and <b>11</b> performed even better than combined treatment with <b>15</b> and <b>16</b> or the double silencing of SMO and MET in resistant cells.</div><div class="NLM_p">We further asked whether the increased antiproliferative effect induced by <b>5</b> and <b>11</b> would be the result of an increased apoptosis. Therefore, we analyzed the induction of apoptosis in the EGFR-mutated HCC827-GR cell line after 72 h treatment. As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b, flow cytometric analysis revealed that treatment with compound <b>5</b> and <b>11</b> significantly increased by several-fold the percentage of apoptotic cells in all tested cell lines. For instance, in HCC827-GR cells, <b>5</b> induced the higher apoptotic rate with a 62% and 84% apoptotic rate at 0.1 and 0.5 μM, respectively (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b), compared to the apoptotic rate of 50 and 65% obtained with the combination of <b>15</b> and <b>16</b> (<i>P</i> < 0.001; <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b).</div><div class="NLM_p">Interestingly, comparative antiproliferative activities were recorded when testing <b>5</b> and <b>11</b> on an EGFR-wild-type H1299 adenocarcinoma NSCLC line, which overexpresses both SMO and MET receptors and is resistant to cisplatin treatment (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">Supporting Information</a>). Nevertheless, it should be mentioned that in this case the antiproliferative activity exerted by <b>5</b> and <b>11</b> should not only be ascribed to the concurrent inhibition of SMO and MET. Indeed, in our previous inspection,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> we demonstrated that, in the same cell line, treatment with <b>15</b> and <b>16</b> (MET inhibitor and SMO antagonist, respectively) did not result in an efficient antiproliferative effect. In this respect, it should be outlined that while <b>5</b> and <b>11</b> demonstrated to be also potent AXL inhibitors, <b>15</b> is unable to inhibit this latter kinase. Therefore, it could be postulated that in the EGFR wild-type H1299 adenocarcinoma NSCLC line, the triple MET/SMO/AXL inhibition might be responsible for the enhanced antiproliferative activity of <b>5</b> and <b>11</b>. Indeed, the additional AXL inhibitory potency was also demonstrated to be responsible for the antiproliferative activity of <b>11</b> against HER2-positive breast tumor cells.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> A further support for this hypothesis is provided by a recent paper by Qu et al., demonstrating that AXL is indeed overexpressed in the H1299 adenocarcinoma NSCLC line and that silencing of this kinase inhibited cell proliferation and migration.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> This might also explain why in the HCC827-GR cell lines <b>5</b> and <b>11</b> are slightly more active than the concurrent treatment with <b>15</b> and <b>16</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).</div><div class="NLM_p">To study the influence of <b>5</b> and <b>11</b> on the activation/expression of key signaling mediators, we further characterized the effects of experimental compounds on the intracellular signaling by Western blotting. We used different doses according to the IC<sub>50</sub> of each drug. As illustrated in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>, treatment of HCC827-GR cells with <b>5</b> and <b>11</b>, for 72 h, effectively blocked SMO and MET activation, confirming the dual inhibitory ability of these drugs. In addition, while not affecting the total MAPK and AKT protein levels, treatment with <b>5</b> and <b>11</b> markedly decrease the activated forms of both proteins, confirming our previous results<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> on the cooperation of Hh with MET pathway to the activation of both MAPK and AKT signaling pathways. In addition, vimentin expression, induced during the acquisition of gefitinib resistance, was significantly decreased after <b>5</b> or <b>11</b> treatment, suggesting that the Hh and MET pathways represent a key mediator of EMT in this model.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects on intracellular pathways by experimental compounds. Western blotting analysis of Hh and MET pathways following treatment with the indicated concentration of compound <b>5</b> and <b>11</b> on HCC827-GR NSCLC cell line. Tubulin was included as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Dual MET/SMO Modulators Inhibit Resistant Human NSCLC Tumor Growth in Vivo</h3><div class="NLM_p">We previously demonstrated that the in vivo blockade of the Hh signaling pathway alone, or alternatively the sole MET pathway, is not sufficient to cause a significant delay in tumor growth, whereas the concurrent inhibition of both pathways resulted in a substantial antitumor activity.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We, therefore, tested the efficacy of compounds <b>5</b> and <b>11</b>, as dual inhibitors of SMO and MET, to overcome the acquisition of resistance to the first-generation EGFR TKIs. Thus, HCC827 NSCLC tumor xenografts were implanted in nude mice and treated with gefitinib (<i>N</i>-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine, <b>17</b>, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">Chart S1</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Then, following tumor regrowth as resistance to <b>17</b> was acquired, mice were randomized to receive <b>5</b> or <b>11</b> ± <b>17</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Indeed, treatment with <b>5</b> or <b>11</b> as single agents caused a significant decrease in tumor size. However, combined treatments of <b>17</b> plus <b>5</b> and <b>17</b> plus <b>11</b> significantly suppressed HCC827-<b>17</b> resistant tumor growth, suggesting that keeping the EGFR blockade during inhibition of SMO and MET is an effective strategy to overcome resistance to first-generation EGFR TKIs (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of the treatment with compound <b>5</b> or <b>11</b> alone or in combination with <b>17</b> or <b>18</b> in human NSCLC tumor xenografts resistant to the EGFR-TKI. Mean tumor volumes of human NSCLC tumor xenografts made resistant to (a) <b>17</b> or (b) <b>18</b> and randomized to treatment with the indicated drugs and combinations. Data represent the average (SD). Student <i>t</i> test was used to compare tumor sizes among different treatment groups at day 21 following the start of treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Subsequently, we also wanted to check if a similar strategy might be applied to EGFR-mutated NSCLC models with acquired resistance to third-generation EGFR inhibitors. We, therefore, performed a similar in vivo experiment inducing resistance to the third-generation inhibitor, osimertinib (<i>N</i>-(2-{[2-(dimethylamino)ethyl]-(methyl)amino}-4-methoxy-5-{[4-(1-methyl-1<i>H</i>-indol-3-yl)pyrimidin-2-yl]amino}phenyl)acrylamide, AZD9291, AstraZeneca, <b>18</b>, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">Chart S1</a>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> because analysis on resistant <b>18</b>-tumors harvested from treated mice, similarly to tumors with acquired resistance to <b>17</b>, evidenced an activation of both Hh and MET pathways, highlighting the role of those two pathways also in the resistance of third-generation inhibitors.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Therefore, mice whose tumors are resistant to <b>18</b> treatment were randomized to treatment with <b>5</b> or <b>11</b> as single agents or a combination of <b>5</b> or <b>11</b> with <b>18</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Interestingly, also HCC827-osimertinib resistant tumors resulted in being particularly sensitive to the dual inhibition of MET and SMO and, to a greater extent, to the triple inhibition of MET/SMO/EGFR (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62675" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62675" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our previous work<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> has highlighted the functional interaction of Hh and MET pathways and the importance of blocking both signaling pathways to revert EMT and enhance tumor sensitivity to anti-EGFR NSCLC models.</div><div class="NLM_p">Stimulated by these findings, herein we were challenged to discover the first dual SMO/MET modulators that are able to overcome resistance to therapy in human NSCLC. Indeed, while these two pharmacological targets are unrelated from the structural point of view, they are able to recognize chemotypes that share common structural features. Thus, taking advantage of the published X-ray structures of the antagonist-bound SMO receptor, a stepwise protocol of receptor-based VS was undertaken to in silico select, among a set of known MET inhibitors, the best candidates that can be recognized by the SMO receptor orthosteric binding site. Of the 12 tested compounds, eight demonstrated the ability to displace <b>13</b> with nanomolar potency. These SMO binders were subsequently assayed in functional studies, allowing the demonstration of their capacity to influence the SMO activation status in a concentration-dependent manner. Moreover, the efficacy of these compounds was reverted by the cotreatment with a known SMO agonist, allowing us to further substantiate the antagonist activity of the eight compounds. To the best of our knowledge, this is one of the first examples in which computational methods were successfully employed to rationally discover multitarget compounds hitting proteins belonging to phylogenetically and structurally distant families (namely the Frizzled class F) GPCRs and class IV tyrosine kinases receptors (TKR). Indeed, it should be mentioned that binding and functional assays were confined to the set of 25 compounds that were commercially available. Indeed, a large number of MET inhibitors have been published and screened through our theoretical protocol that would deserve further experimental testing as SMO antagonists but were not considered in the present study because of their unavailability on the market. In this context, this study should also stimulate the biological evaluation of these latter compounds.</div><div class="NLM_p">Prompted by these encouraging data, cell-based experiments were performed in NSCLC cell lines made resistant to the EGFR-TKI <b>17</b>. Strikingly, in this model, <b>5</b> and <b>11</b> were even more effective in achieving an antiproliferative effect than the combination treatment with a pure MET inhibitor and the SMO antagonist as well as the double silencing of the two target proteins. This result might be explained by the ability of <b>5</b> and <b>11</b> to inhibit AXL TKI. In this respect, both drugs were also the most active apoptosis inducers. When tested in vivo, <b>5</b> and <b>11</b> alone significantly decreased the tumor size of human NSCLC xenografts resistant to the EGFR-TKI, and this effect was potentiated by the coadministration with <b>17</b>. This demonstrates that, at least in our model, the triple inhibition of SMO, MET, and EGFR is indeed the most effective strategy to circumvent drug resistance to EGFR TKIs. The same data were also achieved by cotreatment with the selected drugs and third-generation EGFR TKIs, <b>18</b>.</div><div class="NLM_p">Of note, our findings allow unraveling previous results achieved for <b>5</b> and <b>11</b>. In particular, it has been recently reported that <b>5</b>, when used in combination with erlotinib (EGFR-TKI) in a gastric cancer model, impairs the glycolysis pathway also by inhibiting the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) enzyme, thereby suggesting a novel mechanism of action for this drug.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In addition, it has been recently reported that the Hh signaling promotes glucose utilization and glycolysis, thereby accelerating cell proliferation in breast cancer cells, by positively modulating the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) phosphorylation.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In this scenario, our data reconcile the negative modulation of cancer glycolysis exerted by <b>5</b> with its antagonist activity on SMO receptor.</div><div class="NLM_p">On the other hand, <b>11</b> has been demonstrated to efficiently decrease tumor cell proliferation and to induce apoptosis in Hh-driven medulloblastomas. These data were first explained with the ability of this drug to inhibit MET that was proposed to be a marker of the aforementioned tumor.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Herein we suggest that the efficient antiproliferative activity displayed by <b>11</b> should also be ascribed to a direct interaction with the SMO receptor.</div><div class="NLM_p last">In conclusion, in this work, the tandem application of predictive theoretical studies and in-depth in vitro and in vivo evaluation allowed us to identify from a large number of MET inhibitors those that can negatively modulate the SMO receptor and achieve superior antiproliferative effects in a model of resistant NSCLC tumor. In this context, the identification of <b>5</b> and <b>11</b> as negative modulators of the Hh pathway widens the range of action of these drugs in the context of NSCLC improving the already known AXL and MET targeting activity.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Molecular Modeling</h3><div class="NLM_p">Proteins and ligands setup: The structure of the SMO receptor in complex with the antagonists (4-benzyl-piperazin-1-yl)-(3,5-dimethyl-1-phenyl-1<i>H</i>-pyrazol-4-ylmethylene)-amine<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (SANT-1, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N4W">4N4W</a>),<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> 2-(6-(4-(4-benzylphthalazin-1-yl)piperazin-1-yl)pyridin-3-yl)propan-2-ol<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (ANTA XV, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4QIM">4QIM</a>),<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> 4-fluoro-<i>N</i>-methyl-<i>N</i>-(1-(4-(1-methyl-1<i>H</i>-pyrazol-5-yl)phthalazin-1-yl)piperidin-4-yl)-2-(trifluoromethyl)benzamide<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (LY2940680, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKV">4JKV</a>),<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and <b>13</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R">4O9R</a>)<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> were downloaded from the Protein Data Bank and prepared for docking calculations using the “Protein Preparation Wizard” panel of Schrödinger molecular modeling package.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> In particular, using the “pre-process and analyze structure” tool, the bond orders and disulfide bonds were assigned, all the hydrogen atoms were added, and water molecules were deleted. Using Epik 2.0, a prediction of the side chains hetero groups ionization and tautomeric states was performed.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> An optimization of the hydrogen-bonding network was performed using the “H-bond assignment” tool. Finally, using the “impref utility”, the positions of the hydrogen atoms were optimized by keeping all the heavy atoms in place.</div><div class="NLM_p last">A database of known MET ligands (1911 compounds) was subsequently prepared by interrogating the BindingDB database.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Ligands were prepared for docking using LigPrep.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Hydrogen atoms were added, ionizations states were generated, and tautomers were generated to prepare the required structures. All structures were then subjected to minimization using the OPLS-2005 force field. The same preparation was attained for the database of the known SMO antagonists downloaded from the BindingDB site.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Docking Calculations</h3><div class="NLM_p">According to the results of our very recent retrospective study, the employment of the AutoDock Vina docking software<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> when used against the ensemble of all the four receptors gave the best results in terms of enrichment factors (EF) when considering the lowest percentages of the ranked database (25%).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> AutoDock Vina performances and accuracy are assured by a Lamarckian algorithm and an empirical binding free energy force field. Before the actual docking calculations could be run, both the database of ligands and the receptors had to be converted to the pdbqt format. The latter is very similar to a standard pdb but it includes “Q” (partial charges) and “T” atom types. Preparing the structures involves ensuring that its atoms are assigned the correct atom types, adding Gasteiger charges if necessary, merging nonpolar hydrogens, detecting aromatic carbons, and setting up the “torsion tree” in the case of ligands. Thus, the python scripts prepare_receptor4.py and prepare_ligand4.py, part of MGLTools,<a onclick="showRef(event, 'ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51">(-49-51)</a> were employed by applying the standard settings. After the preparation, the docking was performed using the default settings of Vina, setting a box whose center and dimensions were identical to the one used in our previous work.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Results of these calculations produced four different rankings based on the predicted binding free energy (herein referred to as Δ<i>G</i><sub>VINA</sub>), one for each docking attained on the four receptor structures, which were subsequently unified using a parallel selection method. This selection method resulted in a ranking of the screened compounds in which Δ<i>G</i><sub>VINA</sub> values ranged from −6.5 to −14.8 kcal/mol.</div><div class="NLM_p">Interaction fingerprints and interaction matrices of the SMO ligands against SMO receptors and MET ligands against the same receptors were calculated by employing a routine of the Schröedinger 2015 release. The pose filter routine of the same release was used to count the number of interactions predicted for the MET compounds against D384, Y394, R400, E518, N219, F484, and W281 residues.</div><div class="NLM_p">The fingerprint-based algorithm was used to cluster the 511 MET ligands in order to further refine them into 421 compounds. The canvas similarity and clustering, which is also part of the Schrodinger suite, was employed by applying the following settings: the eighth atom typing scheme for the fingerprinting (atoms distinguished by ring size, aromaticity, HB acceptor/donor, ionization potential, whether terminal, whether halogen; bonds distinguished by bond order), Tanimoto as the similarity metric, and average as linkage as the clustering method. The same method (i.e., canvas similarity using the eighth atom typing scheme for the fingerprinting and Tanimoto as the similarity metric) was also used to evaluate the structural similarity between each of the 12 final compounds and any of the SMO antagonist reported in the BindingDB database.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a><a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">Table S2</a> in Supporting Information reports the Tanimoto similarity index between the 12 compounds and the most similar SMO antagonist. These values range from 7.8% to 32%, demonstrating that the selected ligands are structurally unrelated to the SMO antagonists described so far.</div><div class="NLM_p">All of the pictures were rendered with the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p last">Prior to biological evaluation, the 12 compounds were screened for Pan Assay Interference Compounds using the PAINS-Remover web server (<a href="http://www.cbligand.org" class="extLink">http://www.cbligand.org</a>), which is a data analysis tools implemented for removal of PAINS compounds. All compounds passed this filtering with the exception of compound <b>7</b> and <b>9</b>. Compound <b>7</b> features an anil_di_alk_A substructure that is suggested to interfere with AlphaScreen technology, possibly through efficient quenching of singlet oxygen.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> In our case, we performed a radioligand displacement binding assay so no interference is expected. Compound <b>9</b> features an imine_one_isatin substructure, which was found to interfere sometimes with the AlphaScreen technology “for reasons unknown”,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> as stated by the authors. Also in this case, the tested ligand should not interfere with the implemented radioligand displacement binding assay. On the basis of NMR and MS analysis, all tested compounds have a purity ranging from 96 to 98%.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Cell Lines and Drugs</h3><div class="NLM_p last">The human NSCLC HCC827 cell line was provided by American Type Culture Collection (ATCC, Manassas, VA, USA) and maintained in RPMI-1640 (Sigma-Aldrich, Saint Louis, MO, USA) medium supplemented with 10% fetal bovine serum (FBS; Life Technologies, Gaithersburg, MD) in a humidified atmosphere with 5% CO<sub>2</sub>. The identity of all cell lines was confirmed by STR profiling (Promega, Madison, WV, USA) on an ad hoc basis prior to performing experiments. HCC827-GR (gefitinib resistant) cell line was obtained in vitro, as previously described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Briefly, over a period of 12 months, HCC827 cells were continuously exposed to increasing doses of <b>17</b>, starting from an IC<sub>50</sub> dose that represented the dose to inhibit the growth of 50% of cells. HCC827-GR cells were maintained in culture with the maximum <b>17</b> dose that allowed cellular proliferation. The identity of cells was verified by STR profiling (Promega) on an ad hoc basis prior to performing experiments and repeated for all cell lines after a majority of the experiments were performed. Drugs gefitinib and sonidegib were purchased from Selleck Chemicals (Selleckchem, Houston, TX, USA). <b>18</b> was generously provided by Astra Zeneca.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> SMO Radioligand Binding Assays</h3><div class="NLM_p">Prior to binding experiments, all purchased compounds were analyzed to confirm the sample composition by LC/MS and <sup>1</sup>H NMR experiments. The binding experiments were performed as previously described with few modifications.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Briefly, HCC827-GR cells expressing V404 M SMO receptors were grown in 24-well plates (100000 cells/well) and fixed with 4% (v/v) formaldehyde/PBS for 20 min at room temperature (RT). Cells were subsequently incubated for 4 h at RT in binding buffer (Hanks Balanced Salt Solution (HBSS) without Ca<sup>2+</sup> and Mg<sup>2+</sup> with glucose 1 g/L). Saturation binding experiments were performed using different [<sup>3</sup>H]-<b>13</b> (American Radiolabeled Chemicals, Inc. Art. 1473 a.s. 20 Ci/mmol) concentrations ranging from 0.1 to 500 nM; in competition binding experiments cells were incubated with 25 nM [<sup>3</sup>H]-<b>13</b> and different concentrations of the compounds. Nonspecific binding was determined in the presence of 25 μM of compound <b>14</b>. Incubations were terminated by rapid washing with 1 mL of binding buffer for three times. Then, the bound [<sup>3</sup>H]-<b>13</b> was extracted in 200 μL of 0.1 N NaOH for 12 h and neutralized with 200 μL of 0.1 N HCl. The amount of [<sup>3</sup>H]-<b>13</b> in the extracts was measured using a scintillation counter. For the active compounds, the IC<sub>50</sub> values were determined and <i>K</i><sub>i</sub> values were derived in accordance with the equation of Cheng and Prusoff.</div><div class="NLM_p last">The affinity of the compounds for the wild-type SMO was performed as previously described with few modifications.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Briefly, 15 μg of HEK293T-WT SMO membranes (Multispan Inc., Cod. MC1442; K<sub>d</sub> = 20 nM; <i>B</i><sub>max</sub> = 6.2 pmol/mg protein) were incubated for 4 h at RT in binding buffer (HEPES 50 mM, MgCl<sub>2</sub> 5 mM and BSA 0.02%) containing 25 nM [<sup>3</sup>H]-<b>13</b> (American Radiolabeled Chemicals, Inc. Art. 1473 a.s. 20 Ci/mmol) and different concentrations of the compounds. Nonspecific binding was determined in the presence of 25 μM of compound <b>14</b>. The bound radioactivity was separated by rapid filtration through GF/C glass fiber filters presoaked for 2 h in 0.3% polyethylenimine pH 13.0 and washed three times with 4 mL of ice-cold phosphate-buffered saline with 0.01% Triton X-100, pH 7.0. Radioactivity was measured by liquid scintillation spectrometry. Dose–response curves are reported in Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">Figures S8 and S9</a>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Luciferase Assay</h3><div class="NLM_p">Here, we performed GLI1 luciferase assay to test the influence of selected compounds on GLI1 activity in HCC827-GR cells by using the Dual-Luciferase Assay system (Promega), following the manufacturer’s protocol. For each experiment, a total of 5 × 10<sup>5</sup> cells were seeded in FBS-free medium in 24-well plates and transfection started when cells reach a confluency of 50%. We cotransfected the cells with the GLI1-Luc reporter plasmid (400 ng/well), kindly provided by Dr. Mariolina Castellone<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (University of Naples Federico II) and pRL-TK, Renilla reporter, encoding the Renilla luciferase (Promega), to normalize the results. In GLI1 reporter vector, the transcription of Firefly luciferase gene is under the control of a promoter region specific for the transcription factor GLI1, so GLI1 luciferase activity correlates with the binding of GLI1 to its promoter region; in control reporter, Renilla luciferase activity depends on a constitutive promoter (thymidine kinase). The transfection was done in triplicate using Lipofectamine 2000 (provided by Thermo Fisher Scientific) as transfection reagent according to manufacturer’ instructions. The medium of transfection was replaced after 8 h with culture medium, containing the indicated MET ligands or without the SMO agonist SAG (100 nM) [<i>N</i>-methyl-<i>N</i>′-(3-pyridinylbenzyl)-<i>N</i>′-(3-chlorobenzo[<i>b</i>]thiophene-2-carbonyl)-1,4-diaminocyclohexane], purchased from Sigma-Aldrich.</div><div class="NLM_p">Firefly luciferase is a protein from <i>Photinus pyralis</i> that reacts with its substrate (beetle luciferin, ATP, magnesium, and molecular oxygen),creating luminescence, measured by the luminometer Autolumat LB 953 (EG&G, Berthold, Bad Wildbad, Germany). According to the protocol of the kit Dual-Luciferase Reporter Assay System (Promega), after about 48 h from transfection, we removed the medium and washed once with PBS. Then, we added 100 μL of lysis buffer 1× in each well, shaking for 20 min at RT, and finally scraped.</div><div class="NLM_p last">For the measurement of GLI1 luciferase activity, we mixed by pipetting 30 μL of lysated cells and 30 μL of Luciferase Assay Reagent, containing its substrate for reaction. After the reading at luminometer and the record of data, we added 30 μL of Stop and Glo Reagent, which blocked GLI1 induced Firefly luciferase signal and contained Renilla luciferase substrate and repeated the luminometer measurement to obtain the control values. For the analysis of data, we calculated the average values of GLI1 luciferase signal, normalized to Renilla luciferase values, and represented the results as fold change with respect to control cells and cells transfected with the empty vector; results were the average of three independent experiments.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Protein Expression Analysis</h3><div class="NLM_p last">Protein lysates were obtained by homogenization in RIPA lysis buffer (0.1% sodium dodecyl sulfate (SDS), 0.5% deoxycholate, 1% Nonidet, 100 mmol/L NaCl, 10 mmol/L Tris-HCl (pH 7.4), 0.5 mmol/L dithiothreitol, and 0.5% phenylmethylsulfonyl fluoride, protease inhibitor cocktail (Hoffmann-La Roche), and clarification by centrifugation at 14000 rpm for 10 min a 4 °C. Cancer cells were lysed with Tween-20 lysis buffer (50 mmol/L HEPES, pH 7.4, 150 mmol/L NaCl, 0.1% Tween-20, 10% glycerol, 2.5 mmol/L EGTA, 1 mmol/L EDTA, 1 mmol/L DTT, 1 mmol/L phenylmethylsulfonyl fluoride, and 10 μg/mL of leupeptin and aprotinin). Protein lysates containing comparable amounts of proteins, estimated by a modified Bradford assay (Bio-Rad), were subjected to Western blot analysis as previously described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Immunocomplexes were detected with the enhanced chemiluminescence kit ECL plus, by Thermo Fisher Scientific (Rockford, IL). Desired proteins were probed with corresponding antibodies. Primary antibodies for Western blot analysis against p-MAPK44/42 (Thr202/Tyr204), MAPK44/42, p-AKT (Ser473), AKT, p-MET (Tyr1234/1235), MET, SMO, and GLI1 were obtained from Cell Signaling Technology; monoclonal anti-α-tubulin antibody (T8203) from Sigma Chemical Co. The following secondary antibodies from Bio-Rad were used: goat antirabbit IgG and rabbit antimouse IgG. Immunoreactive proteins were visualized by enhanced chemiluminescence (ECL plus; Thermo Fisher Scientific). Each experiment was done in triplicate.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Cell Proliferation Assays</h3><div class="NLM_p last">Cancer cells were seeded in 96-multiwell plates and were treated with different doses of indicated drugs for 72 h. Cell proliferation was measured with the MTT assay, as previously described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> IC<sub>50</sub> values were determined by interpolation from the dose–response curves. Results represent the median of three separate experiments, each performed in quadruplicate. Synergism was calculated with ComboSyn software, ComboSyn Inc., Paramus, NK. 07652 USA.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> RNA Silencing</h3><div class="NLM_p last">The small inhibitor duplex RNAs (siRNA) (ON-target plus SMARTpool) siSMO, siMET, and siCONTROL Nontargeting Pool (no. D-001206-13-05), used as a negative (scrambled) control, were provided from Dharmacon (Lafayette, CO). Cells were transfected with 100 nM siRNAs using Dharmafect reagent following manufacturer’s instructions. The day before transfection, the cells were plated in 35 mm dishes at 40% of confluence in medium supplemented with 5% FBS without antibiotics. Where necessary, cells were treated with different compounds, as previously described; 24 h before harvesting and cell proliferation or Western blot analysis were then performed.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Assessment of Apoptosis</h3><div class="NLM_p last">Apoptosis was detected by flow cytometry via the examination of altered plasma membrane phospholipid packing by lipophilic dye annexin V as described elsewhere.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Briefly, treated cells were harvested by trypsin, washed twice with PBS, and were then resuspended in binding buffer at a concentration of 1 × 10<sup>6</sup> cells/mL according to the manufacturer’s instruction. Thereafter, 5 μL of annexin V-FITC and 5 μL of propidium iodide were added into 100 μL of cell suspension and incubated for 30 min at room temperature in the dark. After adding 400 μL of binding buffer, labeled cells were counted by flow cytometry within 30 min. All early apoptotic cells (annexin V, positive; propidium iodide, negative), necrotic/late apoptotic cells (double positive), as well as living cells (double negative), were detected by FACSCalibur flow cytometer and subsequently analyzed by Cell Quest software (Becton Dickinson). Argon laser excitation wavelength was 488 nm, whereas emission data were acquired at wavelength 530 nm (FL-1 channel) for FITC and 670 nm (FL-3 c3 channel) for propidium iodide.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> In Vivo Experiments</h3><div class="NLM_p last">The 4–6-week old female balb/c athymic (nu/nu) mice were purchased from Charles River Laboratories. The research protocol was approved and mice were maintained in accordance with the Institutional Guidelines of the University of Campania Luigi Vanvitelli Animal Care and Use Committee. Mice were acclimatized for 1 week before being injected with cancer cells and injected subcutaneously with 10<sup>7</sup> HCC827 cells that had been diluted in 200 μL of Matrigel (Corning Life Sciences, MA, USA), 1:1 in the culture medium. For induction of resistance to <b>17</b> or <b>18</b>, when tumors reached a mean volume of 150 mm<sup>3</sup>, mice were treated with escalating doses of <b>17</b> (from 18.7 to 150 mg/kg/day: 3 weeks with 18.7 mg/kg/day, 3 weeks with 37.5 mg/kg/day, 3 weeks with 75 mg/kg/day, and last the 3 weeks with 150 mg/kg/day) or <b>198</b> (with the same protocol of escalating doses every 3 weeks: 5 mg/kg/day for the first 3 weeks, 10 mg/kg/day for following 3 weeks, 17.5 mg/kg/day for subsequent 3 weeks, and 25 mg/kg daily for last 3 weeks orally) over 4 months to derive <b>17</b>/<b>18</b>-resistant tumors (defined as >25% regrowth from max reduction). At the end of treatment period, resistant tumors were randomized into one of the following four arms: control, <b>5</b>, <b>11</b>, <b>17</b>/<b>18</b> plus <b>5</b>, and <b>17</b>/<b>18</b> plus <b>11</b>. <b>17</b> and <b>18</b> were continued at maximum dose reached before resistance, and <b>5</b> and <b>11</b> were used as single agents and in combination at fixed doses of 15 and 20 mg/kg/day orally, respectively. Body weight and tumor volume were monitored on alternate days. Tumor volume was measured using the formula π/6 larger diameter × (smaller diameter).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Characterization of the pharmacokinetics of <b>11</b> have been already reported by Faria et al., demonstrating that this compound reaches the maximum plasma concentration after 5 h from oral administration.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Characterization of the pharmacokinetics of <b>5</b> demonstrated that this drug reaches a plasma concentration of 0.8 μM when orally administered in mice (20 mg/kg).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00794">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00794" class="ext-link">10.1021/acs.jmedchem.7b00794</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Binding affinities, Tanimoto similarity index, ligand interactions, and compound characterization (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>3</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N4W">4N4W</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>5</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R">4O9R</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>6</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R">4O9R</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_005.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>7</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N4W">4N4W</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_006.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>8</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R">4O9R</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_007.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>11</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKV">4JKV</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_008.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>9</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKV">4JKV</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_009.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>12</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N4W">4N4W</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_010.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>10</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R">4O9R</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_011.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf">jm7b00794_si_001.pdf (2.26 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_002.csv">jm7b00794_si_002.csv (0.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_003.pdb">jm7b00794_si_003.pdb (213.03 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_004.pdb">jm7b00794_si_004.pdb (274.65 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_005.pdb">jm7b00794_si_005.pdb (274.65 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_006.pdb">jm7b00794_si_006.pdb (213.95 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_007.pdb">jm7b00794_si_007.pdb (274.73 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_008.pdb">jm7b00794_si_008.pdb (213.1 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_009.pdb">jm7b00794_si_009.pdb (212.1 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_010.pdb">jm7b00794_si_010.pdb (213.18 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_011.pdb">jm7b00794_si_011.pdb (274.11 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00794" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Floriana Morgillo</span> - <span class="hlFld-Affiliation affiliation">Oncologia Medica,
Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale
“F. Magrassi e A. Lanzara”, Università della Campania “Luigi Vanvitelli”, Via Pansini 6, 80131 Naples, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6a0c060518030b040b0705180d030606052a130b02050544090507"><span class="__cf_email__" data-cfemail="f492989b869d959a95999b86939d98989bb48d959c9b9bda979b99">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandro Cosconati</span> - <span class="hlFld-Affiliation affiliation">DiSTABiF, Università della Campania
“Luigi Vanvitelli”, Via Vivaldi 43, 81100 Caserta, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8900-0968" title="Orcid link">http://orcid.org/0000-0002-8900-0968</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e497858a80968bca878b97878b8a85908da4918a8d87858994858a8d85ca8d90"><span class="__cf_email__" data-cfemail="afdccec1cbddc081ccc0dcccc0c1cedbc6efdac1c6cccec2dfcec1c6ce81c6db">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giorgio Amendola</span> - <span class="hlFld-Affiliation affiliation">DiSTABiF, Università della Campania
“Luigi Vanvitelli”, Via Vivaldi 43, 81100 Caserta, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4271-5031" title="Orcid link">http://orcid.org/0000-0003-4271-5031</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carminia Maria Della Corte</span> - <span class="hlFld-Affiliation affiliation">Oncologia Medica,
Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale
“F. Magrassi e A. Lanzara”, Università della Campania “Luigi Vanvitelli”, Via Pansini 6, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiara Giacomelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6244-602X" title="Orcid link">http://orcid.org/0000-0002-6244-602X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorenzo Botta</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di
Farmacia, Università di Napoli “Federico
II”, Via D. Montesano
49, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Salvatore Di Maro</span> - <span class="hlFld-Affiliation affiliation">DiSTABiF, Università della Campania
“Luigi Vanvitelli”, Via Vivaldi 43, 81100 Caserta, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Messere</span> - <span class="hlFld-Affiliation affiliation">DiSTABiF, Università della Campania
“Luigi Vanvitelli”, Via Vivaldi 43, 81100 Caserta, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenza Ciaramella</span> - <span class="hlFld-Affiliation affiliation">Oncologia Medica,
Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale
“F. Magrassi e A. Lanzara”, Università della Campania “Luigi Vanvitelli”, Via Pansini 6, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sabrina Taliani</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luciana Marinelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di
Farmacia, Università di Napoli “Federico
II”, Via D. Montesano
49, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Letizia Trincavelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia Martini</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9379-3027" title="Orcid link">http://orcid.org/0000-0001-9379-3027</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ettore Novellino</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di
Farmacia, Università di Napoli “Federico
II”, Via D. Montesano
49, 80131 Naples, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2181-2142" title="Orcid link">http://orcid.org/0000-0002-2181-2142</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fortunato Ciardiello</span> - <span class="hlFld-Affiliation affiliation">Oncologia Medica,
Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale
“F. Magrassi e A. Lanzara”, Università della Campania “Luigi Vanvitelli”, Via Pansini 6, 80131 Naples, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. F.M, G.A., and C.M.D.C. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d82e2022-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65712" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65712" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC)-Project MFAG 2013-N.14392 to F.M., by Progetti di Rilevante Interesse Nazionale (PRIN) 2012 (grant no. 2012C5YJSK_003 to L.M. and 2012CTAYSY_002 to S.C.), and by Regione Campania under POR Campania FESR 2007–2013-O.O.2.1 (FarmaBioNet) to A.M. and S.C.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i24" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i24"> Abbreviations Used</h2><tr><td class="NLM_term">TKI</td><td class="NLM_def"><p class="first last">tyrosine kinase inhibitors</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">EGF receptor</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung cancer</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial-to-mesenchymal transition</p></td></tr><tr><td class="NLM_term">Hh</td><td class="NLM_def"><p class="first last">Hedgehog</p></td></tr><tr><td class="NLM_term">SMO</td><td class="NLM_def"><p class="first last">smoothened</p></td></tr><tr><td class="NLM_term">TCGA</td><td class="NLM_def"><p class="first last">the Cancer Genome Atlas</p></td></tr><tr><td class="NLM_term">HGFR</td><td class="NLM_def"><p class="first last">hepatocyte growth factor receptor</p></td></tr><tr><td class="NLM_term">GR</td><td class="NLM_def"><p class="first last">gefitinib resistant</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jemal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thun, M. J.</span><span> </span><span class="NLM_article-title">Cancer Statistics, 2009</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.3322/caac.20006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.3322%2Fcaac.20006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=19474385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BD1MvnsV2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2009&pages=225-249&author=A.+Jemalauthor=R.+Siegelauthor=E.+Wardauthor=Y.+Haoauthor=J.+Xuauthor=M.+J.+Thun&title=Cancer+Statistics%2C+2009&doi=10.3322%2Fcaac.20006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2009</span></div><div class="casAuthors">Jemal Ahmedin; Siegel Rebecca; Ward Elizabeth; Hao Yongping; Xu Jiaquan; Thun Michael J</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">225-49</span>
        ISSN:<span class="NLM_cas:issn">0007-9235</span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics.  Incidence and death rates are standardized by age to the 2000 United States standard million population.  A total of 1,479,350 new cancer cases and 562,340 deaths from cancer are projected to occur in the United States in 2009.  Overall cancer incidence rates decreased in the most recent time period in both men (1.8% per year from 2001 to 2005) and women (0.6% per year from 1998 to 2005), largely because of decreases in the three major cancer sites in men (lung, prostate, and colon and rectum [colorectum]) and in two major cancer sites in women (breast and colorectum).  Overall cancer death rates decreased in men by 19.2% between 1990 and 2005, with decreases in lung (37%), prostate (24%), and colorectal (17%) cancer rates accounting for nearly 80% of the total decrease.  Among women, overall cancer death rates between 1991 and 2005 decreased by 11.4%, with decreases in breast (37%) and colorectal (24%) cancer rates accounting for 60% of the total decrease.  The reduction in the overall cancer death rates has resulted in the avoidance of about 650,000 deaths from cancer over the 15-year period.  This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, education, geographic area, and calendar year.  Although progress has been made in reducing incidence and mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons younger than 85 years of age.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population and by supporting new discoveries in cancer prevention, early detection, and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrRttlY5h-athSDZx9hyjKfW6udTcc2eYLmmJfhYmh6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvnsV2luw%253D%253D&md5=3dbc58ce3b937944077b44eb07fa48b2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.20006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.20006%26sid%3Dliteratum%253Aachs%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DWard%26aufirst%3DE.%26aulast%3DHao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DThun%26aufirst%3DM.%2BJ.%26atitle%3DCancer%2520Statistics%252C%25202009%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2009%26volume%3D59%26spage%3D225%26epage%3D249%26doi%3D10.3322%2Fcaac.20006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span> </span><span class="NLM_article-title">Activation of the hedgehog-signaling pathway in human cancer and the clinical implications</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1038/onc.2009.392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fonc.2009.392" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=469-481&author=L.+Yangauthor=G.+Xieauthor=Q.+Fanauthor=J.+Xie&title=Activation+of+the+hedgehog-signaling+pathway+in+human+cancer+and+the+clinical+implications&doi=10.1038%2Fonc.2009.392"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.392%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DG.%26aulast%3DFan%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520the%2520hedgehog-signaling%2520pathway%2520in%2520human%2520cancer%2520and%2520the%2520clinical%2520implications%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D469%26epage%3D481%26doi%3D10.1038%2Fonc.2009.392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Yuan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petty, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Memoli, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dmitrovsky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, D. J.</span><span> </span><span class="NLM_article-title">Frequent requirement of hedgehog signaling in non-small cell lung carcinoma</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1055</span><span class="refDoi"> DOI: 10.1038/sj.onc.1209860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fsj.onc.1209860" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=1046-1055&author=Z.+Yuanauthor=J.+A.+Goetzauthor=S.+Singhauthor=S.+K.+Ogdenauthor=W.+J.+Pettyauthor=C.+C.+Blackauthor=V.+A.+Memoliauthor=E.+Dmitrovskyauthor=D.+J.+Robbins&title=Frequent+requirement+of+hedgehog+signaling+in+non-small+cell+lung+carcinoma&doi=10.1038%2Fsj.onc.1209860"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209860%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DZ.%26aulast%3DGoetz%26aufirst%3DJ.%2BA.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DOgden%26aufirst%3DS.%2BK.%26aulast%3DPetty%26aufirst%3DW.%2BJ.%26aulast%3DBlack%26aufirst%3DC.%2BC.%26aulast%3DMemoli%26aufirst%3DV.%2BA.%26aulast%3DDmitrovsky%26aufirst%3DE.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DFrequent%2520requirement%2520of%2520hedgehog%2520signaling%2520in%2520non-small%2520cell%2520lung%2520carcinoma%26jtitle%3DOncogene%26date%3D2006%26volume%3D26%26spage%3D1046%26epage%3D1055%26doi%3D10.1038%2Fsj.onc.1209860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ahmad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitah, M. I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginnebaugh, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadgeel, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, F. H.</span><span> </span><span class="NLM_article-title">Inhibition of hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs</span> <span class="citation_source-journal">J. Hematol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="refDoi"> DOI: 10.1186/1756-8722-6-77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1186%2F1756-8722-6-77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=24199791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=77&author=A.+Ahmadauthor=M.+I.+Y.+Maitahauthor=K.+R.+Ginnebaughauthor=Y.+Liauthor=B.+Baoauthor=S.+M.+Gadgeelauthor=F.+H.+Sarkar&title=Inhibition+of+hedgehog+signaling+sensitizes+NSCLC+cells+to+standard+therapies+through+modulation+of+EMT-regulating+miRNAs&doi=10.1186%2F1756-8722-6-77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs</span></div><div class="casAuthors">Ahmad, Aamir; Maitah, Ma'in Y.; Ginnebaugh, Kevin R.; Li, Yiwei; Bao, Bin; Gadgeel, Shirish M.; Sarkar, Fazlul H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77/1-77/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Epidermal growth factor receptor- tyrosine kinase inhibitors (EGFR-TKIs) benefit Non-small cell lung cancer (NSCLC) patients, and an EGFR-TKIi erlotinib, is approved for patients with recurrent NSCLC.  However, resistance to erlotinib is a major clin. problem.  Earlier we have demonstrated the role of Hedgehog (Hh) signaling in Epithelial-to-Mesenchymal transition (EMT) of NSCLC cells, leading to increased proliferation and invasion.  Here, we investigated the role of Hh signaling in erlotinib resistance of TGF-β1-induced NSCLC cells that are reminiscent of EMT cells.  Methods: Hh signaling was inhibited by specific siRNA and by GDC-0449, a small mol. antagonist of G protein coupled receptor smoothened in the Hh pathway.  Not all NSCLC patients are likely to benefit from EGFR-TKIs and, therefore, cisplatin was used to further demonstrate a role of inhibition of Hh signaling in sensitization of resistant EMT cells.  Specific pre- and anti-miRNA prepns. were used to study the mechanistic involvement of miRNAs in drug resistance mechanism.  Results: siRNA-mediated inhibition as well as pharmacol. inhibition of Hh signaling abrogated resistance of NSCLC cells to erlotinib and cisplatin.  It also resulted in re-sensitization of TGF-β1-induced A549 (A549M) cells as well the mesenchymal phenotypic H1299 cells to erlotinib and cisplatin treatment with concomitant up-regulation of cancer stem cell (CSC) markers (Sox2, Nanog and EpCAM) and down-regulation of miR-200 and let-7 family miRNAs.  Ectopic up-regulation of miRNAs, esp. miR-200b and let-7c, significantly diminished the erlotinib resistance of A549M cells.  Inhibition of Hh signaling by GDC-0449 in EMT cells resulted in the attenuation of CSC markers and up-regulation of miR-200b and let-7c, leading to sensitization of EMT cells to drug treatment, thus, confirming a connection between Hh signaling, miRNAs and drug resistance.  Conclusions: We demonstrate that Hh pathway, through EMT-induction, leads to reduced sensitivity to EGFR-TKIs in NSCLCs.  Therefore, targeting Hh pathway may lead to the reversal of EMT phenotype and improve the therapeutic efficacy of EGFR-TKIs in NSCLC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu0PYgu9hK67Vg90H21EOLACvtfcHk0ljT4BtZ4PT0Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVGnsb8%253D&md5=4b4ecfbe14c5d4a161d94eeaef5b4dea</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-77%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DMaitah%26aufirst%3DM.%2BI.%2BY.%26aulast%3DGinnebaugh%26aufirst%3DK.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBao%26aufirst%3DB.%26aulast%3DGadgeel%26aufirst%3DS.%2BM.%26aulast%3DSarkar%26aufirst%3DF.%2BH.%26atitle%3DInhibition%2520of%2520hedgehog%2520signaling%2520sensitizes%2520NSCLC%2520cells%2520to%2520standard%2520therapies%2520through%2520modulation%2520of%2520EMT-regulating%2520miRNAs%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26spage%3D77%26doi%3D10.1186%2F1756-8722-6-77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Tsao, A.; Byers, L. A.; Diao, L.; Wang, J.; Weinstein, J. N.; Meric-Bernstam, F.; Aldape, K.; Heymach, J. V.</span><span> </span><span class="NLM_article-title">P2.06-032-SMO mutations occur in non-small cell lung cancer (NSCLC) and may respond to hedgehog inhibitors</span>. 15th World Conference on Lung Cancer, 2013, Sydney, Australia,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+Tsao&author=L.+A.+Byers&author=L.+Diao&author=J.+Wang&author=J.+N.+Weinstein&author=F.+Meric-Bernstam&author=K.+Aldape&author=J.+V.+Heymach&title=P2.06-032-SMO+mutations+occur+in+non-small+cell+lung+cancer+%28NSCLC%29+and+may+respond+to+hedgehog+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DTsao%26aufirst%3DA.%26atitle%3DP2.06-032-SMO%2520mutations%2520occur%2520in%2520non-small%2520cell%2520lung%2520cancer%2520%2528NSCLC%2529%2520and%2520may%2520respond%2520to%2520hedgehog%2520inhibitors%26jtitle%3D15th%2520World%2520Conference%2520on%2520Lung%2520Cancer%252C%25202013%252C%2520Sydney%252C%2520Australia%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Reungwetwattana, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. I.</span><span> </span><span class="NLM_article-title">The race to target MET exon 14 skipping alterations in non-small cell lung cancer: the why, the how, the who, the unknown, and the inevitable</span> <span class="citation_source-journal">Lung Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.lungcan.2016.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.lungcan.2016.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=28024693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252FpsVOgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2017&pages=27-37&author=T.+Reungwetwattanaauthor=Y.+Liangauthor=V.+Zhuauthor=S.+I.+Ou&title=The+race+to+target+MET+exon+14+skipping+alterations+in+non-small+cell+lung+cancer%3A+the+why%2C+the+how%2C+the+who%2C+the+unknown%2C+and+the+inevitable&doi=10.1016%2Fj.lungcan.2016.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable</span></div><div class="casAuthors">Reungwetwattana Thanyanan; Liang Ying; Zhu Viola; Ou Sai-Hong Ignatius</div><div class="citationInfo"><span class="NLM_cas:title">Lung cancer (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A number of small molecule tyrosine kinase inhibitors (TKIs) have now been approved for the treatment of non-small cell lung cancers (NSCLC), including those targeted against epidermal growth factor receptor, anaplastic lymphoma kinase, and ROS1.  Despite a wealth of agents developed to target the receptor tyrosine kinase, MET, clinical outcomes have as yet been disappointing, leading to pessimism about the role of MET in the pathogenesis of NSCLC.  However, in recent years, there has been a renewed interest in MET exon 14 alterations as potential drivers of lung cancer.  MET exon 14 alterations, which result in increased MET protein levels due to disrupted ubiquitin-mediated degradation, occur at a prevalence of around 3% in adenocarcinomas and around 2% in other lung neoplasms, making them attractive targets for the treatment of lung cancer.  At least five MET-targeted TKIs, including crizotinib, cabozantinib, capmatinib, tepotinib, and glesatinib, are being investigated clinically for patients with MET exon 14 altered-NSCLC.  A further two compounds have shown activity in preclinical models.  In this article, we review the current clinical and preclinical data available for these TKIs, along with a number of other potential therapeutic options, including antibodies and immunotherapy.  A number of questions remain unanswered regarding the future of MET TKIs, but unfortunately, the development of resistance to targeted therapies is inevitable.  Resistance is expected to arise as a result of receptor tyrosine kinase mutation or from upregulation of MET ligand expression; potential strategies to overcome resistance are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSsrhwBD9iXx7rIbt-tGZmxfW6udTcc2eZSLyARKkq6j7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252FpsVOgug%253D%253D&md5=eda8010813a950d0851da13c2404ccb6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2016.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2016.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DReungwetwattana%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DV.%26aulast%3DOu%26aufirst%3DS.%2BI.%26atitle%3DThe%2520race%2520to%2520target%2520MET%2520exon%252014%2520skipping%2520alterations%2520in%2520non-small%2520cell%2520lung%2520cancer%253A%2520the%2520why%252C%2520the%2520how%252C%2520the%2520who%252C%2520the%2520unknown%252C%2520and%2520the%2520inevitable%26jtitle%3DLung%2520Cancer.%26date%3D2017%26volume%3D103%26spage%3D27%26epage%3D37%26doi%3D10.1016%2Fj.lungcan.2016.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Della Corte, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellevicine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicidomini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitagliano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malapelle, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Accardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papaccio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troiani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciardiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgillo, F.</span><span> </span><span class="NLM_article-title">SMO gene amplification and activation of the hedgehog pathway as novel mechanisms of resistance to anti-epidermal growth factor receptor drugs in human lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4686</span><span class="NLM_x">–</span> <span class="NLM_lpage">4697</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-3319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F1078-0432.CCR-14-3319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=26124204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1yltrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=4686-4697&author=C.+M.+Della+Corteauthor=C.+Bellevicineauthor=G.+Vicidominiauthor=D.+Vitaglianoauthor=U.+Malapelleauthor=M.+Accardoauthor=A.+Fabozziauthor=A.+Fiorelliauthor=M.+Fasanoauthor=F.+Papaccioauthor=E.+Martinelliauthor=T.+Troianiauthor=G.+Tronconeauthor=M.+Santiniauthor=R.+Biancoauthor=F.+Ciardielloauthor=F.+Morgillo&title=SMO+gene+amplification+and+activation+of+the+hedgehog+pathway+as+novel+mechanisms+of+resistance+to+anti-epidermal+growth+factor+receptor+drugs+in+human+lung+cancer&doi=10.1158%2F1078-0432.CCR-14-3319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer</span></div><div class="casAuthors">Della Corte, Carminia Maria; Bellevicine, Claudio; Vicidomini, Giovanni; Vitagliano, Donata; Malapelle, Umberto; Accardo, Marina; Fabozzi, Alessio; Fiorelli, Alfonso; Fasano, Morena; Papaccio, Federica; Martinelli, Erika; Troiani, Teresa; Troncone, Giancarlo; Santini, Mario; Bianco, Roberto; Ciardiello, Fortunato; Morgillo, Floriana</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4686-4697</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Resistance to tyrosine kinase inhibitors (TKI) of EGF receptor (EGFR) is often related to activation of other signaling pathways and evolution through a mesenchymal phenotype.  Exptl. Design: Because the Hedgehog (Hh) pathway has emerged as an important mediator of epithelial-to-mesenchymal transition (EMT), we studied the activation of Hh signaling in models of EGFR-TKIs intrinsic or acquired resistance from both EGFR-mutated and wild-type (WT) non-small cell lung cancer (NSCLC) cell lines.  Results: Activation of the Hh pathway was found in both models of EGFR-mutated and EGFR-WT NSCLC cell line resistant to EGFR-TKIs.  In EGFR-mutated HCC827-GR cells, we found SMO (the Hh receptor) gene amplification, MET activation, and the functional interaction of these two signaling pathways.  In HCC827-GR cells, inhibition of SMO or downregulation of GLI1 (the most important Hh-induced transcription factor) expression in combination with MET inhibition exerted significant antitumor activity.  In EGFR-WT NSCLC cell lines resistant to EGFR inhibitors, the combined inhibition of SMO and EGFR exerted a strong antiproliferative activity with a complete inhibition of PI3K/Akt and MAPK phosphorylation.  In addn., the inhibition of SMO by the use of LDE225 sensitizes EGFR-WT NSCLC cells to std. chemotherapy.  Conclusions:This result supports the role of the Hh pathway in mediating resistance to anti-EGFR-TKIs through the induction of EMT and suggests new opportunities to design new treatment strategies in lung cancer.  Clin Cancer Res; 21(20); 4686-97. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYOY5WwUklDbVg90H21EOLACvtfcHk0lhJaxCYDb3wHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1yltrvM&md5=eddc0ddb457551bd237f883ed87fa8f9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-3319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-3319%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BCorte%26aufirst%3DC.%2BM.%26aulast%3DBellevicine%26aufirst%3DC.%26aulast%3DVicidomini%26aufirst%3DG.%26aulast%3DVitagliano%26aufirst%3DD.%26aulast%3DMalapelle%26aufirst%3DU.%26aulast%3DAccardo%26aufirst%3DM.%26aulast%3DFabozzi%26aufirst%3DA.%26aulast%3DFiorelli%26aufirst%3DA.%26aulast%3DFasano%26aufirst%3DM.%26aulast%3DPapaccio%26aufirst%3DF.%26aulast%3DMartinelli%26aufirst%3DE.%26aulast%3DTroiani%26aufirst%3DT.%26aulast%3DTroncone%26aufirst%3DG.%26aulast%3DSantini%26aufirst%3DM.%26aulast%3DBianco%26aufirst%3DR.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DMorgillo%26aufirst%3DF.%26atitle%3DSMO%2520gene%2520amplification%2520and%2520activation%2520of%2520the%2520hedgehog%2520pathway%2520as%2520novel%2520mechanisms%2520of%2520resistance%2520to%2520anti-epidermal%2520growth%2520factor%2520receptor%2520drugs%2520in%2520human%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D4686%26epage%3D4697%26doi%3D10.1158%2F1078-0432.CCR-14-3319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Della Corte, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malapelle, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigliar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaramella, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troiani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciardiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgillo, F.</span><span> </span><span class="NLM_article-title">Efficacy of continuous EGFR-inhibition and role of hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">23020</span><span class="NLM_x">–</span> <span class="NLM_lpage">23032</span><span class="refDoi"> DOI: 10.18632/oncotarget.15479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.18632%2Foncotarget.15479" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=23020-23032&author=C.+M.+Della+Corteauthor=U.+Malapelleauthor=E.+Vigliarauthor=F.+Pepeauthor=G.+Tronconeauthor=V.+Ciaramellaauthor=T.+Troianiauthor=E.+Martinelliauthor=V.+Belliauthor=F.+Ciardielloauthor=F.+Morgillo&title=Efficacy+of+continuous+EGFR-inhibition+and+role+of+hedgehog+in+EGFR+acquired+resistance+in+human+lung+cancer+cells+with+activating+mutation+of+EGFR&doi=10.18632%2Foncotarget.15479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15479%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BCorte%26aufirst%3DC.%2BM.%26aulast%3DMalapelle%26aufirst%3DU.%26aulast%3DVigliar%26aufirst%3DE.%26aulast%3DPepe%26aufirst%3DF.%26aulast%3DTroncone%26aufirst%3DG.%26aulast%3DCiaramella%26aufirst%3DV.%26aulast%3DTroiani%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DE.%26aulast%3DBelli%26aufirst%3DV.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DMorgillo%26aufirst%3DF.%26atitle%3DEfficacy%2520of%2520continuous%2520EGFR-inhibition%2520and%2520role%2520of%2520hedgehog%2520in%2520EGFR%2520acquired%2520resistance%2520in%2520human%2520lung%2520cancer%2520cells%2520with%2520activating%2520mutation%2520of%2520EGFR%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D23020%26epage%3D23032%26doi%3D10.18632%2Foncotarget.15479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Anighoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span> </span><span class="NLM_article-title">Polypharmacology: challenges and opportunities in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7874</span><span class="NLM_x">–</span> <span class="NLM_lpage">7887</span><span class="refDoi"> DOI: 10.1021/jm5006463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7874-7887&author=A.+Anighoroauthor=J.+Bajorathauthor=G.+Rastelli&title=Polypharmacology%3A+challenges+and+opportunities+in+drug+discovery&doi=10.1021%2Fjm5006463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology: Challenges and Opportunities in Drug Discovery</span></div><div class="casAuthors">Anighoro, Andrew; Bajorath, Jurgen; Rastelli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7874-7887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biol. target, shares the spotlight with an emerging and alternative polypharmacol. approach.  Polypharmacol. suggests that more effective drugs can be developed by specifically modulating multiple targets.  It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches.  In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs.  In this review, we will compare advantages and disadvantages of multitarget vs. combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOTyEu80AZrVg90H21EOLACvtfcHk0ljMKwRnhvqhoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I&md5=5ab36c961a84462d90bc25130d90a281</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm5006463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006463%26sid%3Dliteratum%253Aachs%26aulast%3DAnighoro%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DRastelli%26aufirst%3DG.%26atitle%3DPolypharmacology%253A%2520challenges%2520and%2520opportunities%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7874%26epage%3D7887%26doi%3D10.1021%2Fjm5006463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Nosengo, N.</span><span> </span><span class="NLM_article-title">Can you teach old drugs new tricks?</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">534</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span><span class="refDoi"> DOI: 10.1038/534314a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2F534314a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=27306171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BC2s7gs1ylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=534&publication_year=2016&pages=314-316&author=N.+Nosengo&title=Can+you+teach+old+drugs+new+tricks%3F&doi=10.1038%2F534314a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Can you teach old drugs new tricks?</span></div><div class="casAuthors">Nosengo Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">534</span>
        (<span class="NLM_cas:issue">7607</span>),
    <span class="NLM_cas:pages">314-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyEEcSAsN0zhdUSIfHIn4FfW6udTcc2eaj66Q865CAf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7gs1ylug%253D%253D&md5=e521004f61101d4936d8e1f07454e843</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F534314a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F534314a%26sid%3Dliteratum%253Aachs%26aulast%3DNosengo%26aufirst%3DN.%26atitle%3DCan%2520you%2520teach%2520old%2520drugs%2520new%2520tricks%253F%26jtitle%3DNature%26date%3D2016%26volume%3D534%26spage%3D314%26epage%3D316%26doi%3D10.1038%2F534314a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorissen, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilson, M. K.</span><span> </span><span class="NLM_article-title">BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1093/nar/gkl999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1093%2Fnar%2Fgkl999" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=198-201&author=T.+Liuauthor=Y.+Linauthor=X.+Wenauthor=R.+N.+Jorissenauthor=M.+K.+Gilson&title=BindingDB%3A+a+web-accessible+database+of+experimentally+determined+protein%E2%80%93ligand+binding+affinities&doi=10.1093%2Fnar%2Fgkl999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkl999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkl999%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DJorissen%26aufirst%3DR.%2BN.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26atitle%3DBindingDB%253A%2520a%2520web-accessible%2520database%2520of%2520experimentally%2520determined%2520protein%25E2%2580%2593ligand%2520binding%2520affinities%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3D198%26epage%3D201%26doi%3D10.1093%2Fnar%2Fgkl999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Amendola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span> </span><span class="NLM_article-title">Best matching protein conformations and docking programs for a virtual screening campaign against SMO receptor</span> <span class="citation_source-journal">Mol. Inf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1002/minf.201501021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1002%2Fminf.201501021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=27546038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC28Xns1ejtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=340-349&author=G.+Amendolaauthor=D.+Di+Maioauthor=V.+La+Pietraauthor=S.+Cosconati&title=Best+matching+protein+conformations+and+docking+programs+for+a+virtual+screening+campaign+against+SMO+receptor&doi=10.1002%2Fminf.201501021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Best Matching Protein Conformations and Docking Programs for a Virtual Screening Campaign Against SMO Receptor</span></div><div class="casAuthors">Amendola, Giorgio; Di Maio, Danilo; La Pietra, Valeria; Cosconati, Sandro</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">340-349</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">SMO receptor is one of the main components of the Hedgehog biochem. pathway.  In the last decades compelling body of evidence demonstrated that this receptor is a pertinent target for the treatment of various types of solid tumors.  Recently, the X-ray detn. of the three-dimensional structure of SMO in complex with different antagonists opened up the way for the structure-based design of new antagonists for this receptor that could possibly overcome the limitations connected with the induction of acquired tumor resistance.  Herein, taking advantage of three different docking software (namely Glide, PLANTS, and Vina) and of the available SMO structures we set up a retrospective virtual screening (VS) protocol.  A database, made up by known SMO antagonists and compds. with no alleged activity against the receptor was created and screened against the different SMO structures.  To evaluate the performance of the ranking in VS calcns. different statistical metrics (EF, AUAC and BEDROC) were employed allowing to identify the best performing VS docking protocol.  Results of these studies will serve as a platform for the application of structure-based VS against the pharmaceutically relevant SMO receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLZsC1z2lsDbVg90H21EOLACvtfcHk0ljMKwRnhvqhoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xns1ejtb8%253D&md5=f7bf821475a7eb2a91ece8ee61245894</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fminf.201501021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201501021%26sid%3Dliteratum%253Aachs%26aulast%3DAmendola%26aufirst%3DG.%26aulast%3DDi%2BMaio%26aufirst%3DD.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DCosconati%26aufirst%3DS.%26atitle%3DBest%2520matching%2520protein%2520conformations%2520and%2520docking%2520programs%2520for%2520a%2520virtual%2520screening%2520campaign%2520against%2520SMO%2520receptor%26jtitle%3DMol.%2520Inf.%26date%3D2016%26volume%3D35%26spage%3D340%26epage%3D349%26doi%3D10.1002%2Fminf.201501021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4355</span><span class="refDoi"> DOI: 10.1038/ncomms5355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fncomms5355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=25008467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVert7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4355&author=C.+Wangauthor=H.+Wuauthor=T.+Evronauthor=E.+Vardyauthor=G.+W.+Hanauthor=X.+P.+Huangauthor=S.+J.+Hufeisenauthor=T.+J.+Manganoauthor=D.+J.+Urbanauthor=V.+Katritchauthor=V.+Cherezovauthor=M.+G.+Caronauthor=B.+L.+Rothauthor=R.+C.+Stevens&title=Structural+basis+for+Smoothened+receptor+modulation+and+chemoresistance+to+anticancer+drugs&doi=10.1038%2Fncomms5355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs</span></div><div class="casAuthors">Wang, Chong; Wu, Huixian; Evron, Tama; Vardy, Eyal; Han, Gye Won; Huang, Xi-Ping; Hufeisen, Sandy J.; Mangano, Thomas J.; Urban, Dan J.; Katritch, Vsevolod; Cherezov, Vadim; Caron, Marc G.; Roth, Bryan L.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4355</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Smoothened receptor (SMO) mediates signal transduction in the hedgehog pathway, which is implicated in normal development and carcinogenesis.  SMO antagonists can suppress the growth of some tumors; however, mutations at SMO have been found to abolish their antitumor effects, a phenomenon known as chemoresistance.  Here we report three crystal structures of human SMO bound to the antagonists SANT1 and Anta XV, and the agonist, SAG1.5, at 2.6-2.8 Å resoln.  The long and narrow cavity in the transmembrane domain of SMO harbours multiple ligand binding sites, where SANT1 binds at a deeper site as compared with other ligands.  Distinct interactions at D4736.54f elucidated the structural basis for the differential effects of chemoresistance mutations on SMO antagonists.  The agonist SAG1.5 induces a conformational rearrangement of the binding pocket residues, which could contribute to SMO activation.  Collectively, these studies reveal the structural basis for the modulation of SMO by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9pbk2DLpA7LVg90H21EOLACvtfcHk0ljvoWAZRC50rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVert7g%253D&md5=5c7893dd6fd6ee3626a6e9483646c7bd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fncomms5355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5355%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DEvron%26aufirst%3DT.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DMangano%26aufirst%3DT.%2BJ.%26aulast%3DUrban%26aufirst%3DD.%2BJ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520basis%2520for%2520Smoothened%2520receptor%2520modulation%2520and%2520chemoresistance%2520to%2520anticancer%2520drugs%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D4355%26doi%3D10.1038%2Fncomms5355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oorui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiyama, K.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8030</span><span class="NLM_x">–</span> <span class="NLM_lpage">8050</span><span class="refDoi"> DOI: 10.1021/jm2008634</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2008634" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlajur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8030-8050&author=T.+Ishikawaauthor=M.+Setoauthor=H.+Bannoauthor=Y.+Kawakitaauthor=M.+Ooruiauthor=T.+Taniguchiauthor=Y.+Ohtaauthor=T.+Tamuraauthor=A.+Nakayamaauthor=H.+Mikiauthor=H.+Kamiguchiauthor=T.+Tanakaauthor=N.+Habukaauthor=S.+Sogabeauthor=J.+Yanoauthor=K.+Aertgeertsauthor=K.+Kamiyama&title=Design+and+synthesis+of+novel+human+epidermal+growth+factor+receptor+2+%28HER2%29%2Fepidermal+growth+factor+receptor+%28EGFR%29+dual+inhibitors+bearing+a+pyrrolo%5B3%2C2-d%5Dpyrimidine+scaffold&doi=10.1021%2Fjm2008634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-d]pyrimidine Scaffold</span></div><div class="casAuthors">Ishikawa, Tomoyasu; Seto, Masaki; Banno, Hiroshi; Kawakita, Youichi; Oorui, Mami; Taniguchi, Takahiko; Ohta, Yoshikazu; Tamura, Toshiya; Nakayama, Akiko; Miki, Hiroshi; Kamiguchi, Hidenori; Tanaka, Toshimasa; Habuka, Noriyuki; Sogabe, Satoshi; Yano, Jason; Aertgeerts, Kathleen; Kamiyama, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8030-8050</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dual inhibitors of human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR) have been investigated for breast, lung, gastric, prostate, and other cancers; one, lapatinib, is currently approved for breast cancer.  To develop novel HER2/EGFR dual kinase inhibitors, we designed and synthesized pyrrolo[3,2-d]pyrimidine derivs., e.g. I, capable of fitting into the receptors' ATP binding site.  Among the prepd. compds., I showed potent HER2 and EGFR (HER1) inhibitory activities as well as tumor growth inhibitory activity.  The X-ray cocrystal structures of I with both HER2 and EGFR demonstrated that I interacts with the expected residues in their resp. ATP pockets.  Furthermore, reflecting its good oral bioavailability, I exhibited potent in vivo efficacy in HER2-overexpressing tumor xenograft models.  On the basis of these findings, we report I (TAK-285) as a promising candidate for clin. development as a novel HER2/EGFR dual kinase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9QtqAj6idYrVg90H21EOLACvtfcHk0ljvoWAZRC50rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlajur7M&md5=ce030ac133a1c0ff7cb78b269ff85987</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm2008634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2008634%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DSeto%26aufirst%3DM.%26aulast%3DBanno%26aufirst%3DH.%26aulast%3DKawakita%26aufirst%3DY.%26aulast%3DOorui%26aufirst%3DM.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DY.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DMiki%26aufirst%3DH.%26aulast%3DKamiguchi%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DKamiyama%26aufirst%3DK.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520human%2520epidermal%2520growth%2520factor%2520receptor%25202%2520%2528HER2%2529%252Fepidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520dual%2520inhibitors%2520bearing%2520a%2520pyrrolo%255B3%252C2-d%255Dpyrimidine%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8030%26epage%3D8050%26doi%3D10.1021%2Fjm2008634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span> </span><span class="NLM_article-title">Identification and synthesis of N′-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3749</span><span class="NLM_x">–</span> <span class="NLM_lpage">3754</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.bmcl.2011.04.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3749-3754&author=Z.+Liangauthor=D.+Zhangauthor=J.+Aiauthor=L.+Chenauthor=H.+Wangauthor=X.+Kongauthor=M.+Zhengauthor=H.+Liuauthor=C.+Luoauthor=M.+Gengauthor=H.+Jiangauthor=K.+Chen&title=Identification+and+synthesis+of+N%E2%80%B2-%282-oxoindolin-3-ylidene%29hydrazide+derivatives+against+c-Met+kinase&doi=10.1016%2Fj.bmcl.2011.04.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.064%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DK.%26atitle%3DIdentification%2520and%2520synthesis%2520of%2520N%25E2%2580%25B2-%25282-oxoindolin-3-ylidene%2529hydrazide%2520derivatives%2520against%2520c-Met%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3749%26epage%3D3754%26doi%3D10.1016%2Fj.bmcl.2011.04.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemcke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totzke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schächtele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubbutat, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span> </span><span class="NLM_article-title">Dual IGF-1R/SRC inhibitors based on a N′-aroyl-2-(1H-indol-3-yl)-2-oxoacetohydrazide structure</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2759</span><span class="NLM_x">–</span> <span class="NLM_lpage">2769</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.03.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.ejmech.2011.03.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2759-2769&author=S.+Schmidtauthor=L.+Preuauthor=T.+Lemckeauthor=F.+Totzkeauthor=C.+Sch%C3%A4chteleauthor=M.+H.+Kubbutatauthor=C.+Kunick&title=Dual+IGF-1R%2FSRC+inhibitors+based+on+a+N%E2%80%B2-aroyl-2-%281H-indol-3-yl%29-2-oxoacetohydrazide+structure&doi=10.1016%2Fj.ejmech.2011.03.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.03.065%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DLemcke%26aufirst%3DT.%26aulast%3DTotzke%26aufirst%3DF.%26aulast%3DSch%25C3%25A4chtele%26aufirst%3DC.%26aulast%3DKubbutat%26aufirst%3DM.%2BH.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3DDual%2520IGF-1R%252FSRC%2520inhibitors%2520based%2520on%2520a%2520N%25E2%2580%25B2-aroyl-2-%25281H-indol-3-yl%2529-2-oxoacetohydrazide%2520structure%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2759%26epage%3D2769%26doi%3D10.1016%2Fj.ejmech.2011.03.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Claridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeppel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granger, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llewellyn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahhab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deziel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupont, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsalou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chute, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gravel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macleod, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A.</span><span> </span><span class="NLM_article-title">Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2793</span><span class="NLM_x">–</span> <span class="NLM_lpage">2798</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.bmcl.2008.04.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2793-2798&author=S.+Claridgeauthor=F.+Raeppelauthor=M.-C.+Grangerauthor=N.+Bernsteinauthor=O.+Saavedraauthor=L.+Zhanauthor=D.+Llewellynauthor=A.+Wahhabauthor=R.+Dezielauthor=J.+Rahilauthor=N.+Beaulieuauthor=H.+Nguyenauthor=I.+Dupontauthor=A.+Barsalouauthor=C.+Beaulieuauthor=I.+Chuteauthor=S.+Gravelauthor=M.-F.+Robertauthor=S.+Lefebvreauthor=M.+Dubayauthor=R.+Pascalauthor=J.+Gillespieauthor=Z.+Jinauthor=J.+Wangauthor=J.+M.+Bestermanauthor=A.+R.+Macleodauthor=A.+Vaisburg&title=Discovery+of+a+novel+and+potent+series+of+thieno%5B3%2C2-b%5Dpyridine-based+inhibitors+of+c-Met+and+VEGFR2+tyrosine+kinases&doi=10.1016%2Fj.bmcl.2008.04.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DClaridge%26aufirst%3DS.%26aulast%3DRaeppel%26aufirst%3DF.%26aulast%3DGranger%26aufirst%3DM.-C.%26aulast%3DBernstein%26aufirst%3DN.%26aulast%3DSaavedra%26aufirst%3DO.%26aulast%3DZhan%26aufirst%3DL.%26aulast%3DLlewellyn%26aufirst%3DD.%26aulast%3DWahhab%26aufirst%3DA.%26aulast%3DDeziel%26aufirst%3DR.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DBeaulieu%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DDupont%26aufirst%3DI.%26aulast%3DBarsalou%26aufirst%3DA.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DChute%26aufirst%3DI.%26aulast%3DGravel%26aufirst%3DS.%26aulast%3DRobert%26aufirst%3DM.-F.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DDubay%26aufirst%3DM.%26aulast%3DPascal%26aufirst%3DR.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DMacleod%26aufirst%3DA.%2BR.%26aulast%3DVaisburg%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520and%2520potent%2520series%2520of%2520thieno%255B3%252C2-b%255Dpyridine-based%2520inhibitors%2520of%2520c-Met%2520and%2520VEGFR2%2520tyrosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2793%26epage%3D2798%26doi%3D10.1016%2Fj.bmcl.2008.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Schroeder, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, L. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span> </span><span class="NLM_article-title">Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span><span class="refDoi"> DOI: 10.1021/jm801586s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801586s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1251-1254&author=G.+M.+Schroederauthor=Y.+Anauthor=Z.-W.+Caiauthor=X.-T.+Chenauthor=C.+Clarkauthor=L.+A.+M.+Corneliusauthor=J.+Daiauthor=J.+Gullo-Brownauthor=A.+Guptaauthor=B.+Henleyauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=K.+Kimauthor=J.+Lippyauthor=L.+J.+Lombardoauthor=V.+Manneauthor=S.+Oppenheimerauthor=J.+S.+Sackauthor=R.+J.+Schmidtauthor=G.+Shenauthor=K.+Stefanskiauthor=J.+S.+Tokarskiauthor=G.+L.+Trainorauthor=B.+S.+Wautletauthor=D.+Weiauthor=D.+K.+Williamsauthor=Y.+Zhangauthor=Y.+Zhangauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+N-%284-%282-amino-3-chloropyridin-4-yloxy%29-3-fluorophenyl%29-4-ethoxy-1-%284-fluorophenyl%29-2-oxo-1%2C2-dihydropyridine-3-carboxamide+%28BMS-777607%29%2C+a+selective+and+orally+efficacious+inhibitor+of+the+Met+kinase+superfamily&doi=10.1021%2Fjm801586s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily</span></div><div class="casAuthors">Schroeder, Gretchen M.; An, Yongmi; Cai, Zhen-Wei; Chen, Xiao-Tao; Clark, Cheryl; Cornelius, Lyndon A. M.; Dai, Jun; Gullo-Brown, Johnni; Gupta, Ashok; Henley, Benjamin; Hunt, John T.; Jeyaseelan, Robert; Kamath, Amrita; Kim, Kyoung; Lippy, Jonathan; Lombardo, Louis J.; Manne, Veeraswamy; Oppenheimer, Simone; Sack, John S.; Schmidt, Robert J.; Shen, Guoxiang; Stefanski, Kevin; Tokarski, John S.; Trainor, George L.; Wautlet, Barri S.; Wei, Donna; Williams, David K.; Zhang, Yingru; Zhang, Yueping; Fargnoli, Joseph; Borzilleri, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1251-1254</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituted N-(4-(2-aminopyridin-4-yloxy)-3-fluoro-phenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamides were identified as potent and selective Met kinase inhibitors.  Substitution of the pyridine 3-position gave improved enzyme potency, while substitution of the pyridone 4-position led to improved aq. soly. and kinase selectivity.  Analog 10 demonstrated complete tumor stasis in a Met-dependent GTL-16 human gastric carcinoma xenograft model following oral administration.  Because of its excellent in vivo efficacy and favorable pharmacokinetic and preclin. safety profiles, 10 has been advanced into phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAHEvJXf0Fq7Vg90H21EOLACvtfcHk0lhylPjXiG6tLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCnsLc%253D&md5=784623be820fcc8b931200ced3a476df</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm801586s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801586s%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DG.%2BM.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DChen%26aufirst%3DX.-T.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%2BM.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282-amino-3-chloropyridin-4-yloxy%2529-3-fluorophenyl%2529-4-ethoxy-1-%25284-fluorophenyl%2529-2-oxo-1%252C2-dihydropyridine-3-carboxamide%2520%2528BMS-777607%2529%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520the%2520Met%2520kinase%2520superfamily%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1251%26epage%3D1254%26doi%3D10.1021%2Fjm801586s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Guagnano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Douget, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghausen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drueckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, D. G.</span><span> </span><span class="NLM_article-title">Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7066</span><span class="NLM_x">–</span> <span class="NLM_lpage">7083</span><span class="refDoi"> DOI: 10.1021/jm2006222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2006222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7066-7083&author=V.+Guagnanoauthor=P.+Furetauthor=C.+Spankaauthor=V.+Bordasauthor=M.+Le+Dougetauthor=C.+Stammauthor=J.+Brueggenauthor=M.+R.+Jensenauthor=C.+Schnellauthor=H.+Schmidauthor=M.+Wartmannauthor=J.+Berghausenauthor=P.+Drueckesauthor=A.+Zimmerlinauthor=D.+Bussiereauthor=J.+Murrayauthor=D.+G.+Porta&title=Discovery+of+3-%282%2C6-dichloro-3%2C5-dimethoxy-phenyl%29-1-%7B6-%5B4-%284-ethyl-piperazin-1-yl%29-phenylamino%5D-pyrimidin-4-yl%7D-1-methyl-urea+%28NVP-BGJ398%29%2C+a+potent+and+selective+inhibitor+of+the+fibroblast+growth+factor+receptor+family+of+receptor+tyrosine+kinase&doi=10.1021%2Fjm2006222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase</span></div><div class="casAuthors">Guagnano, Vito; Furet, Pascal; Spanka, Carsten; Bordas, Vincent; Le Douget, Mickael; Stamm, Christelle; Brueggen, Josef; Jensen, Michael R.; Schnell, Christian; Schmid, Herbert; Wartmann, Markus; Berghausen, Joerg; Drueckes, Peter; Zimmerlin, Alfred; Bussiere, Dirksen; Murray, Jeremy; Graus Porta, Diana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7066-7083</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of N-aryl-N'-pyrimidin-4-yl ureas has been optimized to afford potent and selective inhibitors of the fibroblast growth factor receptor tyrosine kinases 1, 2, and 3 by rationally designing the substitution pattern of the aryl ring.  On the basis of its in vitro profile, compd. 1h (NVP-BGJ398) was selected for in vivo evaluation and showed significant antitumor activity in RT112 bladder cancer xenografts models overexpressing wild-type FGFR3.  These results support the potential therapeutic use of 1h as a new anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSC1v0A_6I_bVg90H21EOLACvtfcHk0lhKUvRMf-lMtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvK&md5=f9a2d742294cd3814e872bdd8add1ffa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm2006222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2006222%26sid%3Dliteratum%253Aachs%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSpanka%26aufirst%3DC.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DLe%2BDouget%26aufirst%3DM.%26aulast%3DStamm%26aufirst%3DC.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DH.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DBerghausen%26aufirst%3DJ.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DZimmerlin%26aufirst%3DA.%26aulast%3DBussiere%26aufirst%3DD.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DPorta%26aufirst%3DD.%2BG.%26atitle%3DDiscovery%2520of%25203-%25282%252C6-dichloro-3%252C5-dimethoxy-phenyl%2529-1-%257B6-%255B4-%25284-ethyl-piperazin-1-yl%2529-phenylamino%255D-pyrimidin-4-yl%257D-1-methyl-urea%2520%2528NVP-BGJ398%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520fibroblast%2520growth%2520factor%2520receptor%2520family%2520of%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7066%26epage%3D7083%26doi%3D10.1021%2Fjm2006222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Rowbottom, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprankle, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardane, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepomuceno, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenta, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitnick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apuy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones-Bolin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span> </span><span class="NLM_article-title">Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue b1 (BRAF) V600E</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1082</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span><span class="refDoi"> DOI: 10.1021/jm2009925</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2009925" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1082-1105&author=M.+W.+Rowbottomauthor=R.+Faraoniauthor=Q.+Chaoauthor=B.+T.+Campbellauthor=A.+G.+Laiauthor=E.+Settiauthor=M.+Ezawaauthor=K.+G.+Sprankleauthor=S.+Abrahamauthor=L.+Tranauthor=B.+Strussauthor=M.+Gibneyauthor=R.+C.+Armstrongauthor=R.+N.+Gunawardaneauthor=R.+R.+Nepomucenoauthor=I.+Valentaauthor=H.+Huaauthor=M.+F.+Gardnerauthor=M.+D.+Cramerauthor=D.+Gitnickauthor=D.+E.+Inskoauthor=J.+L.+Apuyauthor=S.+Jones-Bolinauthor=A.+K.+Ghoseauthor=T.+Herbertzauthor=M.+A.+Atorauthor=B.+D.+Dorseyauthor=B.+Ruggeriauthor=M.+Williamsauthor=S.+Bhagwatauthor=J.+Jamesauthor=M.+W.+Holladay&title=Identification+of+1-%283-%286%2C7-dimethoxyquinazolin-4-yloxy%29phenyl%29-3-%285-%281%2C1%2C1-trifluoro-2-methylpropan-2-yl%29isoxazol-3-yl%29urea+hydrochloride+%28CEP-32496%29%2C+a+highly+potent+and+orally+efficacious+inhibitor+of+V-RAF+murine+sarcoma+viral+oncogene+homologue+b1+%28BRAF%29+V600E&doi=10.1021%2Fjm2009925"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm2009925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2009925%26sid%3Dliteratum%253Aachs%26aulast%3DRowbottom%26aufirst%3DM.%2BW.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DChao%26aufirst%3DQ.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DSetti%26aufirst%3DE.%26aulast%3DEzawa%26aufirst%3DM.%26aulast%3DSprankle%26aufirst%3DK.%2BG.%26aulast%3DAbraham%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DL.%26aulast%3DStruss%26aufirst%3DB.%26aulast%3DGibney%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DGunawardane%26aufirst%3DR.%2BN.%26aulast%3DNepomuceno%26aufirst%3DR.%2BR.%26aulast%3DValenta%26aufirst%3DI.%26aulast%3DHua%26aufirst%3DH.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DCramer%26aufirst%3DM.%2BD.%26aulast%3DGitnick%26aufirst%3DD.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DApuy%26aufirst%3DJ.%2BL.%26aulast%3DJones-Bolin%26aufirst%3DS.%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DBhagwat%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DJ.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26atitle%3DIdentification%2520of%25201-%25283-%25286%252C7-dimethoxyquinazolin-4-yloxy%2529phenyl%2529-3-%25285-%25281%252C1%252C1-trifluoro-2-methylpropan-2-yl%2529isoxazol-3-yl%2529urea%2520hydrochloride%2520%2528CEP-32496%2529%252C%2520a%2520highly%2520potent%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520V-RAF%2520murine%2520sarcoma%2520viral%2520oncogene%2520homologue%2520b1%2520%2528BRAF%2529%2520V600E%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1082%26epage%3D1105%26doi%3D10.1021%2Fjm2009925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span><span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lgKTXY5kQcTWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Qian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougheed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joly, A. H.</span><span> </span><span class="NLM_article-title">Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8009</span><span class="NLM_x">–</span> <span class="NLM_lpage">8016</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F0008-5472.CAN-08-4889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=19808973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ynurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=8009-8016&author=F.+Qianauthor=S.+Engstauthor=K.+Yamaguchiauthor=P.+Yuauthor=K.-A.+Wonauthor=L.+Mockauthor=T.+Louauthor=J.+Tanauthor=C.+Liauthor=D.+Tamauthor=J.+Lougheedauthor=F.+M.+Yakesauthor=F.+Bentzienauthor=W.+Xuauthor=T.+Zaksauthor=R.+Woosterauthor=J.+Greshockauthor=A.+H.+Joly&title=Inhibition+of+tumor+cell+growth%2C+invasion%2C+and+metastasis+by+EXEL-2880+%28XL880%2C+GSK1363089%29%2C+a+novel+inhibitor+of+HGF+and+VEGF+receptor+tyrosine+kinases&doi=10.1158%2F0008-5472.CAN-08-4889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases</span></div><div class="casAuthors">Qian, Fawn; Engst, Stefan; Yamaguchi, Kyoko; Yu, Peiwen; Won, Kwang-Ai; Mock, Lillian; Lou, Tracy; Tan, Jenny; Li, Connie; Tam, Danny; Lougheed, Julie; Yakes, F. Michael; Bentzien, Frauke; Xu, Wei; Zaks, Tal; Wooster, Richard; Greshock, Joel; Joly, Alison H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8009-8016</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), are overexpressed and/or activated in a wide variety of human malignancies.  Vascular endothelial growth factor (VEGF) receptors are expressed on the surface of vascular endothelial cells and cooperate with Met to induce tumor invasion and vascularization.  EXEL-2880 (XL880, GSK1363089) is a small-mol. kinase inhibitor that targets members of the HGF and VEGF receptor tyrosine kinase families, with addnl. inhibitory activity toward KIT, Flt-3, platelet-derived growth factor receptor β, and Tie-2.  Binding of EXEL-2880 to Met and VEGF receptor 2 (KDR) is characterized by a very slow off-rate, consistent with X-ray crystallog. data showing that the inhibitor is deeply bound in the Met kinase active site cleft.  EXEL-2880 inhibits cellular HGF-induced Met phosphorylation and VEGF-induced extracellular signal-regulated kinase phosphorylation and prevents both HGF-induced responses of tumor cells and HGF/VEGF-induced responses of endothelial cells.  In addn., EXEL-2880 prevents anchorage-independent proliferation of tumor cells under both normoxic and hypoxic conditions.  In vivo, these effects produce significant dose-dependent inhibition of tumor burden in an exptl. model of lung metastasis.  Collectively, these data indicate that EXEL-2880 may prevent tumor growth through a direct effect on tumor cell proliferation and by inhibition of invasion and angiogenesis mediated by HGF and VEGF receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoviVE_HZ5p_bVg90H21EOLACvtfcHk0lgKTXY5kQcTWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ynurbF&md5=f3bf5b432ee42b164d23b690828e3c78</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4889%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DF.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DWon%26aufirst%3DK.-A.%26aulast%3DMock%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DLougheed%26aufirst%3DJ.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZaks%26aufirst%3DT.%26aulast%3DWooster%26aufirst%3DR.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DJoly%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520tumor%2520cell%2520growth%252C%2520invasion%252C%2520and%2520metastasis%2520by%2520EXEL-2880%2520%2528XL880%252C%2520GSK1363089%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520HGF%2520and%2520VEGF%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D8009%26epage%3D8016%26doi%3D10.1158%2F0008-5472.CAN-08-4889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoc, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, R. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoreishi-Haack, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukofzer, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartandi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niquette, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donawho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span> </span><span class="NLM_article-title">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span> <span class="citation_source-journal">Mol. Cancer. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span><span class="refDoi"> DOI: 10.1158/1535-7163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F1535-7163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=16648571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=995-1006&author=D.+H.+Albertauthor=P.+Tapangauthor=T.+J.+Magocauthor=L.+J.+Peaseauthor=D.+R.+Reuterauthor=R.+Q.+Weiauthor=J.+Liauthor=J.+Guoauthor=P.+F.+Bousquetauthor=N.+S.+Ghoreishi-Haackauthor=B.+Wangauthor=G.+T.+Bukofzerauthor=Y.+C.+Wangauthor=J.+A.+Stavropoulosauthor=K.+Hartandiauthor=A.+L.+Niquetteauthor=N.+Soniauthor=E.+F.+Johnsonauthor=J.+O.+McCallauthor=J.+J.+Bouskaauthor=Y.+Luoauthor=C.+K.+Donawhoauthor=Y.+Daiauthor=P.+A.+Marcotteauthor=K.+B.+Glaserauthor=M.+R.+Michaelidesauthor=S.+K.+Davidsen&title=Preclinical+activity+of+ABT-869%2C+a+multitargeted+receptor+tyrosine+kinase+inhibitor&doi=10.1158%2F1535-7163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span></div><div class="casAuthors">Albert, Daniel H.; Tapang, Paul; Magoc, Terrance J.; Pease, Lori J.; Reuter, David R.; Wei, Ru-Qi; Li, Junling; Guo, Jun; Bousquet, Peter F.; Ghoreishi-Haack, Nayereh S.; Wang, Baole; Bukofzer, Gail T.; Wang, Yi-Chun; Stavropoulos, Jason A.; Hartandi, Kresna; Niquette, Amanda L.; Soni, Nirupama; Johnson, Eric F.; McCall, J. Owen; Bouska, Jennifer J.; Luo, Yanping; Donawho, Cherrie K.; Dai, Yujia; Marcotte, Patrick A.; Glaser, Keith B.; Michaelides, Michael R.; Davidsen, Steven K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">995-1006</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ABT-869 is a structurally novel, receptor tyrosine kinase (RTK) inhibitor that is a potent inhibitor of members of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor families (e.g., KDR IC50 = 4 nmol/L) but has much less activity (IC50s > 1 μmol/L) against unrelated RTKs, sol. tyrosine kinases, or serine/threonine kinases.  The inhibition profile of ABT-869 is evident in cellular assays of RTK phosphorylation (IC50 = 2, 4, and 7 nmol/L for PDGFR-β, KDR, and CSF-1R, resp.) and VEGF-stimulated proliferation (IC50 = 0.2 nmol/L for human endothelial cells).  ABT-869 is not a general antiproliferative agent because, in most cancer cells, >1,000-fold higher concns. of ABT-869 are required for inhibition of proliferation.  However, ABT-869 exhibits potent antiproliferative and apoptotic effects on cancer cells whose proliferation is dependent on mutant kinases, such as FLT3.  In vivo ABT-869 is effective orally in the mechanism-based murine models of VEGF-induced uterine edema (ED50 = 0.5 mg/kg) and corneal angiogenesis (>50% inhibition, 15 mg/kg).  In tumor growth studies, ABT-869 exhibits efficacy in human fibrosarcoma and breast, colon, and small cell lung carcinoma xenograft models (ED50 = 1.5-5 mg/kg, twice daily) and is also effective (>50% inhibition) in orthotopic breast and glioma models.  Redn. in tumor size and tumor regression was obsd. in epidermoid carcinoma and leukemia xenograft models, resp.  In combination, ABT-869 produced at least additive effects when given with cytotoxic therapies.  Based on pharmacokinetic anal. from tumor growth studies, efficacy correlated more strongly with time over a threshold value (cellular KDR IC50 cor. for blood plasma protein binding = 0.08 μg/mL, ≥7 h) than with plasma area under the curve or Cmax.  These results support clin. assessment of ABT-869 as a therapeutic agent for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkn2KBvMa4wrVg90H21EOLACvtfcHk0lhzqzB3dtLOYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D&md5=a5a60b591b4da7a3c589f1618d9cffb9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1535-7163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DReuter%26aufirst%3DD.%2BR.%26aulast%3DWei%26aufirst%3DR.%2BQ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DGhoreishi-Haack%26aufirst%3DN.%2BS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DBukofzer%26aufirst%3DG.%2BT.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DStavropoulos%26aufirst%3DJ.%2BA.%26aulast%3DHartandi%26aufirst%3DK.%26aulast%3DNiquette%26aufirst%3DA.%2BL.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DMcCall%26aufirst%3DJ.%2BO.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26atitle%3DPreclinical%2520activity%2520of%2520ABT-869%252C%2520a%2520multitargeted%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Cancer.%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D995%26epage%3D1006%26doi%3D10.1158%2F1535-7163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Chen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beachy, P. A.</span><span> </span><span class="NLM_article-title">Inhibition of hedgehog signaling by direct binding of cyclopamine to Smoothened</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2743</span><span class="NLM_x">–</span> <span class="NLM_lpage">2274</span><span class="refDoi"> DOI: 10.1101/gad.1025302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1101%2Fgad.1025302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=12414725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1Sju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=2743-2274&author=J.+K.+Chenauthor=J.+Taipaleauthor=M.+K.+Cooperauthor=P.+A.+Beachy&title=Inhibition+of+hedgehog+signaling+by+direct+binding+of+cyclopamine+to+Smoothened&doi=10.1101%2Fgad.1025302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened</span></div><div class="casAuthors">Chen, James K.; Taipale, Jussi; Cooper, Michael K.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2743-2748</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The steroidal alkaloid cyclopamine has both teratogenic and antitumor activities arising from its ability to specifically block cellular responses to vertebrate Hedgehog signaling.  We show here, using photoaffinity and fluorescent derivs., that this inhibitory effect is mediated by direct binding of cyclopamine to the heptahelical bundle of Smoothened (Smo).  Cyclopamine also can reverse the retention of partially misfolded Smo in the endoplasmic reticulum, presumably through binding-mediated effects on protein conformation.  These observations reveal the mechanism of cyclopamine's teratogenic and antitumor activities and further suggest a role for small mols. in the physiol. regulation of Smo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbLTFYxWwjf7Vg90H21EOLACvtfcHk0lhzqzB3dtLOYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1Sju7o%253D&md5=84dafbf5668c65282470e5fd43876db6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1101%2Fgad.1025302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1025302%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BK.%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DM.%2BK.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DInhibition%2520of%2520hedgehog%2520signaling%2520by%2520direct%2520binding%2520of%2520cyclopamine%2520to%2520Smoothened%26jtitle%3DGenes%2520Dev.%26date%3D2002%26volume%3D16%26spage%3D2743%26epage%3D2274%26doi%3D10.1101%2Fgad.1025302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gunzner, J.; Sutherlin, D.; Stanley, M.; Bao, L.; Castanedo, G.; Lalonde, R.; Wang, S.; Reynolds, M.; Savage, S.; Malesky, K.; Dina, M.</span><span> </span><span class="NLM_article-title">Preparation of arylpyridines as inhibitors of hedgehog signalling</span>. PCT Int. Appl. WO 2006028958 A2, March 16,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+Gunzner&author=D.+Sutherlin&author=M.+Stanley&author=L.+Bao&author=G.+Castanedo&author=R.+Lalonde&author=S.+Wang&author=M.+Reynolds&author=S.+Savage&author=K.+Malesky&author=M.+Dina&title=Preparation+of+arylpyridines+as+inhibitors+of+hedgehog+signalling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGunzner%26aufirst%3DJ.%26atitle%3DPreparation%2520of%2520arylpyridines%2520as%2520inhibitors%2520of%2520hedgehog%2520signalling%26jtitle%3DPCT%2520Int.%2520Appl.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gooden, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barak, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyerly, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span> </span><span class="NLM_article-title">Identification of a novel smoothened antagonist that potently suppresses hedgehog signaling</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6751</span><span class="NLM_x">–</span> <span class="NLM_lpage">6757</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.bmc.2012.09.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6751-6757&author=J.+Wangauthor=R.+A.+Mookauthor=J.+Luauthor=D.+M.+Goodenauthor=A.+Ribeiroauthor=A.+Guoauthor=L.+S.+Barakauthor=H.+K.+Lyerlyauthor=W.+Chen&title=Identification+of+a+novel+smoothened+antagonist+that+potently+suppresses+hedgehog+signaling&doi=10.1016%2Fj.bmc.2012.09.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DGooden%26aufirst%3DD.%2BM.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DA.%26aulast%3DBarak%26aufirst%3DL.%2BS.%26aulast%3DLyerly%26aufirst%3DH.%2BK.%26aulast%3DChen%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520a%2520novel%2520smoothened%2520antagonist%2520that%2520potently%2520suppresses%2520hedgehog%2520signaling%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6751%26epage%3D6757%26doi%3D10.1016%2Fj.bmc.2012.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Rahnama, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimokawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teglund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toftgård, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaphiropoulos, P. G.</span><span> </span><span class="NLM_article-title">Inhibition of GLI1 gene activation by Patched1</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">394</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1042/BJ20050941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1042%2FBJ20050941" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2006&pages=19-26&author=F.+Rahnamaauthor=T.+Shimokawaauthor=M.+Lauthauthor=C.+Fintaauthor=P.+Kogermanauthor=S.+Teglundauthor=R.+Toftg%C3%A5rdauthor=P.+G.+Zaphiropoulos&title=Inhibition+of+GLI1+gene+activation+by+Patched1&doi=10.1042%2FBJ20050941"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1042%2FBJ20050941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20050941%26sid%3Dliteratum%253Aachs%26aulast%3DRahnama%26aufirst%3DF.%26aulast%3DShimokawa%26aufirst%3DT.%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DFinta%26aufirst%3DC.%26aulast%3DKogerman%26aufirst%3DP.%26aulast%3DTeglund%26aufirst%3DS.%26aulast%3DToftg%25C3%25A5rd%26aufirst%3DR.%26aulast%3DZaphiropoulos%26aufirst%3DP.%2BG.%26atitle%3DInhibition%2520of%2520GLI1%2520gene%2520activation%2520by%2520Patched1%26jtitle%3DBiochem.%2520J.%26date%3D2006%26volume%3D394%26spage%3D19%26epage%3D26%26doi%3D10.1042%2FBJ20050941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Frank-Kamenetsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guicherit, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichterle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumcrot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulok, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. A.</span><span> </span><span class="NLM_article-title">Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists</span> <span class="citation_source-journal">J. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="refDoi"> DOI: 10.1186/1475-4924-1-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1186%2F1475-4924-1-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=12437772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BD2czltlGjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=10&author=M.+Frank-Kamenetskyauthor=X.+M.+Zhangauthor=S.+Bottegaauthor=O.+Guicheritauthor=H.+Wichterleauthor=H.+Dudekauthor=D.+Bumcrotauthor=F.+Y.+Wangauthor=S.+Jonesauthor=J.+Shulokauthor=L.+L.+Rubinauthor=J.+A.+Porter&title=Small-molecule+modulators+of+Hedgehog+signaling%3A+identification+and+characterization+of+Smoothened+agonists+and+antagonists&doi=10.1186%2F1475-4924-1-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists</span></div><div class="casAuthors">Frank-Kamenetsky Maria; Zhang Xiaoyan M; Bottega Steve; Guicherit Oivin; Wichterle Hynek; Dudek Henryk; Bumcrot David; Wang Frank Y; Jones Simon; Shulok Janine; Rubin Lee L; Porter Jeffery A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The Hedgehog (Hh) signaling pathway is vital to animal development as it mediates the differentiation of multiple cell types during embryogenesis.  In adults, Hh signaling can be activated to facilitate tissue maintenance and repair.  Moreover, stimulation of the Hh pathway has shown therapeutic efficacy in models of neuropathy.  The underlying mechanisms of Hh signal transduction remain obscure, however: little is known about the communication between the pathway suppressor Patched (Ptc), a multipass transmembrane protein that directly binds Hh, and the pathway activator Smoothened (Smo), a protein that is related to G-protein-coupled receptors and is capable of constitutive activation in the absence of Ptc.  RESULTS:  We have identified and characterized a synthetic non-peptidyl small molecule, Hh-Ag, that acts as an agonist of the Hh pathway.  This Hh agonist promotes cell-type-specific proliferation and concentration-dependent differentiation in vitro, while in utero it rescues aspects of the Hh-signaling defect in Sonic hedgehog-null, but not Smo-null, mouse embryos.  Biochemical studies with Hh-Ag, the Hh-signaling antagonist cyclopamine, and a novel Hh-signaling inhibitor Cur61414, reveal that the action of all these compounds is independent of Hh-protein ligand and of the Hh receptor Ptc, as each binds directly to Smo.  CONCLUSIONS:  Smo can have its activity modulated directly by synthetic small molecules.  These studies raise the possibility that Hh signaling may be regulated by endogenous small molecules in vivo and provide potent compounds with which to test the therapeutic value of activating the Hh-signaling pathway in the treatment of traumatic and chronic degenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgamHYwQTiLwWRJ3OJdH_qfW6udTcc2eZ53cMP8L-Tzbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czltlGjtw%253D%253D&md5=7790e4fe15fecdf4be53946a4c338c01</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1186%2F1475-4924-1-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-4924-1-10%26sid%3Dliteratum%253Aachs%26aulast%3DFrank-Kamenetsky%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%2BM.%26aulast%3DBottega%26aufirst%3DS.%26aulast%3DGuicherit%26aufirst%3DO.%26aulast%3DWichterle%26aufirst%3DH.%26aulast%3DDudek%26aufirst%3DH.%26aulast%3DBumcrot%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DF.%2BY.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DShulok%26aufirst%3DJ.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520modulators%2520of%2520Hedgehog%2520signaling%253A%2520identification%2520and%2520characterization%2520of%2520Smoothened%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Biol.%26date%3D2002%26volume%3D1%26spage%3D10%26doi%3D10.1186%2F1475-4924-1-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Rosell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wannesson, L.</span><span> </span><span class="NLM_article-title">A genetic snapshot of small cell lung cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">771</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F2159-8290.CD-12-0346" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=769-771&author=R.+Rosellauthor=L.+Wannesson&title=A+genetic+snapshot+of+small+cell+lung+cancer&doi=10.1158%2F2159-8290.CD-12-0346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0346%26sid%3Dliteratum%253Aachs%26aulast%3DRosell%26aufirst%3DR.%26aulast%3DWannesson%26aufirst%3DL.%26atitle%3DA%2520genetic%2520snapshot%2520of%2520small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2012%26volume%3D2%26spage%3D769%26epage%3D771%26doi%3D10.1158%2F2159-8290.CD-12-0346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englund, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peukert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Moslin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pferdekamper, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, J. F.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsch, M.</span><span> </span><span class="NLM_article-title">Discovery of NVP-LDE225, a potent and selective smoothened antagonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span><span class="refDoi"> DOI: 10.1021/ml1000307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1Cqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=130-134&author=S.+Panauthor=X.+Wuauthor=J.+Jiangauthor=W.+Gaoauthor=Y.+Wanauthor=D.+Chengauthor=D.+Hanauthor=J.+Liuauthor=N.+P.+Englundauthor=Y.+Wangauthor=S.+Peukertauthor=K.+Miller-Moslinauthor=J.+Yuanauthor=R.+Guoauthor=M.+Matsumotoauthor=A.+Vattayauthor=Y.+Jiangauthor=J.+Tsaoauthor=F.+Sunauthor=A.+C.+Pferdekamperauthor=S.+Doddauthor=T.+Tuntlandauthor=W.+Maniaraauthor=J.+F.+Kelleherauthor=Y.+M.+Yaoauthor=M.+Warmuthauthor=J.+Williamsauthor=M.+Dorsch&title=Discovery+of+NVP-LDE225%2C+a+potent+and+selective+smoothened+antagonist&doi=10.1021%2Fml1000307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist</span></div><div class="casAuthors">Pan, Shifeng; Wu, Xu; Jiang, Jiqing; Gao, Wenqi; Wan, Yongqin; Cheng, Dai; Han, Dong; Liu, Jun; Englund, Nathan P.; Wang, Yan; Peukert, Stefan; Miller-Moslin, Karen; Yuan, Jing; Guo, Ribo; Matsumoto, Melissa; Vattay, Anthony; Jiang, Yun; Tsao, Jeffrey; Sun, Fangxian; Pferdekamper, AnneMarie C.; Dodd, Stephanie; Tuntland, Tove; Maniara, Wieslawa; Kelleher, Joseph F., III; Yao, Yung-mae; Warmuth, Markus; Williams, Juliet; Dorsch, Marion</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-134</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The blockade of aberrant hedgehog (Hh) signaling has shown promise for therapeutic intervention in cancer.  A cell-based phenotypic high-throughput screen was performed, and the lead structure (1) was identified as an inhibitor of the Hh pathway via antagonism of the Smoothened receptor (Smo).  Structure-activity relation studies led to the discovery of a potent and specific Smoothened antagonist N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide (5m, NVP-LDE225), which is currently in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkXrdZB74WfbVg90H21EOLACvtfcHk0lj7nFmMUJCM-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1Cqt7c%253D&md5=c4d1348e8d47ed9561151ce59305531e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fml1000307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000307%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEnglund%26aufirst%3DN.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DTsao%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DPferdekamper%26aufirst%3DA.%2BC.%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26aulast%3DYao%26aufirst%3DY.%2BM.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DDorsch%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520NVP-LDE225%252C%2520a%2520potent%2520and%2520selective%2520smoothened%2520antagonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D130%26epage%3D134%26doi%3D10.1021%2Fml1000307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruganti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramphal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D. B.</span><span> </span><span class="NLM_article-title">A selective small molecule inhibitor of MET kinase inhibits METdependent phenotypes in vitro and exhibits cytoreductive antimutor activity in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7345</span><span class="NLM_x">–</span> <span class="NLM_lpage">7355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7345-7355&author=J.+G.+Christensenauthor=R.+Schreckauthor=J.+Burrowsauthor=P.+Kurugantiauthor=E.+Chanauthor=P.+Leauthor=J.+Chenauthor=X.+Wangauthor=L.+Ruslimauthor=R.+Blakeauthor=K.+E.+Lipsonauthor=J.+Ramphalauthor=S.+Doauthor=J.+J.+Cuiauthor=J.+M.+Cherringtonauthor=D.+B.+Mendel&title=A+selective+small+molecule+inhibitor+of+MET+kinase+inhibits+METdependent+phenotypes+in+vitro+and+exhibits+cytoreductive+antimutor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DKuruganti%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DBlake%26aufirst%3DR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DRamphal%26aufirst%3DJ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DA%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520MET%2520kinase%2520inhibits%2520METdependent%2520phenotypes%2520in%2520vitro%2520and%2520exhibits%2520cytoreductive%2520antimutor%2520activity%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7345%26epage%3D7355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halsey, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathe, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span> </span><span class="NLM_article-title">Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6871</span><span class="NLM_x">–</span> <span class="NLM_lpage">6878</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F0008-5472.CAN-08-4490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6871-6878&author=L.+Liuauthor=J.+Gregerauthor=H.+Shiauthor=Y.+Liuauthor=J.+Greshockauthor=R.+Annanauthor=W.+Halseyauthor=G.+M.+Satheauthor=A.-M.+Martinauthor=T.+M.+Gilmer&title=Novel+mechanism+of+lapatinib+resistance+in+HER2-positive+breast+tumor+cells%3A+activation+of+AXL&doi=10.1158%2F0008-5472.CAN-08-4490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4490%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGreger%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DAnnan%26aufirst%3DR.%26aulast%3DHalsey%26aufirst%3DW.%26aulast%3DSathe%26aufirst%3DG.%2BM.%26aulast%3DMartin%26aufirst%3DA.-M.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DNovel%2520mechanism%2520of%2520lapatinib%2520resistance%2520in%2520HER2-positive%2520breast%2520tumor%2520cells%253A%2520activation%2520of%2520AXL%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6871%26epage%3D6878%26doi%3D10.1158%2F0008-5472.CAN-08-4490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Role of AXL expression in non-small cell lung cancer</span> <span class="citation_source-journal">Oncol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5085</span><span class="NLM_x">–</span> <span class="NLM_lpage">5091</span><span class="refDoi"> DOI: 10.3892/ol.2016.5356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.3892%2Fol.2016.5356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=28105215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BC1c7nsFWqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=5085-5091&author=X.+Quauthor=J.+Liuauthor=X.+Zhongauthor=X.+Liauthor=Q.+Zhang&title=Role+of+AXL+expression+in+non-small+cell+lung+cancer&doi=10.3892%2Fol.2016.5356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Role of AXL expression in non-small cell lung cancer</span></div><div class="casAuthors">Qu Xiaohan; Zhong Xinwen; Li Xi; Zhang Qigang; Liu Jinlu</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">5085-5091</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">The present study aimed to investigate the expression profile of AXL in non-small cell lung cancer (NSCLC) and its clinical significance.  The current study included 257 NSCLC patients, tyrosine-protein kinase receptor UFO (AXL) expression in paired lung cancer and adjacent normal lung tissues of NSCLC patients were compared by immunohistochemistry, western blot analysis and quantitative polymerase chain reaction (qPCR).  These methods were used to detect the expression of the AXL gene and protein in fresh tissues from 35 patients.  Small interfering RNA (siRNA) was transfected into the H1299 lung cancer cell line to knock down AXL expression; the effects of AXL-siRNA on cell proliferation and migration were examined by MTT and Transwell migration assay, respectively.  It was found that AXL staining density in lung cancer tissues was significantly increased compared with adjacent normal lung tissues (55.25 vs. 26.85%; P<0.01); and the expression level of AXL in NSCLC patients was significantly associated with the degree of tumor differentiation (P<0.01) and the clinical stage of disease (P<0.01).  Western blotting and qPCR showed that AXL expression was significantly higher in cancer tissues compared with that in adjacent lung tissue (P<0.05).  Additionally, the current study also showed that AXL-siRNA inhibited H1299 cell proliferation and migration in vitro.  The present study demonstrates the association between increased expression of AXL in NSCLC and the low differentiation phenotype, and its effects on cell proliferation and migration, suggesting its potential clinical values for the prognosis of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIJGiIlA3U8bFU0A1HOshhfW6udTcc2eZC0EOoJcwOM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7nsFWqtA%253D%253D&md5=25e218b7e52998c98136cf1e932dcd93</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3892%2Fol.2016.5356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2016.5356%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DRole%2520of%2520AXL%2520expression%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DOncol.%2520Lett.%26date%3D2016%26volume%3D12%26spage%3D5085%26epage%3D5091%26doi%3D10.3892%2Fol.2016.5356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Xu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span> </span><span class="NLM_article-title">C5-substituted pyrido[2,3-<i>d</i>]pyrimidin-7-ones as highly specific kinase inhibitors targeting the clinical resistance-related EGFR<sup>T790M</sup> mutant</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1697</span><span class="refDoi"> DOI: 10.1039/C5MD00208G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1039%2FC5MD00208G" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1693-1697&author=T.+Xuauthor=T.+Pengauthor=X.+Renauthor=L.+Zhangauthor=L.+Yuauthor=J.+Luoauthor=Z.+Zhangauthor=Z.+Tuauthor=L.+Tongauthor=Z.+Huangauthor=X.+Luauthor=M.+Gengauthor=H.+Xieauthor=J.+Dingauthor=K.+Ding&title=C5-substituted+pyrido%5B2%2C3-d%5Dpyrimidin-7-ones+as+highly+specific+kinase+inhibitors+targeting+the+clinical+resistance-related+EGFRT790M+mutant&doi=10.1039%2FC5MD00208G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2FC5MD00208G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00208G%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DT.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DC5-substituted%2520pyrido%255B2%252C3-d%255Dpyrimidin-7-ones%2520as%2520highly%2520specific%2520kinase%2520inhibitors%2520targeting%2520the%2520clinical%2520resistance-related%2520EGFRT790M%2520mutant%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1693%26epage%3D1697%26doi%3D10.1039%2FC5MD00208G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Cross, D. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiorghiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebhan, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitzler, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orme, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, M. R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Kadhimi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinowska, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, G. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantarini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span> </span><span class="NLM_article-title">AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-14-0337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F2159-8290.CD-14-0337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=24893891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVykur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=1046-1061&author=D.+A.+E.+Crossauthor=S.+E.+Ashtonauthor=S.+Ghiorghiuauthor=C.+Eberleinauthor=C.+A.+Nebhanauthor=P.+J.+Spitzlerauthor=J.+P.+Ormeauthor=M.+R.+V.+Finlayauthor=R.+A.+Wardauthor=M.+J.+Mellorauthor=G.+Hughesauthor=A.+Rahiauthor=V.+N.+Jacobsauthor=M.+R.+Brewerauthor=E.+Ichiharaauthor=J.+Sunauthor=H.+Jinauthor=P.+Ballardauthor=K.+Al-Kadhimiauthor=R.+Rowlinsonauthor=T.+Klinowskaauthor=G.+H.+P.+Richmondauthor=M.+Cantariniauthor=D.+W.+Kimauthor=M.+R.+Ransonauthor=W.+Pao&title=AZD9291%2C+an+irreversible+EGFR+TKI%2C+overcomes+T790M-mediated+resistance+to+EGFR+inhibitors+in+lung+cancer&doi=10.1158%2F2159-8290.CD-14-0337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer</span></div><div class="casAuthors">Cross, Darren A. E.; Ashton, Susan E.; Ghiorghiu, Serban; Eberlein, Cath; Nebhan, Caroline A.; Spitzler, Paula J.; Orme, Jonathon P.; Finlay, M. Raymond V.; Ward, Richard A.; Mellor, Martine J.; Hughes, Gareth; Rahi, Amar; Jacobs, Vivien N.; Brewer, Monica Red; Ichihara, Eiki; Sun, Jing; Jin, Hailing; Ballard, Peter; Al-Kadhimi, Katherine; Rowlinson, Rachel; Klinowska, Teresa; Richmond, Graham H. P.; Cantarini, Mireille; Kim, Dong-Wan; Ranson, Malcolm R.; Pao, William</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1046-1061</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A third-generation EGFR inhibitor selectively targets EGFR mutants, including T790M, but not wild-type EGFR, and induces durable antitumor responses in preclin. models and patients with NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDo3e2pAh8YbVg90H21EOLACvtfcHk0lhEzZSAR0KFwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVykur%252FP&md5=f72e56f9463236ddc89eef32a4ab61b3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-14-0337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-14-0337%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DD.%2BA.%2BE.%26aulast%3DAshton%26aufirst%3DS.%2BE.%26aulast%3DGhiorghiu%26aufirst%3DS.%26aulast%3DEberlein%26aufirst%3DC.%26aulast%3DNebhan%26aufirst%3DC.%2BA.%26aulast%3DSpitzler%26aufirst%3DP.%2BJ.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DMellor%26aufirst%3DM.%2BJ.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DRahi%26aufirst%3DA.%26aulast%3DJacobs%26aufirst%3DV.%2BN.%26aulast%3DBrewer%26aufirst%3DM.%2BR.%26aulast%3DIchihara%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DBallard%26aufirst%3DP.%26aulast%3DAl-Kadhimi%26aufirst%3DK.%26aulast%3DRowlinson%26aufirst%3DR.%26aulast%3DKlinowska%26aufirst%3DT.%26aulast%3DRichmond%26aufirst%3DG.%2BH.%2BP.%26aulast%3DCantarini%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DD.%2BW.%26aulast%3DRanson%26aufirst%3DM.%2BR.%26aulast%3DPao%26aufirst%3DW.%26atitle%3DAZD9291%252C%2520an%2520irreversible%2520EGFR%2520TKI%252C%2520overcomes%2520T790M-mediated%2520resistance%2520to%2520EGFR%2520inhibitors%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2014%26volume%3D4%26spage%3D1046%26epage%3D1061%26doi%3D10.1158%2F2159-8290.CD-14-0337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Bonfils, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ste-Croix, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroun, C. R.</span><span> </span><span class="NLM_article-title">The combination of MGCD265, a Met/VEGFR inhibitor in clinical development, and erlotinib potently inhibits tumor growth by altering multiple pathways including glycolysis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1790</span><span class="NLM_x">–</span> <span class="NLM_lpage">1790</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2012-1790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F1538-7445.AM2012-1790" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=1790-1790&author=C.+Bonfilsauthor=N.+Beaulieuauthor=M.+Fournelauthor=H.+Ste-Croixauthor=J.+M.+Bestermanauthor=C.+R.+Maroun&title=The+combination+of+MGCD265%2C+a+Met%2FVEGFR+inhibitor+in+clinical+development%2C+and+erlotinib+potently+inhibits+tumor+growth+by+altering+multiple+pathways+including+glycolysis&doi=10.1158%2F1538-7445.AM2012-1790"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2012-1790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2012-1790%26sid%3Dliteratum%253Aachs%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DBeaulieu%26aufirst%3DN.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DSte-Croix%26aufirst%3DH.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DMaroun%26aufirst%3DC.%2BR.%26atitle%3DThe%2520combination%2520of%2520MGCD265%252C%2520a%2520Met%252FVEGFR%2520inhibitor%2520in%2520clinical%2520development%252C%2520and%2520erlotinib%2520potently%2520inhibits%2520tumor%2520growth%2520by%2520altering%2520multiple%2520pathways%2520including%2520glycolysis%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D1790%26epage%3D1790%26doi%3D10.1158%2F1538-7445.AM2012-1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ge, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span> </span><span class="NLM_article-title">Sonic hedgehog stimulates glycolysis and proliferation of breast cancer cells: modulation of PFKFB3 activation</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">464</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2015.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.bbrc.2015.07.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2015&pages=862-868&author=X.+Geauthor=P.+Lyuauthor=Y.+Guauthor=L.+Liauthor=J.+Liauthor=Y.+Wangauthor=L.+Zhangauthor=C.+Fuauthor=Z.+Cao&title=Sonic+hedgehog+stimulates+glycolysis+and+proliferation+of+breast+cancer+cells%3A+modulation+of+PFKFB3+activation&doi=10.1016%2Fj.bbrc.2015.07.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DX.%26aulast%3DLyu%26aufirst%3DP.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DZ.%26atitle%3DSonic%2520hedgehog%2520stimulates%2520glycolysis%2520and%2520proliferation%2520of%2520breast%2520cancer%2520cells%253A%2520modulation%2520of%2520PFKFB3%2520activation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D464%26spage%3D862%26epage%3D868%26doi%3D10.1016%2Fj.bbrc.2015.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Faria, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golbourn, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubuc, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnihotri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garzia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaswamy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leadley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northcott, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croul, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korshunov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutka, J. T.</span><span> </span><span class="NLM_article-title">Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-3629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F0008-5472.CAN-13-3629" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=134-146&author=C.+C.+Fariaauthor=B.+J.+Golbournauthor=A.+M.+Dubucauthor=M.+Remkeauthor=R.+J.+Diazauthor=S.+Agnihotriauthor=A.+Luckauthor=N.+Sabhaauthor=S.+Olsenauthor=X.+Wuauthor=L.+Garziaauthor=V.+Ramaswamyauthor=S.+C.+Mackauthor=X.+Wangauthor=M.+Leadleyauthor=D.+Reynaudauthor=L.+Erminiauthor=M.+Postauthor=P.+A.+Northcottauthor=S.+M.+Pfisterauthor=S.+E.+Croulauthor=M.+Koolauthor=A.+Korshunovauthor=C.+A.+Smithauthor=M.+D.+Taylorauthor=J.+T.+Rutka&title=Foretinib+is+effective+therapy+for+metastatic+sonic+hedgehog+medulloblastoma&doi=10.1158%2F0008-5472.CAN-13-3629"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-3629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-3629%26sid%3Dliteratum%253Aachs%26aulast%3DFaria%26aufirst%3DC.%2BC.%26aulast%3DGolbourn%26aufirst%3DB.%2BJ.%26aulast%3DDubuc%26aufirst%3DA.%2BM.%26aulast%3DRemke%26aufirst%3DM.%26aulast%3DDiaz%26aufirst%3DR.%2BJ.%26aulast%3DAgnihotri%26aufirst%3DS.%26aulast%3DLuck%26aufirst%3DA.%26aulast%3DSabha%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGarzia%26aufirst%3DL.%26aulast%3DRamaswamy%26aufirst%3DV.%26aulast%3DMack%26aufirst%3DS.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLeadley%26aufirst%3DM.%26aulast%3DReynaud%26aufirst%3DD.%26aulast%3DErmini%26aufirst%3DL.%26aulast%3DPost%26aufirst%3DM.%26aulast%3DNorthcott%26aufirst%3DP.%2BA.%26aulast%3DPfister%26aufirst%3DS.%2BM.%26aulast%3DCroul%26aufirst%3DS.%2BE.%26aulast%3DKool%26aufirst%3DM.%26aulast%3DKorshunov%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DC.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%2BD.%26aulast%3DRutka%26aufirst%3DJ.%2BT.%26atitle%3DForetinib%2520is%2520effective%2520therapy%2520for%2520metastatic%2520sonic%2520hedgehog%2520medulloblastoma%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D134%26epage%3D146%26doi%3D10.1158%2F0008-5472.CAN-13-3629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Chen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beachy, P. A.</span><span> </span><span class="NLM_article-title">Small molecule modulation of smoothened activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">14071</span><span class="NLM_x">–</span> <span class="NLM_lpage">14076</span><span class="refDoi"> DOI: 10.1073/pnas.182542899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1073%2Fpnas.182542899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=12391318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD38XosF2itro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=14071-14076&author=J.+K.+Chenauthor=J.+Taipaleauthor=K.+E.+Youngauthor=T.+Maitiauthor=P.+A.+Beachy&title=Small+molecule+modulation+of+smoothened+activity&doi=10.1073%2Fpnas.182542899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule modulation of Smoothened activity</span></div><div class="casAuthors">Chen, James K.; Taipale, Jussi; Young, Keith E.; Maiti, Tapan; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">14071-14076</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Smoothened (Smo), a distant relative of G protein-coupled receptors, mediates Hedgehog (Hh) signaling during embryonic development and can initiate or transmit ligand-independent pathway activation in tumorigenesis.  Although the cellular mechanisms that regulate Smo function remain unclear, the direct inhibition of Smo by cyclopamine, a plant-derived steroidal alkaloid, suggests that endogenous small mols. may be involved.  Here we demonstrate that SAG, a chlorobenzothiophene-contg. Hh pathway agonist, binds to the Smo heptahelical bundle in a manner that antagonizes cyclopamine action.  In addn., we have identified four small mols. that directly inhibit Smo activity but are structurally distinct from cyclopamine.  Functional and biochem. studies of these compds. provide evidence for the small mol. modulation of Smo through multiple mechanisms and yield insights into the physiol. regulation of Smo activity.  The mechanistic differences between the Smo antagonists may be useful in the therapeutic manipulation of Hh signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGuyQOc-zOmrVg90H21EOLACvtfcHk0lhaJooPUk3Zuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosF2itro%253D&md5=c3573be833dbdb00ba569b57ad373f10</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.182542899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.182542899%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BK.%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DK.%2BE.%26aulast%3DMaiti%26aufirst%3DT.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DSmall%2520molecule%2520modulation%2520of%2520smoothened%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D14071%26epage%3D14076%26doi%3D10.1073%2Fpnas.182542899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4355</span><span class="refDoi"> DOI: 10.1038/ncomms5355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fncomms5355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=25008467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVert7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4355&author=C.+Wangauthor=H.+Wuauthor=T.+Evronauthor=E.+Vardyauthor=G.+W.+Hanauthor=X.-P.+Huangauthor=S.+J.+Hufeisenauthor=T.+J.+Manganoauthor=D.+J.+Urbanauthor=V.+Katritchauthor=V.+Cherezovauthor=M.+G.+Caronauthor=B.+L.+Rothauthor=R.+C.+Stevens&title=Structural+basis+for+Smoothened+receptor+modulation+and+chemoresistance+to+anticancer+drugs&doi=10.1038%2Fncomms5355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs</span></div><div class="casAuthors">Wang, Chong; Wu, Huixian; Evron, Tama; Vardy, Eyal; Han, Gye Won; Huang, Xi-Ping; Hufeisen, Sandy J.; Mangano, Thomas J.; Urban, Dan J.; Katritch, Vsevolod; Cherezov, Vadim; Caron, Marc G.; Roth, Bryan L.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4355</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Smoothened receptor (SMO) mediates signal transduction in the hedgehog pathway, which is implicated in normal development and carcinogenesis.  SMO antagonists can suppress the growth of some tumors; however, mutations at SMO have been found to abolish their antitumor effects, a phenomenon known as chemoresistance.  Here we report three crystal structures of human SMO bound to the antagonists SANT1 and Anta XV, and the agonist, SAG1.5, at 2.6-2.8 Å resoln.  The long and narrow cavity in the transmembrane domain of SMO harbours multiple ligand binding sites, where SANT1 binds at a deeper site as compared with other ligands.  Distinct interactions at D4736.54f elucidated the structural basis for the differential effects of chemoresistance mutations on SMO antagonists.  The agonist SAG1.5 induces a conformational rearrangement of the binding pocket residues, which could contribute to SMO activation.  Collectively, these studies reveal the structural basis for the modulation of SMO by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9pbk2DLpA7LVg90H21EOLACvtfcHk0liBk3Fy5XlQkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVert7g%253D&md5=5c7893dd6fd6ee3626a6e9483646c7bd</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fncomms5355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5355%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DEvron%26aufirst%3DT.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DMangano%26aufirst%3DT.%2BJ.%26aulast%3DUrban%26aufirst%3DD.%2BJ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520basis%2520for%2520Smoothened%2520receptor%2520modulation%2520and%2520chemoresistance%2520to%2520anticancer%2520drugs%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D4355%26doi%3D10.1038%2Fncomms5355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Miller-Moslin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peukert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEwan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llamas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusuff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourret, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamurthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, J. F.</span><span> </span><span class="NLM_article-title">III.1-Amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3954</span><span class="NLM_x">–</span> <span class="NLM_lpage">3968</span><span class="refDoi"> DOI: 10.1021/jm900309j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900309j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3954-3968&author=K.+Miller-Moslinauthor=S.+Peukertauthor=R.+K.+Jainauthor=M.+A.+McEwanauthor=R.+Karkiauthor=L.+Llamasauthor=N.+Yusuffauthor=F.+Heauthor=Y.+Liauthor=Y.+Sunauthor=M.+Daiauthor=L.+Perezauthor=W.+Michaelauthor=T.+Shengauthor=H.+Leiauthor=R.+Zhangauthor=J.+Williamsauthor=A.+Bourretauthor=A.+Ramamurthyauthor=J.+Yuanauthor=R.+Guoauthor=M.+Matsumotoauthor=A.+Vattayauthor=W.+Maniaraauthor=A.+Amaralauthor=M.+Dorschauthor=J.+F.+Kelleher&title=III.1-Amino-4-benzylphthalazines+as+orally+bioavailable+smoothened+antagonists+with+antitumor+activity&doi=10.1021%2Fjm900309j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm900309j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900309j%26sid%3Dliteratum%253Aachs%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DMcEwan%26aufirst%3DM.%2BA.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DLlamas%26aufirst%3DL.%26aulast%3DYusuff%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DMichael%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DBourret%26aufirst%3DA.%26aulast%3DRamamurthy%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DAmaral%26aufirst%3DA.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26atitle%3DIII.1-Amino-4-benzylphthalazines%2520as%2520orally%2520bioavailable%2520smoothened%2520antagonists%2520with%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3954%26epage%3D3968%26doi%3D10.1021%2Fjm900309j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Hipskind, P. A.; Patel, B. K.; Wilson, T.</span><span> </span><span class="NLM_article-title">Preparation of disubstituted phthalazine derivatives for use as hedgehog pathway antagonists and useful in treatment of cancer</span>. PCT Int. Appl. WO 2010147917 A1, Dec 23,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=P.+A.+Hipskind&author=B.+K.+Patel&author=T.+Wilson&title=Preparation+of+disubstituted+phthalazine+derivatives+for+use+as+hedgehog+pathway+antagonists+and+useful+in+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHipskind%26aufirst%3DP.%2BA.%26atitle%3DPreparation%2520of%2520disubstituted%2520phthalazine%2520derivatives%2520for%2520use%2520as%2520hedgehog%2520pathway%2520antagonists%2520and%2520useful%2520in%2520treatment%2520of%2520cancer%26jtitle%3DPCT%2520Int.%2520Appl.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structure of the human smoothened receptor bound to an antitumour agent</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">497</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span><span class="refDoi"> DOI: 10.1038/nature12167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fnature12167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=23636324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFylsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2013&pages=338-343&author=C.+Wangauthor=H.+Wuauthor=V.+Katritchauthor=G.+W.+Hanauthor=X.-P.+Huangauthor=W.+Liuauthor=F.+Y.+Siuauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+smoothened+receptor+bound+to+an+antitumour+agent&doi=10.1038%2Fnature12167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human smoothened receptor bound to an antitumour agent</span></div><div class="casAuthors">Wang, Chong; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Huang, Xi-Ping; Liu, Wei; Siu, Fai Yiu; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">497</span>
        (<span class="NLM_cas:issue">7449</span>),
    <span class="NLM_cas:pages">338-343</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The smoothened (SMO) receptor, a key signal transducer in the hedgehog signalling pathway, is responsible for the maintenance of normal embryonic development and is implicated in carcinogenesis.  It is classified as a class frizzled (class F) G-protein-coupled receptor (GPCR), although the canonical hedgehog signalling pathway involves the GLI transcription factors and the sequence similarity with class A GPCRs is less than 10%.  Here we report the crystal structure of the transmembrane domain of the human SMO receptor bound to the small-mol. antagonist LY2940680 at 2.5 Å resoln.  Although the SMO receptor shares the seven-transmembrane helical (7TM) fold, most of the conserved motifs for class A GPCRs are absent, and the structure reveals an unusually complex arrangement of long extracellular loops stabilized by four disulfide bonds.  The ligand binds at the extracellular end of the seven-transmembrane-helix bundle and forms extensive contacts with the loops.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmaIV6OXnzIrVg90H21EOLACvtfcHk0liRpNWWNtok1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFylsb0%253D&md5=fdd96ac77bcf93d5c8da46e5630795b2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature12167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12167%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSiu%26aufirst%3DF.%2BY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520smoothened%2520receptor%2520bound%2520to%2520an%2520antitumour%2520agent%26jtitle%3DNature%26date%3D2013%26volume%3D497%26spage%3D338%26epage%3D343%26doi%3D10.1038%2Fnature12167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Weierstall, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, J. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doak, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromme, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromme, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotjohann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatsepin, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messerschmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koglin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoeman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirian, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyerlein, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span> </span><span class="NLM_article-title">Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="refDoi"> DOI: 10.1038/ncomms4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fncomms4309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=24525480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BC2cvltVeqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3309&author=U.+Weierstallauthor=D.+Jamesauthor=C.+Wangauthor=T.+A.+Whiteauthor=D.+Wangauthor=W.+Liuauthor=J.+C.+H.+Spenceauthor=R.+B.+Doakauthor=G.+Nelsonauthor=P.+Frommeauthor=R.+Frommeauthor=I.+Grotjohannauthor=C.+Kupitzauthor=N.+A.+Zatsepinauthor=H.+Liuauthor=S.+Basuauthor=D.+Wackerauthor=G.+W.+Hanauthor=V.+Katritchauthor=S.+Boutetauthor=M.+Messerschmidtauthor=G.+J.+Williamsauthor=J.+E.+Koglinauthor=M.+M.+Seibertauthor=M.+Klinkerauthor=C.+Gatiauthor=R.+L.+Shoemanauthor=A.+Bartyauthor=H.+N.+Chapmanauthor=R.+A.+Kirianauthor=K.+R.+Beyerleinauthor=R.+C.+Stevensauthor=D.+Liauthor=S.+T.+A.+Shahauthor=N.+Howeauthor=M.+Caffreyauthor=V.+Cherezov&title=Lipidic+cubic+phase+injector+facilitates+membrane+protein+serial+femtosecond+crystallography&doi=10.1038%2Fncomms4309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography</span></div><div class="casAuthors">Weierstall Uwe; James Daniel; Wang Dingjie; Spence John C H; Bruce Doak R; Nelson Garrett; Zatsepin Nadia A; Liu Haiguang; Wang Chong; Liu Wei; Wacker Daniel; Han Gye Won; Katritch Vsevolod; Stevens Raymond C; Cherezov Vadim; White Thomas A; Gati Cornelius; Barty Anton; Beyerlein Kenneth R; Fromme Petra; Fromme Raimund; Grotjohann Ingo; Kupitz Christopher; Basu Shibom; Boutet Sebastien; Messerschmidt Marc; Williams Garth J; Koglin Jason E; Marvin Seibert M; Klinker Markus; Shoeman Robert L; Chapman Henry N; Kirian Richard A; Li Dianfan; Shah Syed T A; Howe Nicole; Caffrey Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3309</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lipidic cubic phase (LCP) crystallization has proven successful for high-resolution structure determination of challenging membrane proteins.  Here we present a technique for extruding gel-like LCP with embedded membrane protein microcrystals, providing a continuously renewed source of material for serial femtosecond crystallography.  Data collected from sub-10-μm-sized crystals produced with less than 0.5 mg of purified protein yield structural insights regarding cyclopamine binding to the Smoothened receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDUg0uqQckxOWhZTslLrfffW6udTcc2ebjDOzu-QtWdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvltVeqsA%253D%253D&md5=ce335fa0a5bfeb8990c836e7f425e2d2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fncomms4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4309%26sid%3Dliteratum%253Aachs%26aulast%3DWeierstall%26aufirst%3DU.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DT.%2BA.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSpence%26aufirst%3DJ.%2BC.%2BH.%26aulast%3DDoak%26aufirst%3DR.%2BB.%26aulast%3DNelson%26aufirst%3DG.%26aulast%3DFromme%26aufirst%3DP.%26aulast%3DFromme%26aufirst%3DR.%26aulast%3DGrotjohann%26aufirst%3DI.%26aulast%3DKupitz%26aufirst%3DC.%26aulast%3DZatsepin%26aufirst%3DN.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DBoutet%26aufirst%3DS.%26aulast%3DMesserschmidt%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DKoglin%26aufirst%3DJ.%2BE.%26aulast%3DSeibert%26aufirst%3DM.%2BM.%26aulast%3DKlinker%26aufirst%3DM.%26aulast%3DGati%26aufirst%3DC.%26aulast%3DShoeman%26aufirst%3DR.%2BL.%26aulast%3DBarty%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DH.%2BN.%26aulast%3DKirian%26aufirst%3DR.%2BA.%26aulast%3DBeyerlein%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DS.%2BT.%2BA.%26aulast%3DHowe%26aufirst%3DN.%26aulast%3DCaffrey%26aufirst%3DM.%26aulast%3DCherezov%26aufirst%3DV.%26atitle%3DLipidic%2520cubic%2520phase%2520injector%2520facilitates%2520membrane%2520protein%2520serial%2520femtosecond%2520crystallography%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D3309%26doi%3D10.1038%2Fncomms4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span>Maestro, <span class="NLM_edition">version 10</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.schrodinger.com/" class="extLink">http://www.schrodinger.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+10%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015%3B+http%3A%2F%2Fwww.schrodinger.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span>Epik, <span class="NLM_edition">version 2.2</span>; <span class="NLM_publisher-name">Schrodinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Epik%2C+version+2.2%3B+Schrodinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DEpik%26pub%3DSchrodinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span>LigPrep, <span class="NLM_edition">version 2.5</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2009&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2785</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span><span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lgSgnFsEYadnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Sanner, M. F.</span><span> </span><span class="NLM_article-title">Python: a programming language for software integration and development</span> <span class="citation_source-journal">J. Mol. Graph. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10660911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=57-61&author=M.+F.+Sanner&title=Python%3A+a+programming+language+for+software+integration+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Python: a programming language for software integration and development</span></div><div class="casAuthors">Sanner, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The use of interpreted languages in biocomputing has been investigated to create a programmable, dynamic environment in which components can be tied together at a high level.  This work has demonstrated the benefits of such an approach and the features of the interpreted language that are key to successful component integration.  This involved Python, an interpreted, interactive, object-oriented programming language.  It provides high-level data structures such as list and associative arrays, dynamic typing and dynamic binding, modules, classes, exceptions, automatic memory management and others.  Python has been found to be instrumental in the mol. modeling research environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCFXA1JC8X7Vg90H21EOLACvtfcHk0lgpFZRLMNDAHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D&md5=3bf94934548080055dda54f68468c656</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26atitle%3DPython%253A%2520a%2520programming%2520language%2520for%2520software%2520integration%2520and%2520development%26jtitle%3DJ.%2520Mol.%2520Graph.%2520Model.%26date%3D1999%26volume%3D17%26spage%3D57%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Pettersen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrin, T. E.</span><span> </span><span class="NLM_article-title">UCSF Chimera: a visualization system for exploratory research and analysis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera%3A+a+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0lgpFZRLMNDAHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera%253A%2520a%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (pains) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28pains%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgv9CYVr6N8rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528pains%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Castellone, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laukkanen, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alì, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutkind, J. S.</span><span> </span><span class="NLM_article-title">Cross talk between the bombesin neuropeptide receptor and sonic hedgehog pathways in small cell lung carcinoma</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1679</span><span class="NLM_x">–</span> <span class="NLM_lpage">1687</span><span class="refDoi"> DOI: 10.1038/onc.2014.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fonc.2014.104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1679-1687&author=M.+D.+Castelloneauthor=M.+O.+Laukkanenauthor=H.+Teramotoauthor=R.+Bellelliauthor=G.+Al%C3%ACauthor=G.+Fontaniniauthor=M.+Santoroauthor=J.+S.+Gutkind&title=Cross+talk+between+the+bombesin+neuropeptide+receptor+and+sonic+hedgehog+pathways+in+small+cell+lung+carcinoma&doi=10.1038%2Fonc.2014.104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.104%26sid%3Dliteratum%253Aachs%26aulast%3DCastellone%26aufirst%3DM.%2BD.%26aulast%3DLaukkanen%26aufirst%3DM.%2BO.%26aulast%3DTeramoto%26aufirst%3DH.%26aulast%3DBellelli%26aufirst%3DR.%26aulast%3DAl%25C3%25AC%26aufirst%3DG.%26aulast%3DFontanini%26aufirst%3DG.%26aulast%3DSantoro%26aufirst%3DM.%26aulast%3DGutkind%26aufirst%3DJ.%2BS.%26atitle%3DCross%2520talk%2520between%2520the%2520bombesin%2520neuropeptide%2520receptor%2520and%2520sonic%2520hedgehog%2520pathways%2520in%2520small%2520cell%2520lung%2520carcinoma%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D1679%26epage%3D1687%26doi%3D10.1038%2Fonc.2014.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupont, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonfils, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ste-Croix, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoyne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakovic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeppel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeppel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannion, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroun, C.</span><span> </span><span class="NLM_article-title">Potent preclinical antitumor activity of MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor in phase II clinical development, in combination with an EGFR Inhibitor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">3612</span><span class="NLM_x">–</span> <span class="NLM_lpage">3612</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM10-3612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F1538-7445.AM10-3612" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=3612-3612&author=M.+Fournelauthor=I.+Dupontauthor=C.+Bonfilsauthor=M.+Dubayauthor=H.+Ste-Croixauthor=C.+Beaulieuauthor=N.+Beaulieuauthor=C.+Lemoyneauthor=J.+Wangauthor=L.+Isakovicauthor=S.+Claridgeauthor=O.+Saavedraauthor=F.+Raeppelauthor=S.+Raeppelauthor=M.+Mannionauthor=A.+Vaisburgauthor=R.+E.+Martellauthor=J.+M.+Bestermanauthor=C.+Maroun&title=Potent+preclinical+antitumor+activity+of+MGCD265%2C+an+orally+active+Met%2FVEGFR+multitargeted+kinase+inhibitor+in+phase+II+clinical+development%2C+in+combination+with+an+EGFR+Inhibitor&doi=10.1158%2F1538-7445.AM10-3612"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM10-3612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM10-3612%26sid%3Dliteratum%253Aachs%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DDupont%26aufirst%3DI.%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DDubay%26aufirst%3DM.%26aulast%3DSte-Croix%26aufirst%3DH.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DBeaulieu%26aufirst%3DN.%26aulast%3DLemoyne%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DIsakovic%26aufirst%3DL.%26aulast%3DClaridge%26aufirst%3DS.%26aulast%3DSaavedra%26aufirst%3DO.%26aulast%3DRaeppel%26aufirst%3DF.%26aulast%3DRaeppel%26aufirst%3DS.%26aulast%3DMannion%26aufirst%3DM.%26aulast%3DVaisburg%26aufirst%3DA.%26aulast%3DMartell%26aufirst%3DR.%2BE.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DMaroun%26aufirst%3DC.%26atitle%3DPotent%2520preclinical%2520antitumor%2520activity%2520of%2520MGCD265%252C%2520an%2520orally%2520active%2520Met%252FVEGFR%2520multitargeted%2520kinase%2520inhibitor%2520in%2520phase%2520II%2520clinical%2520development%252C%2520in%2520combination%2520with%2520an%2520EGFR%2520Inhibitor%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D3612%26epage%3D3612%26doi%3D10.1158%2F1538-7445.AM10-3612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingzhi  Hong</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>, <span class="hlFld-ContribAuthor ">John V.  Heymach</span>, <span class="hlFld-ContribAuthor ">Xiuning  Le</span>. </span><span class="cited-content_cbyCitation_article-title">Current and future treatment options for
              MET
              exon 14 skipping alterations in non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Medical Oncology</span><span> <strong>2021,</strong> <em>13 </em>, 175883592199297. <a href="https://doi.org/10.1177/1758835921992976" title="DOI URL">https://doi.org/10.1177/1758835921992976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1758835921992976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1758835921992976%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Medical%2520Oncology%26atitle%3DCurrent%252Band%252Bfuture%252Btreatment%252Boptions%252Bfor%252BMET%252Bexon%252B14%252Bskipping%252Balterations%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DHong%26aufirst%3DLingzhi%26date%3D2021%26date%3D2021%26volume%3D13%26spage%3D175883592199297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyu  Wu</span>, <span class="hlFld-ContribAuthor ">Feng  Xu</span>, <span class="hlFld-ContribAuthor ">Zhenzhen  Yang</span>, <span class="hlFld-ContribAuthor ">Zhonglu  Ke</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Can  Ye</span>, <span class="hlFld-ContribAuthor ">Qidong  Yan</span>, <span class="hlFld-ContribAuthor ">Shijie  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation, and molecular docking of ((4-([1,2,4]triazolo[4,3-
              b
              ][1,2,4,5]tetrazin-6-yl) piperazin-1-yl)methyl) benzohydrazide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2020,</strong> <em>44 </em>
                                    (9-10)
                                     , 543-550. <a href="https://doi.org/10.1177/1747519820911278" title="DOI URL">https://doi.org/10.1177/1747519820911278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1747519820911278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1747519820911278%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bmolecular%252Bdocking%252Bof%252B%252528%2525284-%252528%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-%252Bb%252B%25255D%25255B1%25252C2%25252C4%25252C5%25255Dtetrazin-6-yl%252529%252Bpiperazin-1-yl%252529methyl%252529%252Bbenzohydrazide%252Bderivatives%26aulast%3DWu%26aufirst%3DXiaoyu%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D9-10%26spage%3D543%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing  Huang</span>, <span class="hlFld-ContribAuthor ">Enliang  Li</span>, <span class="hlFld-ContribAuthor ">Hang  Shen</span>, <span class="hlFld-ContribAuthor ">Xun  Wang</span>, <span class="hlFld-ContribAuthor ">Tianyu  Tang</span>, <span class="hlFld-ContribAuthor ">Xiaozhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Xu</span>, <span class="hlFld-ContribAuthor ">Zengwei  Tang</span>, <span class="hlFld-ContribAuthor ">Chengxiang  Guo</span>, <span class="hlFld-ContribAuthor ">Xueli  Bai</span>, <span class="hlFld-ContribAuthor ">Tingbo  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fcell.2020.00152" title="DOI URL">https://doi.org/10.3389/fcell.2020.00152</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2020.00152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2020.00152%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DTargeting%252Bthe%252BHGF%25252FMET%252BAxis%252Bin%252BCancer%252BTherapy%25253A%252BChallenges%252Bin%252BResistance%252Band%252BOpportunities%252Bfor%252BImprovement%26aulast%3DHuang%26aufirst%3DXing%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baijiao  An</span>, <span class="hlFld-ContribAuthor ">Tingting  Pan</span>, <span class="hlFld-ContribAuthor ">Jinhui  Hu</span>, <span class="hlFld-ContribAuthor ">Yanqing  Pang</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Albert S.C.  Chan</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of a potent and selective third-generation EGFR kinase inhibitor as a therapy for EGFR L858R/T790M double mutant non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111709. <a href="https://doi.org/10.1016/j.ejmech.2019.111709" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111709%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdiscovery%252Bof%252Ba%252Bpotent%252Band%252Bselective%252Bthird-generation%252BEGFR%252Bkinase%252Binhibitor%252Bas%252Ba%252Btherapy%252Bfor%252BEGFR%252BL858R%25252FT790M%252Bdouble%252Bmutant%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DAn%26aufirst%3DBaijiao%26date%3D2019%26volume%3D183%26spage%3D111709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirti Kandhwal  Chahal</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">Irina  Kufareva</span>, <span class="hlFld-ContribAuthor ">Milind  Parle</span>, <span class="hlFld-ContribAuthor ">Donald L.  Durden</span>, <span class="hlFld-ContribAuthor ">Robert J.  Wechsler-Reya</span>, <span class="hlFld-ContribAuthor ">Clark C.  Chen</span>, <span class="hlFld-ContribAuthor ">Ruben  Abagyan</span>, . </span><span class="cited-content_cbyCitation_article-title">Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2019,</strong> <em>14 </em>
                                    (9)
                                     , e0214901. <a href="https://doi.org/10.1371/journal.pone.0214901" title="DOI URL">https://doi.org/10.1371/journal.pone.0214901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0214901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0214901%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DNilotinib%25252C%252Ban%252Bapproved%252Bleukemia%252Bdrug%25252C%252Binhibits%252Bsmoothened%252Bsignaling%252Bin%252BHedgehog-dependent%252Bmedulloblastoma%26aulast%3DChahal%26aufirst%3DKirti%2BKandhwal%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D9%26spage%3De0214901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Dimou</span>, <span class="hlFld-ContribAuthor ">A.  Bamias</span>, <span class="hlFld-ContribAuthor ">H.  Gogas</span>, <span class="hlFld-ContribAuthor ">K.  Syrigos</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of the Hedgehog pathway in lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Lung Cancer</span><span> <strong>2019,</strong> <em>133 </em>, 56-61. <a href="https://doi.org/10.1016/j.lungcan.2019.05.004" title="DOI URL">https://doi.org/10.1016/j.lungcan.2019.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lungcan.2019.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lungcan.2019.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DLung%2520Cancer%26atitle%3DInhibition%252Bof%252Bthe%252BHedgehog%252Bpathway%252Bin%252Blung%252Bcancer%26aulast%3DDimou%26aufirst%3DA.%26date%3D2019%26volume%3D133%26spage%3D56%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zeng  Wu-Lan</span>, <span class="hlFld-ContribAuthor ">Xin  Wan</span>. </span><span class="cited-content_cbyCitation_article-title">The crystal structure of 3-cyclohexyl-1,5-dioxaspiro[5.5]undecane-2,4-dione, C15H22O4. </span><span class="cited-content_cbyCitation_journal-name">Zeitschrift für Kristallographie - New Crystal Structures</span><span> <strong>2019,</strong> <em>234 </em>
                                    (4)
                                     , 619-620. <a href="https://doi.org/10.1515/ncrs-2018-0572" title="DOI URL">https://doi.org/10.1515/ncrs-2018-0572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/ncrs-2018-0572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fncrs-2018-0572%26sid%3Dliteratum%253Aachs%26jtitle%3DZeitschrift%2520f%25C3%25BCr%2520Kristallographie%2520-%2520New%2520Crystal%2520Structures%26atitle%3DThe%252Bcrystal%252Bstructure%252Bof%252B3-cyclohexyl-1%25252C5-dioxaspiro%25255B5.5%25255Dundecane-2%25252C4-dione%25252C%252BC15H22O4%26aulast%3DWu-Lan%26aufirst%3DZeng%26date%3D2019%26volume%3D234%26issue%3D4%26spage%3D619%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun  Cheng</span>, <span class="hlFld-ContribAuthor ">Minliang  Yang</span>, <span class="hlFld-ContribAuthor ">Jingxian  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Correlation the between the regulation of miRNA‑1 in c‑Met‑induced EMT and cervical cancer progression. </span><span class="cited-content_cbyCitation_journal-name">Oncology Letters</span><span> <strong>2019,</strong> <em> </em><a href="https://doi.org/10.3892/ol.2019.9971" title="DOI URL">https://doi.org/10.3892/ol.2019.9971</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ol.2019.9971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fol.2019.9971%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Letters%26atitle%3DCorrelation%252Bthe%252Bbetween%252Bthe%252Bregulation%252Bof%252BmiRNA%2525E2%252580%2525911%252Bin%252Bc%2525E2%252580%252591Met%2525E2%252580%252591induced%252BEMT%252Band%252Bcervical%252Bcancer%252Bprogression%26aulast%3DCheng%26aufirst%3DYun%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heng  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhijun  Sun</span>, <span class="hlFld-ContribAuthor ">Zhaopeng  Liu</span>, <span class="hlFld-ContribAuthor ">Chun  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (24)
                                     , 2855-2875. <a href="https://doi.org/10.4155/fmc-2018-0200" title="DOI URL">https://doi.org/10.4155/fmc-2018-0200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0200%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DOvercoming%252Bthe%252Bemerging%252Bdrug%252Bresistance%252Bof%252Bsmoothened%25253A%252Ban%252Boverview%252Bof%252Bsmall-molecule%252BSMO%252Bantagonists%252Bwith%252Bantiresistance%252Bactivity%26aulast%3DZhang%26aufirst%3DHeng%26date%3D2018%26volume%3D10%26issue%3D24%26spage%3D2855%26epage%3D2875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Papaccio</span>, <span class="hlFld-ContribAuthor ">Carminia  Della Corte</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Viscardi</span>, <span class="hlFld-ContribAuthor ">Raimondo  Di Liello</span>, <span class="hlFld-ContribAuthor ">Giovanna  Esposito</span>, <span class="hlFld-ContribAuthor ">Francesca  Sparano</span>, <span class="hlFld-ContribAuthor ">Fortunato  Ciardiello</span>, <span class="hlFld-ContribAuthor ">Floriana  Morgillo</span>. </span><span class="cited-content_cbyCitation_article-title">HGF/MET and the Immune System: Relevance for Cancer Immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (11)
                                     , 3595. <a href="https://doi.org/10.3390/ijms19113595" title="DOI URL">https://doi.org/10.3390/ijms19113595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19113595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19113595%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DHGF%25252FMET%252Band%252Bthe%252BImmune%252BSystem%25253A%252BRelevance%252Bfor%252BCancer%252BImmunotherapy%26aulast%3DPapaccio%26aufirst%3DFederica%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D11%26spage%3D3595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Etienne  Giroux-Leprieur</span>, <span class="hlFld-ContribAuthor ">Adrien  Costantini</span>, <span class="hlFld-ContribAuthor ">Vivianne  Ding</span>, <span class="hlFld-ContribAuthor ">Biao  He</span>. </span><span class="cited-content_cbyCitation_article-title">Hedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (9)
                                     , 2835. <a href="https://doi.org/10.3390/ijms19092835" title="DOI URL">https://doi.org/10.3390/ijms19092835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19092835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19092835%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DHedgehog%252BSignaling%252Bin%252BLung%252BCancer%25253A%252BFrom%252BOncogenesis%252Bto%252BCancer%252BTreatment%252BResistance%26aulast%3DGiroux-Leprieur%26aufirst%3DEtienne%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D9%26spage%3D2835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Etienne Giroux  Leprieur</span>, <span class="hlFld-ContribAuthor ">David M.  Jablons</span>, <span class="hlFld-ContribAuthor ">Biao  He</span>. </span><span class="cited-content_cbyCitation_article-title">Old Sonic Hedgehog, new tricks: a new paradigm in thoracic malignancies. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (18)
                                     , 14680-14691. <a href="https://doi.org/10.18632/oncotarget.24411" title="DOI URL">https://doi.org/10.18632/oncotarget.24411</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.24411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.24411%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DOld%252BSonic%252BHedgehog%25252C%252Bnew%252Btricks%25253A%252Ba%252Bnew%252Bparadigm%252Bin%252Bthoracic%252Bmalignancies%26aulast%3DLeprieur%26aufirst%3DEtienne%2BGiroux%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D18%26spage%3D14680%26epage%3D14691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Jiankang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 449-463. <a href="https://doi.org/10.1016/j.ejmech.2017.11.049" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.11.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.11.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.11.049%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploiting%252Bpolypharmacology%252Bfor%252Bimproving%252Btherapeutic%252Boutcome%252Bof%252Bkinase%252Binhibitors%252B%252528KIs%252529%25253A%252BAn%252Bupdate%252Bof%252Brecent%252Bmedicinal%252Bchemistry%252Befforts%26aulast%3DMa%26aufirst%3DXiaodong%26date%3D2018%26volume%3D143%26spage%3D449%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Interaction fingerprints calculated through docking experiments for SMO antagonists (a) and MET inhibitors (b) with the four SMO receptor structures. The most frequently contacted residues are labeled. (c) Structures of the MET inhibitors identified as potential SMO antagonists along with their IC<sub>50</sub> or <i>K</i><sub>d</sub> values. For each MET inhibitor, the reported IC<sub>50</sub> or <i>K</i><sub>d</sub> values correspond to the ones indicated in the paper where they were first published. For compound <b>1</b>, see ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>; for compounds <b>2</b>, <b>4</b>, and <b>9</b>, ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>; for compounds <b>3</b>, <b>5</b>, <b>6</b>, <b>7</b>, <b>8</b>, <b>10</b>, <b>11</b>, and <b>12</b>, see refs <a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20 ref21 ref22">16−22</a>, and <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SMO binding analysis. Saturation assay of [<sup>3</sup>H]-<b>13</b> binding to HCC827-GR cells. Cells were incubated 4 h at RT in binding buffer containing increasing concentrations of [<sup>3</sup>H]-<b>13</b>. Nonspecific binding was determined in the presence of 25 μM of compound <b>14</b>. Scatchard plot analysis of the specific binding. Data are means ± SEM (<i>n</i> = 3) of a representative experiment over three independent experiments. The ability of each of the 12 potential dual inhibitors to displace 25 nM [<sup>3</sup>H]-<b>13</b> specific binding is reported in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Predicted binding pose of compound <b>3</b>, <b>5</b>, and <b>7</b>–<b>12</b> in the SMO X-ray structure. Compounds are represented as green sticks, while receptor as orange sticks and transparent white ribbons. H-bonds are represented as dashed yellow lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. GLI1-driven luciferase expression in HCC827-GR cells during treatment with compounds <b>3</b>, <b>5</b>, and <b>7</b>–<b>12</b> at 2 (a) and 60 μM (b) and in combination with SAG at a concentration of 100 nM. CTR bars represent the response obtained for HCC827-GR untreated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Biological activity of experimental compounds on the HCC827-GR NSCLC cell line. (a) MTT proliferation assay performed on NSCLC HCC827-GR cells with the indicated treatments. The results are the average ± SD of three independent experiments, each done in triplicate. (b) Apoptosis was evaluated as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> with annexin V staining in HCC827-GR cancer cells, which were treated with the indicated concentration of drugs. Columns, mean of three identical wells of a single representative experiment; bars, top 95% confidence interval.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects on intracellular pathways by experimental compounds. Western blotting analysis of Hh and MET pathways following treatment with the indicated concentration of compound <b>5</b> and <b>11</b> on HCC827-GR NSCLC cell line. Tubulin was included as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/medium/jm-2017-00794d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of the treatment with compound <b>5</b> or <b>11</b> alone or in combination with <b>17</b> or <b>18</b> in human NSCLC tumor xenografts resistant to the EGFR-TKI. Mean tumor volumes of human NSCLC tumor xenografts made resistant to (a) <b>17</b> or (b) <b>18</b> and randomized to treatment with the indicated drugs and combinations. Data represent the average (SD). Student <i>t</i> test was used to compare tumor sizes among different treatment groups at day 21 following the start of treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00794/20170908/images/large/jm-2017-00794d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00794&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14232" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14232" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jemal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thun, M. J.</span><span> </span><span class="NLM_article-title">Cancer Statistics, 2009</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.3322/caac.20006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.3322%2Fcaac.20006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=19474385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BD1MvnsV2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2009&pages=225-249&author=A.+Jemalauthor=R.+Siegelauthor=E.+Wardauthor=Y.+Haoauthor=J.+Xuauthor=M.+J.+Thun&title=Cancer+Statistics%2C+2009&doi=10.3322%2Fcaac.20006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2009</span></div><div class="casAuthors">Jemal Ahmedin; Siegel Rebecca; Ward Elizabeth; Hao Yongping; Xu Jiaquan; Thun Michael J</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">225-49</span>
        ISSN:<span class="NLM_cas:issn">0007-9235</span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics.  Incidence and death rates are standardized by age to the 2000 United States standard million population.  A total of 1,479,350 new cancer cases and 562,340 deaths from cancer are projected to occur in the United States in 2009.  Overall cancer incidence rates decreased in the most recent time period in both men (1.8% per year from 2001 to 2005) and women (0.6% per year from 1998 to 2005), largely because of decreases in the three major cancer sites in men (lung, prostate, and colon and rectum [colorectum]) and in two major cancer sites in women (breast and colorectum).  Overall cancer death rates decreased in men by 19.2% between 1990 and 2005, with decreases in lung (37%), prostate (24%), and colorectal (17%) cancer rates accounting for nearly 80% of the total decrease.  Among women, overall cancer death rates between 1991 and 2005 decreased by 11.4%, with decreases in breast (37%) and colorectal (24%) cancer rates accounting for 60% of the total decrease.  The reduction in the overall cancer death rates has resulted in the avoidance of about 650,000 deaths from cancer over the 15-year period.  This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, education, geographic area, and calendar year.  Although progress has been made in reducing incidence and mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons younger than 85 years of age.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population and by supporting new discoveries in cancer prevention, early detection, and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrRttlY5h-athSDZx9hyjKfW6udTcc2eY3QPUUv6og4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvnsV2luw%253D%253D&md5=3dbc58ce3b937944077b44eb07fa48b2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.20006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.20006%26sid%3Dliteratum%253Aachs%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DWard%26aufirst%3DE.%26aulast%3DHao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DThun%26aufirst%3DM.%2BJ.%26atitle%3DCancer%2520Statistics%252C%25202009%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2009%26volume%3D59%26spage%3D225%26epage%3D249%26doi%3D10.3322%2Fcaac.20006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span> </span><span class="NLM_article-title">Activation of the hedgehog-signaling pathway in human cancer and the clinical implications</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1038/onc.2009.392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fonc.2009.392" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=469-481&author=L.+Yangauthor=G.+Xieauthor=Q.+Fanauthor=J.+Xie&title=Activation+of+the+hedgehog-signaling+pathway+in+human+cancer+and+the+clinical+implications&doi=10.1038%2Fonc.2009.392"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.392%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DG.%26aulast%3DFan%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520the%2520hedgehog-signaling%2520pathway%2520in%2520human%2520cancer%2520and%2520the%2520clinical%2520implications%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D469%26epage%3D481%26doi%3D10.1038%2Fonc.2009.392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Yuan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petty, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Memoli, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dmitrovsky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, D. J.</span><span> </span><span class="NLM_article-title">Frequent requirement of hedgehog signaling in non-small cell lung carcinoma</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1055</span><span class="refDoi"> DOI: 10.1038/sj.onc.1209860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fsj.onc.1209860" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=1046-1055&author=Z.+Yuanauthor=J.+A.+Goetzauthor=S.+Singhauthor=S.+K.+Ogdenauthor=W.+J.+Pettyauthor=C.+C.+Blackauthor=V.+A.+Memoliauthor=E.+Dmitrovskyauthor=D.+J.+Robbins&title=Frequent+requirement+of+hedgehog+signaling+in+non-small+cell+lung+carcinoma&doi=10.1038%2Fsj.onc.1209860"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209860%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DZ.%26aulast%3DGoetz%26aufirst%3DJ.%2BA.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DOgden%26aufirst%3DS.%2BK.%26aulast%3DPetty%26aufirst%3DW.%2BJ.%26aulast%3DBlack%26aufirst%3DC.%2BC.%26aulast%3DMemoli%26aufirst%3DV.%2BA.%26aulast%3DDmitrovsky%26aufirst%3DE.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DFrequent%2520requirement%2520of%2520hedgehog%2520signaling%2520in%2520non-small%2520cell%2520lung%2520carcinoma%26jtitle%3DOncogene%26date%3D2006%26volume%3D26%26spage%3D1046%26epage%3D1055%26doi%3D10.1038%2Fsj.onc.1209860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ahmad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitah, M. I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginnebaugh, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadgeel, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, F. H.</span><span> </span><span class="NLM_article-title">Inhibition of hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs</span> <span class="citation_source-journal">J. Hematol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="refDoi"> DOI: 10.1186/1756-8722-6-77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1186%2F1756-8722-6-77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=24199791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=77&author=A.+Ahmadauthor=M.+I.+Y.+Maitahauthor=K.+R.+Ginnebaughauthor=Y.+Liauthor=B.+Baoauthor=S.+M.+Gadgeelauthor=F.+H.+Sarkar&title=Inhibition+of+hedgehog+signaling+sensitizes+NSCLC+cells+to+standard+therapies+through+modulation+of+EMT-regulating+miRNAs&doi=10.1186%2F1756-8722-6-77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs</span></div><div class="casAuthors">Ahmad, Aamir; Maitah, Ma'in Y.; Ginnebaugh, Kevin R.; Li, Yiwei; Bao, Bin; Gadgeel, Shirish M.; Sarkar, Fazlul H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77/1-77/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Epidermal growth factor receptor- tyrosine kinase inhibitors (EGFR-TKIs) benefit Non-small cell lung cancer (NSCLC) patients, and an EGFR-TKIi erlotinib, is approved for patients with recurrent NSCLC.  However, resistance to erlotinib is a major clin. problem.  Earlier we have demonstrated the role of Hedgehog (Hh) signaling in Epithelial-to-Mesenchymal transition (EMT) of NSCLC cells, leading to increased proliferation and invasion.  Here, we investigated the role of Hh signaling in erlotinib resistance of TGF-β1-induced NSCLC cells that are reminiscent of EMT cells.  Methods: Hh signaling was inhibited by specific siRNA and by GDC-0449, a small mol. antagonist of G protein coupled receptor smoothened in the Hh pathway.  Not all NSCLC patients are likely to benefit from EGFR-TKIs and, therefore, cisplatin was used to further demonstrate a role of inhibition of Hh signaling in sensitization of resistant EMT cells.  Specific pre- and anti-miRNA prepns. were used to study the mechanistic involvement of miRNAs in drug resistance mechanism.  Results: siRNA-mediated inhibition as well as pharmacol. inhibition of Hh signaling abrogated resistance of NSCLC cells to erlotinib and cisplatin.  It also resulted in re-sensitization of TGF-β1-induced A549 (A549M) cells as well the mesenchymal phenotypic H1299 cells to erlotinib and cisplatin treatment with concomitant up-regulation of cancer stem cell (CSC) markers (Sox2, Nanog and EpCAM) and down-regulation of miR-200 and let-7 family miRNAs.  Ectopic up-regulation of miRNAs, esp. miR-200b and let-7c, significantly diminished the erlotinib resistance of A549M cells.  Inhibition of Hh signaling by GDC-0449 in EMT cells resulted in the attenuation of CSC markers and up-regulation of miR-200b and let-7c, leading to sensitization of EMT cells to drug treatment, thus, confirming a connection between Hh signaling, miRNAs and drug resistance.  Conclusions: We demonstrate that Hh pathway, through EMT-induction, leads to reduced sensitivity to EGFR-TKIs in NSCLCs.  Therefore, targeting Hh pathway may lead to the reversal of EMT phenotype and improve the therapeutic efficacy of EGFR-TKIs in NSCLC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu0PYgu9hK67Vg90H21EOLACvtfcHk0liCMoPXL0ix5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVGnsb8%253D&md5=4b4ecfbe14c5d4a161d94eeaef5b4dea</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-77%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DMaitah%26aufirst%3DM.%2BI.%2BY.%26aulast%3DGinnebaugh%26aufirst%3DK.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBao%26aufirst%3DB.%26aulast%3DGadgeel%26aufirst%3DS.%2BM.%26aulast%3DSarkar%26aufirst%3DF.%2BH.%26atitle%3DInhibition%2520of%2520hedgehog%2520signaling%2520sensitizes%2520NSCLC%2520cells%2520to%2520standard%2520therapies%2520through%2520modulation%2520of%2520EMT-regulating%2520miRNAs%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26spage%3D77%26doi%3D10.1186%2F1756-8722-6-77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Tsao, A.; Byers, L. A.; Diao, L.; Wang, J.; Weinstein, J. N.; Meric-Bernstam, F.; Aldape, K.; Heymach, J. V.</span><span> </span><span class="NLM_article-title">P2.06-032-SMO mutations occur in non-small cell lung cancer (NSCLC) and may respond to hedgehog inhibitors</span>. 15th World Conference on Lung Cancer, 2013, Sydney, Australia,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+Tsao&author=L.+A.+Byers&author=L.+Diao&author=J.+Wang&author=J.+N.+Weinstein&author=F.+Meric-Bernstam&author=K.+Aldape&author=J.+V.+Heymach&title=P2.06-032-SMO+mutations+occur+in+non-small+cell+lung+cancer+%28NSCLC%29+and+may+respond+to+hedgehog+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DTsao%26aufirst%3DA.%26atitle%3DP2.06-032-SMO%2520mutations%2520occur%2520in%2520non-small%2520cell%2520lung%2520cancer%2520%2528NSCLC%2529%2520and%2520may%2520respond%2520to%2520hedgehog%2520inhibitors%26jtitle%3D15th%2520World%2520Conference%2520on%2520Lung%2520Cancer%252C%25202013%252C%2520Sydney%252C%2520Australia%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Reungwetwattana, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. I.</span><span> </span><span class="NLM_article-title">The race to target MET exon 14 skipping alterations in non-small cell lung cancer: the why, the how, the who, the unknown, and the inevitable</span> <span class="citation_source-journal">Lung Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.lungcan.2016.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.lungcan.2016.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=28024693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252FpsVOgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2017&pages=27-37&author=T.+Reungwetwattanaauthor=Y.+Liangauthor=V.+Zhuauthor=S.+I.+Ou&title=The+race+to+target+MET+exon+14+skipping+alterations+in+non-small+cell+lung+cancer%3A+the+why%2C+the+how%2C+the+who%2C+the+unknown%2C+and+the+inevitable&doi=10.1016%2Fj.lungcan.2016.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable</span></div><div class="casAuthors">Reungwetwattana Thanyanan; Liang Ying; Zhu Viola; Ou Sai-Hong Ignatius</div><div class="citationInfo"><span class="NLM_cas:title">Lung cancer (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A number of small molecule tyrosine kinase inhibitors (TKIs) have now been approved for the treatment of non-small cell lung cancers (NSCLC), including those targeted against epidermal growth factor receptor, anaplastic lymphoma kinase, and ROS1.  Despite a wealth of agents developed to target the receptor tyrosine kinase, MET, clinical outcomes have as yet been disappointing, leading to pessimism about the role of MET in the pathogenesis of NSCLC.  However, in recent years, there has been a renewed interest in MET exon 14 alterations as potential drivers of lung cancer.  MET exon 14 alterations, which result in increased MET protein levels due to disrupted ubiquitin-mediated degradation, occur at a prevalence of around 3% in adenocarcinomas and around 2% in other lung neoplasms, making them attractive targets for the treatment of lung cancer.  At least five MET-targeted TKIs, including crizotinib, cabozantinib, capmatinib, tepotinib, and glesatinib, are being investigated clinically for patients with MET exon 14 altered-NSCLC.  A further two compounds have shown activity in preclinical models.  In this article, we review the current clinical and preclinical data available for these TKIs, along with a number of other potential therapeutic options, including antibodies and immunotherapy.  A number of questions remain unanswered regarding the future of MET TKIs, but unfortunately, the development of resistance to targeted therapies is inevitable.  Resistance is expected to arise as a result of receptor tyrosine kinase mutation or from upregulation of MET ligand expression; potential strategies to overcome resistance are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSsrhwBD9iXx7rIbt-tGZmxfW6udTcc2eYpiXt9YfGz5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252FpsVOgug%253D%253D&md5=eda8010813a950d0851da13c2404ccb6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2016.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2016.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DReungwetwattana%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DV.%26aulast%3DOu%26aufirst%3DS.%2BI.%26atitle%3DThe%2520race%2520to%2520target%2520MET%2520exon%252014%2520skipping%2520alterations%2520in%2520non-small%2520cell%2520lung%2520cancer%253A%2520the%2520why%252C%2520the%2520how%252C%2520the%2520who%252C%2520the%2520unknown%252C%2520and%2520the%2520inevitable%26jtitle%3DLung%2520Cancer.%26date%3D2017%26volume%3D103%26spage%3D27%26epage%3D37%26doi%3D10.1016%2Fj.lungcan.2016.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Della Corte, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellevicine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicidomini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitagliano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malapelle, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Accardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papaccio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troiani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciardiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgillo, F.</span><span> </span><span class="NLM_article-title">SMO gene amplification and activation of the hedgehog pathway as novel mechanisms of resistance to anti-epidermal growth factor receptor drugs in human lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4686</span><span class="NLM_x">–</span> <span class="NLM_lpage">4697</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-3319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F1078-0432.CCR-14-3319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=26124204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1yltrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=4686-4697&author=C.+M.+Della+Corteauthor=C.+Bellevicineauthor=G.+Vicidominiauthor=D.+Vitaglianoauthor=U.+Malapelleauthor=M.+Accardoauthor=A.+Fabozziauthor=A.+Fiorelliauthor=M.+Fasanoauthor=F.+Papaccioauthor=E.+Martinelliauthor=T.+Troianiauthor=G.+Tronconeauthor=M.+Santiniauthor=R.+Biancoauthor=F.+Ciardielloauthor=F.+Morgillo&title=SMO+gene+amplification+and+activation+of+the+hedgehog+pathway+as+novel+mechanisms+of+resistance+to+anti-epidermal+growth+factor+receptor+drugs+in+human+lung+cancer&doi=10.1158%2F1078-0432.CCR-14-3319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer</span></div><div class="casAuthors">Della Corte, Carminia Maria; Bellevicine, Claudio; Vicidomini, Giovanni; Vitagliano, Donata; Malapelle, Umberto; Accardo, Marina; Fabozzi, Alessio; Fiorelli, Alfonso; Fasano, Morena; Papaccio, Federica; Martinelli, Erika; Troiani, Teresa; Troncone, Giancarlo; Santini, Mario; Bianco, Roberto; Ciardiello, Fortunato; Morgillo, Floriana</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4686-4697</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Resistance to tyrosine kinase inhibitors (TKI) of EGF receptor (EGFR) is often related to activation of other signaling pathways and evolution through a mesenchymal phenotype.  Exptl. Design: Because the Hedgehog (Hh) pathway has emerged as an important mediator of epithelial-to-mesenchymal transition (EMT), we studied the activation of Hh signaling in models of EGFR-TKIs intrinsic or acquired resistance from both EGFR-mutated and wild-type (WT) non-small cell lung cancer (NSCLC) cell lines.  Results: Activation of the Hh pathway was found in both models of EGFR-mutated and EGFR-WT NSCLC cell line resistant to EGFR-TKIs.  In EGFR-mutated HCC827-GR cells, we found SMO (the Hh receptor) gene amplification, MET activation, and the functional interaction of these two signaling pathways.  In HCC827-GR cells, inhibition of SMO or downregulation of GLI1 (the most important Hh-induced transcription factor) expression in combination with MET inhibition exerted significant antitumor activity.  In EGFR-WT NSCLC cell lines resistant to EGFR inhibitors, the combined inhibition of SMO and EGFR exerted a strong antiproliferative activity with a complete inhibition of PI3K/Akt and MAPK phosphorylation.  In addn., the inhibition of SMO by the use of LDE225 sensitizes EGFR-WT NSCLC cells to std. chemotherapy.  Conclusions:This result supports the role of the Hh pathway in mediating resistance to anti-EGFR-TKIs through the induction of EMT and suggests new opportunities to design new treatment strategies in lung cancer.  Clin Cancer Res; 21(20); 4686-97. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYOY5WwUklDbVg90H21EOLACvtfcHk0lgq71myZ0oIWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1yltrvM&md5=eddc0ddb457551bd237f883ed87fa8f9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-3319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-3319%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BCorte%26aufirst%3DC.%2BM.%26aulast%3DBellevicine%26aufirst%3DC.%26aulast%3DVicidomini%26aufirst%3DG.%26aulast%3DVitagliano%26aufirst%3DD.%26aulast%3DMalapelle%26aufirst%3DU.%26aulast%3DAccardo%26aufirst%3DM.%26aulast%3DFabozzi%26aufirst%3DA.%26aulast%3DFiorelli%26aufirst%3DA.%26aulast%3DFasano%26aufirst%3DM.%26aulast%3DPapaccio%26aufirst%3DF.%26aulast%3DMartinelli%26aufirst%3DE.%26aulast%3DTroiani%26aufirst%3DT.%26aulast%3DTroncone%26aufirst%3DG.%26aulast%3DSantini%26aufirst%3DM.%26aulast%3DBianco%26aufirst%3DR.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DMorgillo%26aufirst%3DF.%26atitle%3DSMO%2520gene%2520amplification%2520and%2520activation%2520of%2520the%2520hedgehog%2520pathway%2520as%2520novel%2520mechanisms%2520of%2520resistance%2520to%2520anti-epidermal%2520growth%2520factor%2520receptor%2520drugs%2520in%2520human%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D4686%26epage%3D4697%26doi%3D10.1158%2F1078-0432.CCR-14-3319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Della Corte, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malapelle, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigliar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaramella, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troiani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciardiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgillo, F.</span><span> </span><span class="NLM_article-title">Efficacy of continuous EGFR-inhibition and role of hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">23020</span><span class="NLM_x">–</span> <span class="NLM_lpage">23032</span><span class="refDoi"> DOI: 10.18632/oncotarget.15479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.18632%2Foncotarget.15479" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=23020-23032&author=C.+M.+Della+Corteauthor=U.+Malapelleauthor=E.+Vigliarauthor=F.+Pepeauthor=G.+Tronconeauthor=V.+Ciaramellaauthor=T.+Troianiauthor=E.+Martinelliauthor=V.+Belliauthor=F.+Ciardielloauthor=F.+Morgillo&title=Efficacy+of+continuous+EGFR-inhibition+and+role+of+hedgehog+in+EGFR+acquired+resistance+in+human+lung+cancer+cells+with+activating+mutation+of+EGFR&doi=10.18632%2Foncotarget.15479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15479%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BCorte%26aufirst%3DC.%2BM.%26aulast%3DMalapelle%26aufirst%3DU.%26aulast%3DVigliar%26aufirst%3DE.%26aulast%3DPepe%26aufirst%3DF.%26aulast%3DTroncone%26aufirst%3DG.%26aulast%3DCiaramella%26aufirst%3DV.%26aulast%3DTroiani%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DE.%26aulast%3DBelli%26aufirst%3DV.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DMorgillo%26aufirst%3DF.%26atitle%3DEfficacy%2520of%2520continuous%2520EGFR-inhibition%2520and%2520role%2520of%2520hedgehog%2520in%2520EGFR%2520acquired%2520resistance%2520in%2520human%2520lung%2520cancer%2520cells%2520with%2520activating%2520mutation%2520of%2520EGFR%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D23020%26epage%3D23032%26doi%3D10.18632%2Foncotarget.15479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Anighoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span> </span><span class="NLM_article-title">Polypharmacology: challenges and opportunities in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7874</span><span class="NLM_x">–</span> <span class="NLM_lpage">7887</span><span class="refDoi"> DOI: 10.1021/jm5006463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7874-7887&author=A.+Anighoroauthor=J.+Bajorathauthor=G.+Rastelli&title=Polypharmacology%3A+challenges+and+opportunities+in+drug+discovery&doi=10.1021%2Fjm5006463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology: Challenges and Opportunities in Drug Discovery</span></div><div class="casAuthors">Anighoro, Andrew; Bajorath, Jurgen; Rastelli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7874-7887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biol. target, shares the spotlight with an emerging and alternative polypharmacol. approach.  Polypharmacol. suggests that more effective drugs can be developed by specifically modulating multiple targets.  It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches.  In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs.  In this review, we will compare advantages and disadvantages of multitarget vs. combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOTyEu80AZrVg90H21EOLACvtfcHk0lgq71myZ0oIWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I&md5=5ab36c961a84462d90bc25130d90a281</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm5006463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006463%26sid%3Dliteratum%253Aachs%26aulast%3DAnighoro%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DRastelli%26aufirst%3DG.%26atitle%3DPolypharmacology%253A%2520challenges%2520and%2520opportunities%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7874%26epage%3D7887%26doi%3D10.1021%2Fjm5006463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Nosengo, N.</span><span> </span><span class="NLM_article-title">Can you teach old drugs new tricks?</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">534</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span><span class="refDoi"> DOI: 10.1038/534314a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2F534314a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=27306171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BC2s7gs1ylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=534&publication_year=2016&pages=314-316&author=N.+Nosengo&title=Can+you+teach+old+drugs+new+tricks%3F&doi=10.1038%2F534314a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Can you teach old drugs new tricks?</span></div><div class="casAuthors">Nosengo Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">534</span>
        (<span class="NLM_cas:issue">7607</span>),
    <span class="NLM_cas:pages">314-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyEEcSAsN0zhdUSIfHIn4FfW6udTcc2eaaLjmPqJoGKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7gs1ylug%253D%253D&md5=e521004f61101d4936d8e1f07454e843</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F534314a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F534314a%26sid%3Dliteratum%253Aachs%26aulast%3DNosengo%26aufirst%3DN.%26atitle%3DCan%2520you%2520teach%2520old%2520drugs%2520new%2520tricks%253F%26jtitle%3DNature%26date%3D2016%26volume%3D534%26spage%3D314%26epage%3D316%26doi%3D10.1038%2F534314a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorissen, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilson, M. K.</span><span> </span><span class="NLM_article-title">BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1093/nar/gkl999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1093%2Fnar%2Fgkl999" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=198-201&author=T.+Liuauthor=Y.+Linauthor=X.+Wenauthor=R.+N.+Jorissenauthor=M.+K.+Gilson&title=BindingDB%3A+a+web-accessible+database+of+experimentally+determined+protein%E2%80%93ligand+binding+affinities&doi=10.1093%2Fnar%2Fgkl999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkl999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkl999%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DJorissen%26aufirst%3DR.%2BN.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26atitle%3DBindingDB%253A%2520a%2520web-accessible%2520database%2520of%2520experimentally%2520determined%2520protein%25E2%2580%2593ligand%2520binding%2520affinities%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3D198%26epage%3D201%26doi%3D10.1093%2Fnar%2Fgkl999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Amendola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span> </span><span class="NLM_article-title">Best matching protein conformations and docking programs for a virtual screening campaign against SMO receptor</span> <span class="citation_source-journal">Mol. Inf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1002/minf.201501021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1002%2Fminf.201501021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=27546038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC28Xns1ejtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=340-349&author=G.+Amendolaauthor=D.+Di+Maioauthor=V.+La+Pietraauthor=S.+Cosconati&title=Best+matching+protein+conformations+and+docking+programs+for+a+virtual+screening+campaign+against+SMO+receptor&doi=10.1002%2Fminf.201501021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Best Matching Protein Conformations and Docking Programs for a Virtual Screening Campaign Against SMO Receptor</span></div><div class="casAuthors">Amendola, Giorgio; Di Maio, Danilo; La Pietra, Valeria; Cosconati, Sandro</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">340-349</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">SMO receptor is one of the main components of the Hedgehog biochem. pathway.  In the last decades compelling body of evidence demonstrated that this receptor is a pertinent target for the treatment of various types of solid tumors.  Recently, the X-ray detn. of the three-dimensional structure of SMO in complex with different antagonists opened up the way for the structure-based design of new antagonists for this receptor that could possibly overcome the limitations connected with the induction of acquired tumor resistance.  Herein, taking advantage of three different docking software (namely Glide, PLANTS, and Vina) and of the available SMO structures we set up a retrospective virtual screening (VS) protocol.  A database, made up by known SMO antagonists and compds. with no alleged activity against the receptor was created and screened against the different SMO structures.  To evaluate the performance of the ranking in VS calcns. different statistical metrics (EF, AUAC and BEDROC) were employed allowing to identify the best performing VS docking protocol.  Results of these studies will serve as a platform for the application of structure-based VS against the pharmaceutically relevant SMO receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLZsC1z2lsDbVg90H21EOLACvtfcHk0lg34ZBbVgKXGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xns1ejtb8%253D&md5=f7bf821475a7eb2a91ece8ee61245894</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fminf.201501021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201501021%26sid%3Dliteratum%253Aachs%26aulast%3DAmendola%26aufirst%3DG.%26aulast%3DDi%2BMaio%26aufirst%3DD.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DCosconati%26aufirst%3DS.%26atitle%3DBest%2520matching%2520protein%2520conformations%2520and%2520docking%2520programs%2520for%2520a%2520virtual%2520screening%2520campaign%2520against%2520SMO%2520receptor%26jtitle%3DMol.%2520Inf.%26date%3D2016%26volume%3D35%26spage%3D340%26epage%3D349%26doi%3D10.1002%2Fminf.201501021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4355</span><span class="refDoi"> DOI: 10.1038/ncomms5355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fncomms5355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=25008467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVert7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4355&author=C.+Wangauthor=H.+Wuauthor=T.+Evronauthor=E.+Vardyauthor=G.+W.+Hanauthor=X.+P.+Huangauthor=S.+J.+Hufeisenauthor=T.+J.+Manganoauthor=D.+J.+Urbanauthor=V.+Katritchauthor=V.+Cherezovauthor=M.+G.+Caronauthor=B.+L.+Rothauthor=R.+C.+Stevens&title=Structural+basis+for+Smoothened+receptor+modulation+and+chemoresistance+to+anticancer+drugs&doi=10.1038%2Fncomms5355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs</span></div><div class="casAuthors">Wang, Chong; Wu, Huixian; Evron, Tama; Vardy, Eyal; Han, Gye Won; Huang, Xi-Ping; Hufeisen, Sandy J.; Mangano, Thomas J.; Urban, Dan J.; Katritch, Vsevolod; Cherezov, Vadim; Caron, Marc G.; Roth, Bryan L.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4355</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Smoothened receptor (SMO) mediates signal transduction in the hedgehog pathway, which is implicated in normal development and carcinogenesis.  SMO antagonists can suppress the growth of some tumors; however, mutations at SMO have been found to abolish their antitumor effects, a phenomenon known as chemoresistance.  Here we report three crystal structures of human SMO bound to the antagonists SANT1 and Anta XV, and the agonist, SAG1.5, at 2.6-2.8 Å resoln.  The long and narrow cavity in the transmembrane domain of SMO harbours multiple ligand binding sites, where SANT1 binds at a deeper site as compared with other ligands.  Distinct interactions at D4736.54f elucidated the structural basis for the differential effects of chemoresistance mutations on SMO antagonists.  The agonist SAG1.5 induces a conformational rearrangement of the binding pocket residues, which could contribute to SMO activation.  Collectively, these studies reveal the structural basis for the modulation of SMO by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9pbk2DLpA7LVg90H21EOLACvtfcHk0lg34ZBbVgKXGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVert7g%253D&md5=5c7893dd6fd6ee3626a6e9483646c7bd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fncomms5355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5355%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DEvron%26aufirst%3DT.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DMangano%26aufirst%3DT.%2BJ.%26aulast%3DUrban%26aufirst%3DD.%2BJ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520basis%2520for%2520Smoothened%2520receptor%2520modulation%2520and%2520chemoresistance%2520to%2520anticancer%2520drugs%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D4355%26doi%3D10.1038%2Fncomms5355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oorui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiyama, K.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8030</span><span class="NLM_x">–</span> <span class="NLM_lpage">8050</span><span class="refDoi"> DOI: 10.1021/jm2008634</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2008634" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlajur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8030-8050&author=T.+Ishikawaauthor=M.+Setoauthor=H.+Bannoauthor=Y.+Kawakitaauthor=M.+Ooruiauthor=T.+Taniguchiauthor=Y.+Ohtaauthor=T.+Tamuraauthor=A.+Nakayamaauthor=H.+Mikiauthor=H.+Kamiguchiauthor=T.+Tanakaauthor=N.+Habukaauthor=S.+Sogabeauthor=J.+Yanoauthor=K.+Aertgeertsauthor=K.+Kamiyama&title=Design+and+synthesis+of+novel+human+epidermal+growth+factor+receptor+2+%28HER2%29%2Fepidermal+growth+factor+receptor+%28EGFR%29+dual+inhibitors+bearing+a+pyrrolo%5B3%2C2-d%5Dpyrimidine+scaffold&doi=10.1021%2Fjm2008634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-d]pyrimidine Scaffold</span></div><div class="casAuthors">Ishikawa, Tomoyasu; Seto, Masaki; Banno, Hiroshi; Kawakita, Youichi; Oorui, Mami; Taniguchi, Takahiko; Ohta, Yoshikazu; Tamura, Toshiya; Nakayama, Akiko; Miki, Hiroshi; Kamiguchi, Hidenori; Tanaka, Toshimasa; Habuka, Noriyuki; Sogabe, Satoshi; Yano, Jason; Aertgeerts, Kathleen; Kamiyama, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8030-8050</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dual inhibitors of human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR) have been investigated for breast, lung, gastric, prostate, and other cancers; one, lapatinib, is currently approved for breast cancer.  To develop novel HER2/EGFR dual kinase inhibitors, we designed and synthesized pyrrolo[3,2-d]pyrimidine derivs., e.g. I, capable of fitting into the receptors' ATP binding site.  Among the prepd. compds., I showed potent HER2 and EGFR (HER1) inhibitory activities as well as tumor growth inhibitory activity.  The X-ray cocrystal structures of I with both HER2 and EGFR demonstrated that I interacts with the expected residues in their resp. ATP pockets.  Furthermore, reflecting its good oral bioavailability, I exhibited potent in vivo efficacy in HER2-overexpressing tumor xenograft models.  On the basis of these findings, we report I (TAK-285) as a promising candidate for clin. development as a novel HER2/EGFR dual kinase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9QtqAj6idYrVg90H21EOLACvtfcHk0lhiA_qJu7YE2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlajur7M&md5=ce030ac133a1c0ff7cb78b269ff85987</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm2008634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2008634%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DSeto%26aufirst%3DM.%26aulast%3DBanno%26aufirst%3DH.%26aulast%3DKawakita%26aufirst%3DY.%26aulast%3DOorui%26aufirst%3DM.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DY.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DMiki%26aufirst%3DH.%26aulast%3DKamiguchi%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DKamiyama%26aufirst%3DK.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520human%2520epidermal%2520growth%2520factor%2520receptor%25202%2520%2528HER2%2529%252Fepidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520dual%2520inhibitors%2520bearing%2520a%2520pyrrolo%255B3%252C2-d%255Dpyrimidine%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8030%26epage%3D8050%26doi%3D10.1021%2Fjm2008634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span> </span><span class="NLM_article-title">Identification and synthesis of N′-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3749</span><span class="NLM_x">–</span> <span class="NLM_lpage">3754</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.bmcl.2011.04.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3749-3754&author=Z.+Liangauthor=D.+Zhangauthor=J.+Aiauthor=L.+Chenauthor=H.+Wangauthor=X.+Kongauthor=M.+Zhengauthor=H.+Liuauthor=C.+Luoauthor=M.+Gengauthor=H.+Jiangauthor=K.+Chen&title=Identification+and+synthesis+of+N%E2%80%B2-%282-oxoindolin-3-ylidene%29hydrazide+derivatives+against+c-Met+kinase&doi=10.1016%2Fj.bmcl.2011.04.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.064%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DK.%26atitle%3DIdentification%2520and%2520synthesis%2520of%2520N%25E2%2580%25B2-%25282-oxoindolin-3-ylidene%2529hydrazide%2520derivatives%2520against%2520c-Met%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3749%26epage%3D3754%26doi%3D10.1016%2Fj.bmcl.2011.04.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemcke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totzke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schächtele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubbutat, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span> </span><span class="NLM_article-title">Dual IGF-1R/SRC inhibitors based on a N′-aroyl-2-(1H-indol-3-yl)-2-oxoacetohydrazide structure</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2759</span><span class="NLM_x">–</span> <span class="NLM_lpage">2769</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.03.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.ejmech.2011.03.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2759-2769&author=S.+Schmidtauthor=L.+Preuauthor=T.+Lemckeauthor=F.+Totzkeauthor=C.+Sch%C3%A4chteleauthor=M.+H.+Kubbutatauthor=C.+Kunick&title=Dual+IGF-1R%2FSRC+inhibitors+based+on+a+N%E2%80%B2-aroyl-2-%281H-indol-3-yl%29-2-oxoacetohydrazide+structure&doi=10.1016%2Fj.ejmech.2011.03.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.03.065%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DLemcke%26aufirst%3DT.%26aulast%3DTotzke%26aufirst%3DF.%26aulast%3DSch%25C3%25A4chtele%26aufirst%3DC.%26aulast%3DKubbutat%26aufirst%3DM.%2BH.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3DDual%2520IGF-1R%252FSRC%2520inhibitors%2520based%2520on%2520a%2520N%25E2%2580%25B2-aroyl-2-%25281H-indol-3-yl%2529-2-oxoacetohydrazide%2520structure%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2759%26epage%3D2769%26doi%3D10.1016%2Fj.ejmech.2011.03.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Claridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeppel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granger, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llewellyn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahhab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deziel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupont, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsalou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chute, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gravel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macleod, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A.</span><span> </span><span class="NLM_article-title">Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2793</span><span class="NLM_x">–</span> <span class="NLM_lpage">2798</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.bmcl.2008.04.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2793-2798&author=S.+Claridgeauthor=F.+Raeppelauthor=M.-C.+Grangerauthor=N.+Bernsteinauthor=O.+Saavedraauthor=L.+Zhanauthor=D.+Llewellynauthor=A.+Wahhabauthor=R.+Dezielauthor=J.+Rahilauthor=N.+Beaulieuauthor=H.+Nguyenauthor=I.+Dupontauthor=A.+Barsalouauthor=C.+Beaulieuauthor=I.+Chuteauthor=S.+Gravelauthor=M.-F.+Robertauthor=S.+Lefebvreauthor=M.+Dubayauthor=R.+Pascalauthor=J.+Gillespieauthor=Z.+Jinauthor=J.+Wangauthor=J.+M.+Bestermanauthor=A.+R.+Macleodauthor=A.+Vaisburg&title=Discovery+of+a+novel+and+potent+series+of+thieno%5B3%2C2-b%5Dpyridine-based+inhibitors+of+c-Met+and+VEGFR2+tyrosine+kinases&doi=10.1016%2Fj.bmcl.2008.04.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DClaridge%26aufirst%3DS.%26aulast%3DRaeppel%26aufirst%3DF.%26aulast%3DGranger%26aufirst%3DM.-C.%26aulast%3DBernstein%26aufirst%3DN.%26aulast%3DSaavedra%26aufirst%3DO.%26aulast%3DZhan%26aufirst%3DL.%26aulast%3DLlewellyn%26aufirst%3DD.%26aulast%3DWahhab%26aufirst%3DA.%26aulast%3DDeziel%26aufirst%3DR.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DBeaulieu%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DDupont%26aufirst%3DI.%26aulast%3DBarsalou%26aufirst%3DA.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DChute%26aufirst%3DI.%26aulast%3DGravel%26aufirst%3DS.%26aulast%3DRobert%26aufirst%3DM.-F.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DDubay%26aufirst%3DM.%26aulast%3DPascal%26aufirst%3DR.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DMacleod%26aufirst%3DA.%2BR.%26aulast%3DVaisburg%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520and%2520potent%2520series%2520of%2520thieno%255B3%252C2-b%255Dpyridine-based%2520inhibitors%2520of%2520c-Met%2520and%2520VEGFR2%2520tyrosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2793%26epage%3D2798%26doi%3D10.1016%2Fj.bmcl.2008.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Schroeder, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, L. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span> </span><span class="NLM_article-title">Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span><span class="refDoi"> DOI: 10.1021/jm801586s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801586s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1251-1254&author=G.+M.+Schroederauthor=Y.+Anauthor=Z.-W.+Caiauthor=X.-T.+Chenauthor=C.+Clarkauthor=L.+A.+M.+Corneliusauthor=J.+Daiauthor=J.+Gullo-Brownauthor=A.+Guptaauthor=B.+Henleyauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=K.+Kimauthor=J.+Lippyauthor=L.+J.+Lombardoauthor=V.+Manneauthor=S.+Oppenheimerauthor=J.+S.+Sackauthor=R.+J.+Schmidtauthor=G.+Shenauthor=K.+Stefanskiauthor=J.+S.+Tokarskiauthor=G.+L.+Trainorauthor=B.+S.+Wautletauthor=D.+Weiauthor=D.+K.+Williamsauthor=Y.+Zhangauthor=Y.+Zhangauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+N-%284-%282-amino-3-chloropyridin-4-yloxy%29-3-fluorophenyl%29-4-ethoxy-1-%284-fluorophenyl%29-2-oxo-1%2C2-dihydropyridine-3-carboxamide+%28BMS-777607%29%2C+a+selective+and+orally+efficacious+inhibitor+of+the+Met+kinase+superfamily&doi=10.1021%2Fjm801586s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily</span></div><div class="casAuthors">Schroeder, Gretchen M.; An, Yongmi; Cai, Zhen-Wei; Chen, Xiao-Tao; Clark, Cheryl; Cornelius, Lyndon A. M.; Dai, Jun; Gullo-Brown, Johnni; Gupta, Ashok; Henley, Benjamin; Hunt, John T.; Jeyaseelan, Robert; Kamath, Amrita; Kim, Kyoung; Lippy, Jonathan; Lombardo, Louis J.; Manne, Veeraswamy; Oppenheimer, Simone; Sack, John S.; Schmidt, Robert J.; Shen, Guoxiang; Stefanski, Kevin; Tokarski, John S.; Trainor, George L.; Wautlet, Barri S.; Wei, Donna; Williams, David K.; Zhang, Yingru; Zhang, Yueping; Fargnoli, Joseph; Borzilleri, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1251-1254</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituted N-(4-(2-aminopyridin-4-yloxy)-3-fluoro-phenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamides were identified as potent and selective Met kinase inhibitors.  Substitution of the pyridine 3-position gave improved enzyme potency, while substitution of the pyridone 4-position led to improved aq. soly. and kinase selectivity.  Analog 10 demonstrated complete tumor stasis in a Met-dependent GTL-16 human gastric carcinoma xenograft model following oral administration.  Because of its excellent in vivo efficacy and favorable pharmacokinetic and preclin. safety profiles, 10 has been advanced into phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAHEvJXf0Fq7Vg90H21EOLACvtfcHk0lgWq9h8TwoLvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCnsLc%253D&md5=784623be820fcc8b931200ced3a476df</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm801586s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801586s%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DG.%2BM.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DChen%26aufirst%3DX.-T.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%2BM.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282-amino-3-chloropyridin-4-yloxy%2529-3-fluorophenyl%2529-4-ethoxy-1-%25284-fluorophenyl%2529-2-oxo-1%252C2-dihydropyridine-3-carboxamide%2520%2528BMS-777607%2529%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520the%2520Met%2520kinase%2520superfamily%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1251%26epage%3D1254%26doi%3D10.1021%2Fjm801586s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Guagnano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Douget, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghausen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drueckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, D. G.</span><span> </span><span class="NLM_article-title">Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7066</span><span class="NLM_x">–</span> <span class="NLM_lpage">7083</span><span class="refDoi"> DOI: 10.1021/jm2006222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2006222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7066-7083&author=V.+Guagnanoauthor=P.+Furetauthor=C.+Spankaauthor=V.+Bordasauthor=M.+Le+Dougetauthor=C.+Stammauthor=J.+Brueggenauthor=M.+R.+Jensenauthor=C.+Schnellauthor=H.+Schmidauthor=M.+Wartmannauthor=J.+Berghausenauthor=P.+Drueckesauthor=A.+Zimmerlinauthor=D.+Bussiereauthor=J.+Murrayauthor=D.+G.+Porta&title=Discovery+of+3-%282%2C6-dichloro-3%2C5-dimethoxy-phenyl%29-1-%7B6-%5B4-%284-ethyl-piperazin-1-yl%29-phenylamino%5D-pyrimidin-4-yl%7D-1-methyl-urea+%28NVP-BGJ398%29%2C+a+potent+and+selective+inhibitor+of+the+fibroblast+growth+factor+receptor+family+of+receptor+tyrosine+kinase&doi=10.1021%2Fjm2006222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase</span></div><div class="casAuthors">Guagnano, Vito; Furet, Pascal; Spanka, Carsten; Bordas, Vincent; Le Douget, Mickael; Stamm, Christelle; Brueggen, Josef; Jensen, Michael R.; Schnell, Christian; Schmid, Herbert; Wartmann, Markus; Berghausen, Joerg; Drueckes, Peter; Zimmerlin, Alfred; Bussiere, Dirksen; Murray, Jeremy; Graus Porta, Diana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7066-7083</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of N-aryl-N'-pyrimidin-4-yl ureas has been optimized to afford potent and selective inhibitors of the fibroblast growth factor receptor tyrosine kinases 1, 2, and 3 by rationally designing the substitution pattern of the aryl ring.  On the basis of its in vitro profile, compd. 1h (NVP-BGJ398) was selected for in vivo evaluation and showed significant antitumor activity in RT112 bladder cancer xenografts models overexpressing wild-type FGFR3.  These results support the potential therapeutic use of 1h as a new anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSC1v0A_6I_bVg90H21EOLACvtfcHk0lg8mv2j4WEGqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvK&md5=f9a2d742294cd3814e872bdd8add1ffa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm2006222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2006222%26sid%3Dliteratum%253Aachs%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSpanka%26aufirst%3DC.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DLe%2BDouget%26aufirst%3DM.%26aulast%3DStamm%26aufirst%3DC.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DH.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DBerghausen%26aufirst%3DJ.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DZimmerlin%26aufirst%3DA.%26aulast%3DBussiere%26aufirst%3DD.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DPorta%26aufirst%3DD.%2BG.%26atitle%3DDiscovery%2520of%25203-%25282%252C6-dichloro-3%252C5-dimethoxy-phenyl%2529-1-%257B6-%255B4-%25284-ethyl-piperazin-1-yl%2529-phenylamino%255D-pyrimidin-4-yl%257D-1-methyl-urea%2520%2528NVP-BGJ398%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520fibroblast%2520growth%2520factor%2520receptor%2520family%2520of%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7066%26epage%3D7083%26doi%3D10.1021%2Fjm2006222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Rowbottom, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprankle, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardane, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepomuceno, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenta, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitnick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apuy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones-Bolin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span> </span><span class="NLM_article-title">Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue b1 (BRAF) V600E</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1082</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span><span class="refDoi"> DOI: 10.1021/jm2009925</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2009925" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1082-1105&author=M.+W.+Rowbottomauthor=R.+Faraoniauthor=Q.+Chaoauthor=B.+T.+Campbellauthor=A.+G.+Laiauthor=E.+Settiauthor=M.+Ezawaauthor=K.+G.+Sprankleauthor=S.+Abrahamauthor=L.+Tranauthor=B.+Strussauthor=M.+Gibneyauthor=R.+C.+Armstrongauthor=R.+N.+Gunawardaneauthor=R.+R.+Nepomucenoauthor=I.+Valentaauthor=H.+Huaauthor=M.+F.+Gardnerauthor=M.+D.+Cramerauthor=D.+Gitnickauthor=D.+E.+Inskoauthor=J.+L.+Apuyauthor=S.+Jones-Bolinauthor=A.+K.+Ghoseauthor=T.+Herbertzauthor=M.+A.+Atorauthor=B.+D.+Dorseyauthor=B.+Ruggeriauthor=M.+Williamsauthor=S.+Bhagwatauthor=J.+Jamesauthor=M.+W.+Holladay&title=Identification+of+1-%283-%286%2C7-dimethoxyquinazolin-4-yloxy%29phenyl%29-3-%285-%281%2C1%2C1-trifluoro-2-methylpropan-2-yl%29isoxazol-3-yl%29urea+hydrochloride+%28CEP-32496%29%2C+a+highly+potent+and+orally+efficacious+inhibitor+of+V-RAF+murine+sarcoma+viral+oncogene+homologue+b1+%28BRAF%29+V600E&doi=10.1021%2Fjm2009925"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm2009925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2009925%26sid%3Dliteratum%253Aachs%26aulast%3DRowbottom%26aufirst%3DM.%2BW.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DChao%26aufirst%3DQ.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DSetti%26aufirst%3DE.%26aulast%3DEzawa%26aufirst%3DM.%26aulast%3DSprankle%26aufirst%3DK.%2BG.%26aulast%3DAbraham%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DL.%26aulast%3DStruss%26aufirst%3DB.%26aulast%3DGibney%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DGunawardane%26aufirst%3DR.%2BN.%26aulast%3DNepomuceno%26aufirst%3DR.%2BR.%26aulast%3DValenta%26aufirst%3DI.%26aulast%3DHua%26aufirst%3DH.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DCramer%26aufirst%3DM.%2BD.%26aulast%3DGitnick%26aufirst%3DD.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DApuy%26aufirst%3DJ.%2BL.%26aulast%3DJones-Bolin%26aufirst%3DS.%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DBhagwat%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DJ.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26atitle%3DIdentification%2520of%25201-%25283-%25286%252C7-dimethoxyquinazolin-4-yloxy%2529phenyl%2529-3-%25285-%25281%252C1%252C1-trifluoro-2-methylpropan-2-yl%2529isoxazol-3-yl%2529urea%2520hydrochloride%2520%2528CEP-32496%2529%252C%2520a%2520highly%2520potent%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520V-RAF%2520murine%2520sarcoma%2520viral%2520oncogene%2520homologue%2520b1%2520%2528BRAF%2529%2520V600E%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1082%26epage%3D1105%26doi%3D10.1021%2Fjm2009925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span><span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lhF3r2cAy65ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Qian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougheed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joly, A. H.</span><span> </span><span class="NLM_article-title">Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8009</span><span class="NLM_x">–</span> <span class="NLM_lpage">8016</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F0008-5472.CAN-08-4889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=19808973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ynurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=8009-8016&author=F.+Qianauthor=S.+Engstauthor=K.+Yamaguchiauthor=P.+Yuauthor=K.-A.+Wonauthor=L.+Mockauthor=T.+Louauthor=J.+Tanauthor=C.+Liauthor=D.+Tamauthor=J.+Lougheedauthor=F.+M.+Yakesauthor=F.+Bentzienauthor=W.+Xuauthor=T.+Zaksauthor=R.+Woosterauthor=J.+Greshockauthor=A.+H.+Joly&title=Inhibition+of+tumor+cell+growth%2C+invasion%2C+and+metastasis+by+EXEL-2880+%28XL880%2C+GSK1363089%29%2C+a+novel+inhibitor+of+HGF+and+VEGF+receptor+tyrosine+kinases&doi=10.1158%2F0008-5472.CAN-08-4889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases</span></div><div class="casAuthors">Qian, Fawn; Engst, Stefan; Yamaguchi, Kyoko; Yu, Peiwen; Won, Kwang-Ai; Mock, Lillian; Lou, Tracy; Tan, Jenny; Li, Connie; Tam, Danny; Lougheed, Julie; Yakes, F. Michael; Bentzien, Frauke; Xu, Wei; Zaks, Tal; Wooster, Richard; Greshock, Joel; Joly, Alison H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8009-8016</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), are overexpressed and/or activated in a wide variety of human malignancies.  Vascular endothelial growth factor (VEGF) receptors are expressed on the surface of vascular endothelial cells and cooperate with Met to induce tumor invasion and vascularization.  EXEL-2880 (XL880, GSK1363089) is a small-mol. kinase inhibitor that targets members of the HGF and VEGF receptor tyrosine kinase families, with addnl. inhibitory activity toward KIT, Flt-3, platelet-derived growth factor receptor β, and Tie-2.  Binding of EXEL-2880 to Met and VEGF receptor 2 (KDR) is characterized by a very slow off-rate, consistent with X-ray crystallog. data showing that the inhibitor is deeply bound in the Met kinase active site cleft.  EXEL-2880 inhibits cellular HGF-induced Met phosphorylation and VEGF-induced extracellular signal-regulated kinase phosphorylation and prevents both HGF-induced responses of tumor cells and HGF/VEGF-induced responses of endothelial cells.  In addn., EXEL-2880 prevents anchorage-independent proliferation of tumor cells under both normoxic and hypoxic conditions.  In vivo, these effects produce significant dose-dependent inhibition of tumor burden in an exptl. model of lung metastasis.  Collectively, these data indicate that EXEL-2880 may prevent tumor growth through a direct effect on tumor cell proliferation and by inhibition of invasion and angiogenesis mediated by HGF and VEGF receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoviVE_HZ5p_bVg90H21EOLACvtfcHk0lhF3r2cAy65ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ynurbF&md5=f3bf5b432ee42b164d23b690828e3c78</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4889%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DF.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DWon%26aufirst%3DK.-A.%26aulast%3DMock%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DLougheed%26aufirst%3DJ.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZaks%26aufirst%3DT.%26aulast%3DWooster%26aufirst%3DR.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DJoly%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520tumor%2520cell%2520growth%252C%2520invasion%252C%2520and%2520metastasis%2520by%2520EXEL-2880%2520%2528XL880%252C%2520GSK1363089%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520HGF%2520and%2520VEGF%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D8009%26epage%3D8016%26doi%3D10.1158%2F0008-5472.CAN-08-4889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoc, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, R. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoreishi-Haack, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukofzer, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartandi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niquette, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donawho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span> </span><span class="NLM_article-title">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span> <span class="citation_source-journal">Mol. Cancer. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span><span class="refDoi"> DOI: 10.1158/1535-7163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F1535-7163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=16648571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=995-1006&author=D.+H.+Albertauthor=P.+Tapangauthor=T.+J.+Magocauthor=L.+J.+Peaseauthor=D.+R.+Reuterauthor=R.+Q.+Weiauthor=J.+Liauthor=J.+Guoauthor=P.+F.+Bousquetauthor=N.+S.+Ghoreishi-Haackauthor=B.+Wangauthor=G.+T.+Bukofzerauthor=Y.+C.+Wangauthor=J.+A.+Stavropoulosauthor=K.+Hartandiauthor=A.+L.+Niquetteauthor=N.+Soniauthor=E.+F.+Johnsonauthor=J.+O.+McCallauthor=J.+J.+Bouskaauthor=Y.+Luoauthor=C.+K.+Donawhoauthor=Y.+Daiauthor=P.+A.+Marcotteauthor=K.+B.+Glaserauthor=M.+R.+Michaelidesauthor=S.+K.+Davidsen&title=Preclinical+activity+of+ABT-869%2C+a+multitargeted+receptor+tyrosine+kinase+inhibitor&doi=10.1158%2F1535-7163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span></div><div class="casAuthors">Albert, Daniel H.; Tapang, Paul; Magoc, Terrance J.; Pease, Lori J.; Reuter, David R.; Wei, Ru-Qi; Li, Junling; Guo, Jun; Bousquet, Peter F.; Ghoreishi-Haack, Nayereh S.; Wang, Baole; Bukofzer, Gail T.; Wang, Yi-Chun; Stavropoulos, Jason A.; Hartandi, Kresna; Niquette, Amanda L.; Soni, Nirupama; Johnson, Eric F.; McCall, J. Owen; Bouska, Jennifer J.; Luo, Yanping; Donawho, Cherrie K.; Dai, Yujia; Marcotte, Patrick A.; Glaser, Keith B.; Michaelides, Michael R.; Davidsen, Steven K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">995-1006</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ABT-869 is a structurally novel, receptor tyrosine kinase (RTK) inhibitor that is a potent inhibitor of members of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor families (e.g., KDR IC50 = 4 nmol/L) but has much less activity (IC50s > 1 μmol/L) against unrelated RTKs, sol. tyrosine kinases, or serine/threonine kinases.  The inhibition profile of ABT-869 is evident in cellular assays of RTK phosphorylation (IC50 = 2, 4, and 7 nmol/L for PDGFR-β, KDR, and CSF-1R, resp.) and VEGF-stimulated proliferation (IC50 = 0.2 nmol/L for human endothelial cells).  ABT-869 is not a general antiproliferative agent because, in most cancer cells, >1,000-fold higher concns. of ABT-869 are required for inhibition of proliferation.  However, ABT-869 exhibits potent antiproliferative and apoptotic effects on cancer cells whose proliferation is dependent on mutant kinases, such as FLT3.  In vivo ABT-869 is effective orally in the mechanism-based murine models of VEGF-induced uterine edema (ED50 = 0.5 mg/kg) and corneal angiogenesis (>50% inhibition, 15 mg/kg).  In tumor growth studies, ABT-869 exhibits efficacy in human fibrosarcoma and breast, colon, and small cell lung carcinoma xenograft models (ED50 = 1.5-5 mg/kg, twice daily) and is also effective (>50% inhibition) in orthotopic breast and glioma models.  Redn. in tumor size and tumor regression was obsd. in epidermoid carcinoma and leukemia xenograft models, resp.  In combination, ABT-869 produced at least additive effects when given with cytotoxic therapies.  Based on pharmacokinetic anal. from tumor growth studies, efficacy correlated more strongly with time over a threshold value (cellular KDR IC50 cor. for blood plasma protein binding = 0.08 μg/mL, ≥7 h) than with plasma area under the curve or Cmax.  These results support clin. assessment of ABT-869 as a therapeutic agent for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkn2KBvMa4wrVg90H21EOLACvtfcHk0lhF3r2cAy65ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D&md5=a5a60b591b4da7a3c589f1618d9cffb9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1535-7163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DReuter%26aufirst%3DD.%2BR.%26aulast%3DWei%26aufirst%3DR.%2BQ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DGhoreishi-Haack%26aufirst%3DN.%2BS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DBukofzer%26aufirst%3DG.%2BT.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DStavropoulos%26aufirst%3DJ.%2BA.%26aulast%3DHartandi%26aufirst%3DK.%26aulast%3DNiquette%26aufirst%3DA.%2BL.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DMcCall%26aufirst%3DJ.%2BO.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26atitle%3DPreclinical%2520activity%2520of%2520ABT-869%252C%2520a%2520multitargeted%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Cancer.%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D995%26epage%3D1006%26doi%3D10.1158%2F1535-7163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Chen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beachy, P. A.</span><span> </span><span class="NLM_article-title">Inhibition of hedgehog signaling by direct binding of cyclopamine to Smoothened</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2743</span><span class="NLM_x">–</span> <span class="NLM_lpage">2274</span><span class="refDoi"> DOI: 10.1101/gad.1025302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1101%2Fgad.1025302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=12414725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1Sju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=2743-2274&author=J.+K.+Chenauthor=J.+Taipaleauthor=M.+K.+Cooperauthor=P.+A.+Beachy&title=Inhibition+of+hedgehog+signaling+by+direct+binding+of+cyclopamine+to+Smoothened&doi=10.1101%2Fgad.1025302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened</span></div><div class="casAuthors">Chen, James K.; Taipale, Jussi; Cooper, Michael K.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2743-2748</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The steroidal alkaloid cyclopamine has both teratogenic and antitumor activities arising from its ability to specifically block cellular responses to vertebrate Hedgehog signaling.  We show here, using photoaffinity and fluorescent derivs., that this inhibitory effect is mediated by direct binding of cyclopamine to the heptahelical bundle of Smoothened (Smo).  Cyclopamine also can reverse the retention of partially misfolded Smo in the endoplasmic reticulum, presumably through binding-mediated effects on protein conformation.  These observations reveal the mechanism of cyclopamine's teratogenic and antitumor activities and further suggest a role for small mols. in the physiol. regulation of Smo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbLTFYxWwjf7Vg90H21EOLACvtfcHk0lj7Z-GrCeeTLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1Sju7o%253D&md5=84dafbf5668c65282470e5fd43876db6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1101%2Fgad.1025302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1025302%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BK.%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DM.%2BK.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DInhibition%2520of%2520hedgehog%2520signaling%2520by%2520direct%2520binding%2520of%2520cyclopamine%2520to%2520Smoothened%26jtitle%3DGenes%2520Dev.%26date%3D2002%26volume%3D16%26spage%3D2743%26epage%3D2274%26doi%3D10.1101%2Fgad.1025302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gunzner, J.; Sutherlin, D.; Stanley, M.; Bao, L.; Castanedo, G.; Lalonde, R.; Wang, S.; Reynolds, M.; Savage, S.; Malesky, K.; Dina, M.</span><span> </span><span class="NLM_article-title">Preparation of arylpyridines as inhibitors of hedgehog signalling</span>. PCT Int. Appl. WO 2006028958 A2, March 16,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+Gunzner&author=D.+Sutherlin&author=M.+Stanley&author=L.+Bao&author=G.+Castanedo&author=R.+Lalonde&author=S.+Wang&author=M.+Reynolds&author=S.+Savage&author=K.+Malesky&author=M.+Dina&title=Preparation+of+arylpyridines+as+inhibitors+of+hedgehog+signalling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGunzner%26aufirst%3DJ.%26atitle%3DPreparation%2520of%2520arylpyridines%2520as%2520inhibitors%2520of%2520hedgehog%2520signalling%26jtitle%3DPCT%2520Int.%2520Appl.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gooden, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barak, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyerly, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span> </span><span class="NLM_article-title">Identification of a novel smoothened antagonist that potently suppresses hedgehog signaling</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6751</span><span class="NLM_x">–</span> <span class="NLM_lpage">6757</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.bmc.2012.09.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6751-6757&author=J.+Wangauthor=R.+A.+Mookauthor=J.+Luauthor=D.+M.+Goodenauthor=A.+Ribeiroauthor=A.+Guoauthor=L.+S.+Barakauthor=H.+K.+Lyerlyauthor=W.+Chen&title=Identification+of+a+novel+smoothened+antagonist+that+potently+suppresses+hedgehog+signaling&doi=10.1016%2Fj.bmc.2012.09.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DGooden%26aufirst%3DD.%2BM.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DA.%26aulast%3DBarak%26aufirst%3DL.%2BS.%26aulast%3DLyerly%26aufirst%3DH.%2BK.%26aulast%3DChen%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520a%2520novel%2520smoothened%2520antagonist%2520that%2520potently%2520suppresses%2520hedgehog%2520signaling%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6751%26epage%3D6757%26doi%3D10.1016%2Fj.bmc.2012.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Rahnama, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimokawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teglund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toftgård, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaphiropoulos, P. G.</span><span> </span><span class="NLM_article-title">Inhibition of GLI1 gene activation by Patched1</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">394</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1042/BJ20050941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1042%2FBJ20050941" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2006&pages=19-26&author=F.+Rahnamaauthor=T.+Shimokawaauthor=M.+Lauthauthor=C.+Fintaauthor=P.+Kogermanauthor=S.+Teglundauthor=R.+Toftg%C3%A5rdauthor=P.+G.+Zaphiropoulos&title=Inhibition+of+GLI1+gene+activation+by+Patched1&doi=10.1042%2FBJ20050941"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1042%2FBJ20050941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20050941%26sid%3Dliteratum%253Aachs%26aulast%3DRahnama%26aufirst%3DF.%26aulast%3DShimokawa%26aufirst%3DT.%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DFinta%26aufirst%3DC.%26aulast%3DKogerman%26aufirst%3DP.%26aulast%3DTeglund%26aufirst%3DS.%26aulast%3DToftg%25C3%25A5rd%26aufirst%3DR.%26aulast%3DZaphiropoulos%26aufirst%3DP.%2BG.%26atitle%3DInhibition%2520of%2520GLI1%2520gene%2520activation%2520by%2520Patched1%26jtitle%3DBiochem.%2520J.%26date%3D2006%26volume%3D394%26spage%3D19%26epage%3D26%26doi%3D10.1042%2FBJ20050941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Frank-Kamenetsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guicherit, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichterle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumcrot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulok, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. A.</span><span> </span><span class="NLM_article-title">Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists</span> <span class="citation_source-journal">J. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="refDoi"> DOI: 10.1186/1475-4924-1-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1186%2F1475-4924-1-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=12437772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BD2czltlGjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=10&author=M.+Frank-Kamenetskyauthor=X.+M.+Zhangauthor=S.+Bottegaauthor=O.+Guicheritauthor=H.+Wichterleauthor=H.+Dudekauthor=D.+Bumcrotauthor=F.+Y.+Wangauthor=S.+Jonesauthor=J.+Shulokauthor=L.+L.+Rubinauthor=J.+A.+Porter&title=Small-molecule+modulators+of+Hedgehog+signaling%3A+identification+and+characterization+of+Smoothened+agonists+and+antagonists&doi=10.1186%2F1475-4924-1-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists</span></div><div class="casAuthors">Frank-Kamenetsky Maria; Zhang Xiaoyan M; Bottega Steve; Guicherit Oivin; Wichterle Hynek; Dudek Henryk; Bumcrot David; Wang Frank Y; Jones Simon; Shulok Janine; Rubin Lee L; Porter Jeffery A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The Hedgehog (Hh) signaling pathway is vital to animal development as it mediates the differentiation of multiple cell types during embryogenesis.  In adults, Hh signaling can be activated to facilitate tissue maintenance and repair.  Moreover, stimulation of the Hh pathway has shown therapeutic efficacy in models of neuropathy.  The underlying mechanisms of Hh signal transduction remain obscure, however: little is known about the communication between the pathway suppressor Patched (Ptc), a multipass transmembrane protein that directly binds Hh, and the pathway activator Smoothened (Smo), a protein that is related to G-protein-coupled receptors and is capable of constitutive activation in the absence of Ptc.  RESULTS:  We have identified and characterized a synthetic non-peptidyl small molecule, Hh-Ag, that acts as an agonist of the Hh pathway.  This Hh agonist promotes cell-type-specific proliferation and concentration-dependent differentiation in vitro, while in utero it rescues aspects of the Hh-signaling defect in Sonic hedgehog-null, but not Smo-null, mouse embryos.  Biochemical studies with Hh-Ag, the Hh-signaling antagonist cyclopamine, and a novel Hh-signaling inhibitor Cur61414, reveal that the action of all these compounds is independent of Hh-protein ligand and of the Hh receptor Ptc, as each binds directly to Smo.  CONCLUSIONS:  Smo can have its activity modulated directly by synthetic small molecules.  These studies raise the possibility that Hh signaling may be regulated by endogenous small molecules in vivo and provide potent compounds with which to test the therapeutic value of activating the Hh-signaling pathway in the treatment of traumatic and chronic degenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgamHYwQTiLwWRJ3OJdH_qfW6udTcc2eYPpVWlxpTjVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czltlGjtw%253D%253D&md5=7790e4fe15fecdf4be53946a4c338c01</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1186%2F1475-4924-1-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-4924-1-10%26sid%3Dliteratum%253Aachs%26aulast%3DFrank-Kamenetsky%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%2BM.%26aulast%3DBottega%26aufirst%3DS.%26aulast%3DGuicherit%26aufirst%3DO.%26aulast%3DWichterle%26aufirst%3DH.%26aulast%3DDudek%26aufirst%3DH.%26aulast%3DBumcrot%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DF.%2BY.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DShulok%26aufirst%3DJ.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520modulators%2520of%2520Hedgehog%2520signaling%253A%2520identification%2520and%2520characterization%2520of%2520Smoothened%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Biol.%26date%3D2002%26volume%3D1%26spage%3D10%26doi%3D10.1186%2F1475-4924-1-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Rosell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wannesson, L.</span><span> </span><span class="NLM_article-title">A genetic snapshot of small cell lung cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">771</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F2159-8290.CD-12-0346" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=769-771&author=R.+Rosellauthor=L.+Wannesson&title=A+genetic+snapshot+of+small+cell+lung+cancer&doi=10.1158%2F2159-8290.CD-12-0346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0346%26sid%3Dliteratum%253Aachs%26aulast%3DRosell%26aufirst%3DR.%26aulast%3DWannesson%26aufirst%3DL.%26atitle%3DA%2520genetic%2520snapshot%2520of%2520small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2012%26volume%3D2%26spage%3D769%26epage%3D771%26doi%3D10.1158%2F2159-8290.CD-12-0346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englund, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peukert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Moslin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pferdekamper, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, J. F.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsch, M.</span><span> </span><span class="NLM_article-title">Discovery of NVP-LDE225, a potent and selective smoothened antagonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span><span class="refDoi"> DOI: 10.1021/ml1000307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1Cqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=130-134&author=S.+Panauthor=X.+Wuauthor=J.+Jiangauthor=W.+Gaoauthor=Y.+Wanauthor=D.+Chengauthor=D.+Hanauthor=J.+Liuauthor=N.+P.+Englundauthor=Y.+Wangauthor=S.+Peukertauthor=K.+Miller-Moslinauthor=J.+Yuanauthor=R.+Guoauthor=M.+Matsumotoauthor=A.+Vattayauthor=Y.+Jiangauthor=J.+Tsaoauthor=F.+Sunauthor=A.+C.+Pferdekamperauthor=S.+Doddauthor=T.+Tuntlandauthor=W.+Maniaraauthor=J.+F.+Kelleherauthor=Y.+M.+Yaoauthor=M.+Warmuthauthor=J.+Williamsauthor=M.+Dorsch&title=Discovery+of+NVP-LDE225%2C+a+potent+and+selective+smoothened+antagonist&doi=10.1021%2Fml1000307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist</span></div><div class="casAuthors">Pan, Shifeng; Wu, Xu; Jiang, Jiqing; Gao, Wenqi; Wan, Yongqin; Cheng, Dai; Han, Dong; Liu, Jun; Englund, Nathan P.; Wang, Yan; Peukert, Stefan; Miller-Moslin, Karen; Yuan, Jing; Guo, Ribo; Matsumoto, Melissa; Vattay, Anthony; Jiang, Yun; Tsao, Jeffrey; Sun, Fangxian; Pferdekamper, AnneMarie C.; Dodd, Stephanie; Tuntland, Tove; Maniara, Wieslawa; Kelleher, Joseph F., III; Yao, Yung-mae; Warmuth, Markus; Williams, Juliet; Dorsch, Marion</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-134</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The blockade of aberrant hedgehog (Hh) signaling has shown promise for therapeutic intervention in cancer.  A cell-based phenotypic high-throughput screen was performed, and the lead structure (1) was identified as an inhibitor of the Hh pathway via antagonism of the Smoothened receptor (Smo).  Structure-activity relation studies led to the discovery of a potent and specific Smoothened antagonist N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide (5m, NVP-LDE225), which is currently in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkXrdZB74WfbVg90H21EOLACvtfcHk0lgpy2vk6bceyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1Cqt7c%253D&md5=c4d1348e8d47ed9561151ce59305531e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fml1000307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000307%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEnglund%26aufirst%3DN.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DTsao%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DPferdekamper%26aufirst%3DA.%2BC.%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26aulast%3DYao%26aufirst%3DY.%2BM.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DDorsch%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520NVP-LDE225%252C%2520a%2520potent%2520and%2520selective%2520smoothened%2520antagonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D130%26epage%3D134%26doi%3D10.1021%2Fml1000307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruganti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramphal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D. B.</span><span> </span><span class="NLM_article-title">A selective small molecule inhibitor of MET kinase inhibits METdependent phenotypes in vitro and exhibits cytoreductive antimutor activity in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7345</span><span class="NLM_x">–</span> <span class="NLM_lpage">7355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7345-7355&author=J.+G.+Christensenauthor=R.+Schreckauthor=J.+Burrowsauthor=P.+Kurugantiauthor=E.+Chanauthor=P.+Leauthor=J.+Chenauthor=X.+Wangauthor=L.+Ruslimauthor=R.+Blakeauthor=K.+E.+Lipsonauthor=J.+Ramphalauthor=S.+Doauthor=J.+J.+Cuiauthor=J.+M.+Cherringtonauthor=D.+B.+Mendel&title=A+selective+small+molecule+inhibitor+of+MET+kinase+inhibits+METdependent+phenotypes+in+vitro+and+exhibits+cytoreductive+antimutor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DKuruganti%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DBlake%26aufirst%3DR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DRamphal%26aufirst%3DJ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DA%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520MET%2520kinase%2520inhibits%2520METdependent%2520phenotypes%2520in%2520vitro%2520and%2520exhibits%2520cytoreductive%2520antimutor%2520activity%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7345%26epage%3D7355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halsey, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathe, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span> </span><span class="NLM_article-title">Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6871</span><span class="NLM_x">–</span> <span class="NLM_lpage">6878</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F0008-5472.CAN-08-4490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6871-6878&author=L.+Liuauthor=J.+Gregerauthor=H.+Shiauthor=Y.+Liuauthor=J.+Greshockauthor=R.+Annanauthor=W.+Halseyauthor=G.+M.+Satheauthor=A.-M.+Martinauthor=T.+M.+Gilmer&title=Novel+mechanism+of+lapatinib+resistance+in+HER2-positive+breast+tumor+cells%3A+activation+of+AXL&doi=10.1158%2F0008-5472.CAN-08-4490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4490%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGreger%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DAnnan%26aufirst%3DR.%26aulast%3DHalsey%26aufirst%3DW.%26aulast%3DSathe%26aufirst%3DG.%2BM.%26aulast%3DMartin%26aufirst%3DA.-M.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DNovel%2520mechanism%2520of%2520lapatinib%2520resistance%2520in%2520HER2-positive%2520breast%2520tumor%2520cells%253A%2520activation%2520of%2520AXL%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6871%26epage%3D6878%26doi%3D10.1158%2F0008-5472.CAN-08-4490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Role of AXL expression in non-small cell lung cancer</span> <span class="citation_source-journal">Oncol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5085</span><span class="NLM_x">–</span> <span class="NLM_lpage">5091</span><span class="refDoi"> DOI: 10.3892/ol.2016.5356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.3892%2Fol.2016.5356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=28105215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BC1c7nsFWqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=5085-5091&author=X.+Quauthor=J.+Liuauthor=X.+Zhongauthor=X.+Liauthor=Q.+Zhang&title=Role+of+AXL+expression+in+non-small+cell+lung+cancer&doi=10.3892%2Fol.2016.5356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Role of AXL expression in non-small cell lung cancer</span></div><div class="casAuthors">Qu Xiaohan; Zhong Xinwen; Li Xi; Zhang Qigang; Liu Jinlu</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">5085-5091</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">The present study aimed to investigate the expression profile of AXL in non-small cell lung cancer (NSCLC) and its clinical significance.  The current study included 257 NSCLC patients, tyrosine-protein kinase receptor UFO (AXL) expression in paired lung cancer and adjacent normal lung tissues of NSCLC patients were compared by immunohistochemistry, western blot analysis and quantitative polymerase chain reaction (qPCR).  These methods were used to detect the expression of the AXL gene and protein in fresh tissues from 35 patients.  Small interfering RNA (siRNA) was transfected into the H1299 lung cancer cell line to knock down AXL expression; the effects of AXL-siRNA on cell proliferation and migration were examined by MTT and Transwell migration assay, respectively.  It was found that AXL staining density in lung cancer tissues was significantly increased compared with adjacent normal lung tissues (55.25 vs. 26.85%; P<0.01); and the expression level of AXL in NSCLC patients was significantly associated with the degree of tumor differentiation (P<0.01) and the clinical stage of disease (P<0.01).  Western blotting and qPCR showed that AXL expression was significantly higher in cancer tissues compared with that in adjacent lung tissue (P<0.05).  Additionally, the current study also showed that AXL-siRNA inhibited H1299 cell proliferation and migration in vitro.  The present study demonstrates the association between increased expression of AXL in NSCLC and the low differentiation phenotype, and its effects on cell proliferation and migration, suggesting its potential clinical values for the prognosis of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIJGiIlA3U8bFU0A1HOshhfW6udTcc2ebBxEOTcv7vF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7nsFWqtA%253D%253D&md5=25e218b7e52998c98136cf1e932dcd93</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3892%2Fol.2016.5356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2016.5356%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DRole%2520of%2520AXL%2520expression%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DOncol.%2520Lett.%26date%3D2016%26volume%3D12%26spage%3D5085%26epage%3D5091%26doi%3D10.3892%2Fol.2016.5356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Xu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span> </span><span class="NLM_article-title">C5-substituted pyrido[2,3-<i>d</i>]pyrimidin-7-ones as highly specific kinase inhibitors targeting the clinical resistance-related EGFR<sup>T790M</sup> mutant</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1697</span><span class="refDoi"> DOI: 10.1039/C5MD00208G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1039%2FC5MD00208G" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1693-1697&author=T.+Xuauthor=T.+Pengauthor=X.+Renauthor=L.+Zhangauthor=L.+Yuauthor=J.+Luoauthor=Z.+Zhangauthor=Z.+Tuauthor=L.+Tongauthor=Z.+Huangauthor=X.+Luauthor=M.+Gengauthor=H.+Xieauthor=J.+Dingauthor=K.+Ding&title=C5-substituted+pyrido%5B2%2C3-d%5Dpyrimidin-7-ones+as+highly+specific+kinase+inhibitors+targeting+the+clinical+resistance-related+EGFRT790M+mutant&doi=10.1039%2FC5MD00208G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2FC5MD00208G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00208G%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DT.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DC5-substituted%2520pyrido%255B2%252C3-d%255Dpyrimidin-7-ones%2520as%2520highly%2520specific%2520kinase%2520inhibitors%2520targeting%2520the%2520clinical%2520resistance-related%2520EGFRT790M%2520mutant%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1693%26epage%3D1697%26doi%3D10.1039%2FC5MD00208G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Cross, D. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiorghiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebhan, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitzler, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orme, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, M. R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Kadhimi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinowska, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, G. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantarini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span> </span><span class="NLM_article-title">AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-14-0337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F2159-8290.CD-14-0337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=24893891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVykur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=1046-1061&author=D.+A.+E.+Crossauthor=S.+E.+Ashtonauthor=S.+Ghiorghiuauthor=C.+Eberleinauthor=C.+A.+Nebhanauthor=P.+J.+Spitzlerauthor=J.+P.+Ormeauthor=M.+R.+V.+Finlayauthor=R.+A.+Wardauthor=M.+J.+Mellorauthor=G.+Hughesauthor=A.+Rahiauthor=V.+N.+Jacobsauthor=M.+R.+Brewerauthor=E.+Ichiharaauthor=J.+Sunauthor=H.+Jinauthor=P.+Ballardauthor=K.+Al-Kadhimiauthor=R.+Rowlinsonauthor=T.+Klinowskaauthor=G.+H.+P.+Richmondauthor=M.+Cantariniauthor=D.+W.+Kimauthor=M.+R.+Ransonauthor=W.+Pao&title=AZD9291%2C+an+irreversible+EGFR+TKI%2C+overcomes+T790M-mediated+resistance+to+EGFR+inhibitors+in+lung+cancer&doi=10.1158%2F2159-8290.CD-14-0337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer</span></div><div class="casAuthors">Cross, Darren A. E.; Ashton, Susan E.; Ghiorghiu, Serban; Eberlein, Cath; Nebhan, Caroline A.; Spitzler, Paula J.; Orme, Jonathon P.; Finlay, M. Raymond V.; Ward, Richard A.; Mellor, Martine J.; Hughes, Gareth; Rahi, Amar; Jacobs, Vivien N.; Brewer, Monica Red; Ichihara, Eiki; Sun, Jing; Jin, Hailing; Ballard, Peter; Al-Kadhimi, Katherine; Rowlinson, Rachel; Klinowska, Teresa; Richmond, Graham H. P.; Cantarini, Mireille; Kim, Dong-Wan; Ranson, Malcolm R.; Pao, William</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1046-1061</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A third-generation EGFR inhibitor selectively targets EGFR mutants, including T790M, but not wild-type EGFR, and induces durable antitumor responses in preclin. models and patients with NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDo3e2pAh8YbVg90H21EOLACvtfcHk0lg1DrM9zQYdRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVykur%252FP&md5=f72e56f9463236ddc89eef32a4ab61b3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-14-0337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-14-0337%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DD.%2BA.%2BE.%26aulast%3DAshton%26aufirst%3DS.%2BE.%26aulast%3DGhiorghiu%26aufirst%3DS.%26aulast%3DEberlein%26aufirst%3DC.%26aulast%3DNebhan%26aufirst%3DC.%2BA.%26aulast%3DSpitzler%26aufirst%3DP.%2BJ.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DMellor%26aufirst%3DM.%2BJ.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DRahi%26aufirst%3DA.%26aulast%3DJacobs%26aufirst%3DV.%2BN.%26aulast%3DBrewer%26aufirst%3DM.%2BR.%26aulast%3DIchihara%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DBallard%26aufirst%3DP.%26aulast%3DAl-Kadhimi%26aufirst%3DK.%26aulast%3DRowlinson%26aufirst%3DR.%26aulast%3DKlinowska%26aufirst%3DT.%26aulast%3DRichmond%26aufirst%3DG.%2BH.%2BP.%26aulast%3DCantarini%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DD.%2BW.%26aulast%3DRanson%26aufirst%3DM.%2BR.%26aulast%3DPao%26aufirst%3DW.%26atitle%3DAZD9291%252C%2520an%2520irreversible%2520EGFR%2520TKI%252C%2520overcomes%2520T790M-mediated%2520resistance%2520to%2520EGFR%2520inhibitors%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2014%26volume%3D4%26spage%3D1046%26epage%3D1061%26doi%3D10.1158%2F2159-8290.CD-14-0337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Bonfils, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ste-Croix, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroun, C. R.</span><span> </span><span class="NLM_article-title">The combination of MGCD265, a Met/VEGFR inhibitor in clinical development, and erlotinib potently inhibits tumor growth by altering multiple pathways including glycolysis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1790</span><span class="NLM_x">–</span> <span class="NLM_lpage">1790</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2012-1790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F1538-7445.AM2012-1790" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=1790-1790&author=C.+Bonfilsauthor=N.+Beaulieuauthor=M.+Fournelauthor=H.+Ste-Croixauthor=J.+M.+Bestermanauthor=C.+R.+Maroun&title=The+combination+of+MGCD265%2C+a+Met%2FVEGFR+inhibitor+in+clinical+development%2C+and+erlotinib+potently+inhibits+tumor+growth+by+altering+multiple+pathways+including+glycolysis&doi=10.1158%2F1538-7445.AM2012-1790"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2012-1790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2012-1790%26sid%3Dliteratum%253Aachs%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DBeaulieu%26aufirst%3DN.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DSte-Croix%26aufirst%3DH.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DMaroun%26aufirst%3DC.%2BR.%26atitle%3DThe%2520combination%2520of%2520MGCD265%252C%2520a%2520Met%252FVEGFR%2520inhibitor%2520in%2520clinical%2520development%252C%2520and%2520erlotinib%2520potently%2520inhibits%2520tumor%2520growth%2520by%2520altering%2520multiple%2520pathways%2520including%2520glycolysis%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D1790%26epage%3D1790%26doi%3D10.1158%2F1538-7445.AM2012-1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ge, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span> </span><span class="NLM_article-title">Sonic hedgehog stimulates glycolysis and proliferation of breast cancer cells: modulation of PFKFB3 activation</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">464</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2015.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1016%2Fj.bbrc.2015.07.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2015&pages=862-868&author=X.+Geauthor=P.+Lyuauthor=Y.+Guauthor=L.+Liauthor=J.+Liauthor=Y.+Wangauthor=L.+Zhangauthor=C.+Fuauthor=Z.+Cao&title=Sonic+hedgehog+stimulates+glycolysis+and+proliferation+of+breast+cancer+cells%3A+modulation+of+PFKFB3+activation&doi=10.1016%2Fj.bbrc.2015.07.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DX.%26aulast%3DLyu%26aufirst%3DP.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DZ.%26atitle%3DSonic%2520hedgehog%2520stimulates%2520glycolysis%2520and%2520proliferation%2520of%2520breast%2520cancer%2520cells%253A%2520modulation%2520of%2520PFKFB3%2520activation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D464%26spage%3D862%26epage%3D868%26doi%3D10.1016%2Fj.bbrc.2015.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Faria, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golbourn, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubuc, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnihotri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garzia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaswamy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leadley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northcott, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croul, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korshunov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutka, J. T.</span><span> </span><span class="NLM_article-title">Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-3629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F0008-5472.CAN-13-3629" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=134-146&author=C.+C.+Fariaauthor=B.+J.+Golbournauthor=A.+M.+Dubucauthor=M.+Remkeauthor=R.+J.+Diazauthor=S.+Agnihotriauthor=A.+Luckauthor=N.+Sabhaauthor=S.+Olsenauthor=X.+Wuauthor=L.+Garziaauthor=V.+Ramaswamyauthor=S.+C.+Mackauthor=X.+Wangauthor=M.+Leadleyauthor=D.+Reynaudauthor=L.+Erminiauthor=M.+Postauthor=P.+A.+Northcottauthor=S.+M.+Pfisterauthor=S.+E.+Croulauthor=M.+Koolauthor=A.+Korshunovauthor=C.+A.+Smithauthor=M.+D.+Taylorauthor=J.+T.+Rutka&title=Foretinib+is+effective+therapy+for+metastatic+sonic+hedgehog+medulloblastoma&doi=10.1158%2F0008-5472.CAN-13-3629"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-3629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-3629%26sid%3Dliteratum%253Aachs%26aulast%3DFaria%26aufirst%3DC.%2BC.%26aulast%3DGolbourn%26aufirst%3DB.%2BJ.%26aulast%3DDubuc%26aufirst%3DA.%2BM.%26aulast%3DRemke%26aufirst%3DM.%26aulast%3DDiaz%26aufirst%3DR.%2BJ.%26aulast%3DAgnihotri%26aufirst%3DS.%26aulast%3DLuck%26aufirst%3DA.%26aulast%3DSabha%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGarzia%26aufirst%3DL.%26aulast%3DRamaswamy%26aufirst%3DV.%26aulast%3DMack%26aufirst%3DS.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLeadley%26aufirst%3DM.%26aulast%3DReynaud%26aufirst%3DD.%26aulast%3DErmini%26aufirst%3DL.%26aulast%3DPost%26aufirst%3DM.%26aulast%3DNorthcott%26aufirst%3DP.%2BA.%26aulast%3DPfister%26aufirst%3DS.%2BM.%26aulast%3DCroul%26aufirst%3DS.%2BE.%26aulast%3DKool%26aufirst%3DM.%26aulast%3DKorshunov%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DC.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%2BD.%26aulast%3DRutka%26aufirst%3DJ.%2BT.%26atitle%3DForetinib%2520is%2520effective%2520therapy%2520for%2520metastatic%2520sonic%2520hedgehog%2520medulloblastoma%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D134%26epage%3D146%26doi%3D10.1158%2F0008-5472.CAN-13-3629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Chen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beachy, P. A.</span><span> </span><span class="NLM_article-title">Small molecule modulation of smoothened activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">14071</span><span class="NLM_x">–</span> <span class="NLM_lpage">14076</span><span class="refDoi"> DOI: 10.1073/pnas.182542899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1073%2Fpnas.182542899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=12391318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD38XosF2itro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=14071-14076&author=J.+K.+Chenauthor=J.+Taipaleauthor=K.+E.+Youngauthor=T.+Maitiauthor=P.+A.+Beachy&title=Small+molecule+modulation+of+smoothened+activity&doi=10.1073%2Fpnas.182542899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule modulation of Smoothened activity</span></div><div class="casAuthors">Chen, James K.; Taipale, Jussi; Young, Keith E.; Maiti, Tapan; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">14071-14076</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Smoothened (Smo), a distant relative of G protein-coupled receptors, mediates Hedgehog (Hh) signaling during embryonic development and can initiate or transmit ligand-independent pathway activation in tumorigenesis.  Although the cellular mechanisms that regulate Smo function remain unclear, the direct inhibition of Smo by cyclopamine, a plant-derived steroidal alkaloid, suggests that endogenous small mols. may be involved.  Here we demonstrate that SAG, a chlorobenzothiophene-contg. Hh pathway agonist, binds to the Smo heptahelical bundle in a manner that antagonizes cyclopamine action.  In addn., we have identified four small mols. that directly inhibit Smo activity but are structurally distinct from cyclopamine.  Functional and biochem. studies of these compds. provide evidence for the small mol. modulation of Smo through multiple mechanisms and yield insights into the physiol. regulation of Smo activity.  The mechanistic differences between the Smo antagonists may be useful in the therapeutic manipulation of Hh signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGuyQOc-zOmrVg90H21EOLACvtfcHk0liHBOv967tfcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosF2itro%253D&md5=c3573be833dbdb00ba569b57ad373f10</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.182542899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.182542899%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BK.%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DK.%2BE.%26aulast%3DMaiti%26aufirst%3DT.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DSmall%2520molecule%2520modulation%2520of%2520smoothened%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D14071%26epage%3D14076%26doi%3D10.1073%2Fpnas.182542899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4355</span><span class="refDoi"> DOI: 10.1038/ncomms5355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fncomms5355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=25008467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVert7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4355&author=C.+Wangauthor=H.+Wuauthor=T.+Evronauthor=E.+Vardyauthor=G.+W.+Hanauthor=X.-P.+Huangauthor=S.+J.+Hufeisenauthor=T.+J.+Manganoauthor=D.+J.+Urbanauthor=V.+Katritchauthor=V.+Cherezovauthor=M.+G.+Caronauthor=B.+L.+Rothauthor=R.+C.+Stevens&title=Structural+basis+for+Smoothened+receptor+modulation+and+chemoresistance+to+anticancer+drugs&doi=10.1038%2Fncomms5355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs</span></div><div class="casAuthors">Wang, Chong; Wu, Huixian; Evron, Tama; Vardy, Eyal; Han, Gye Won; Huang, Xi-Ping; Hufeisen, Sandy J.; Mangano, Thomas J.; Urban, Dan J.; Katritch, Vsevolod; Cherezov, Vadim; Caron, Marc G.; Roth, Bryan L.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4355</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Smoothened receptor (SMO) mediates signal transduction in the hedgehog pathway, which is implicated in normal development and carcinogenesis.  SMO antagonists can suppress the growth of some tumors; however, mutations at SMO have been found to abolish their antitumor effects, a phenomenon known as chemoresistance.  Here we report three crystal structures of human SMO bound to the antagonists SANT1 and Anta XV, and the agonist, SAG1.5, at 2.6-2.8 Å resoln.  The long and narrow cavity in the transmembrane domain of SMO harbours multiple ligand binding sites, where SANT1 binds at a deeper site as compared with other ligands.  Distinct interactions at D4736.54f elucidated the structural basis for the differential effects of chemoresistance mutations on SMO antagonists.  The agonist SAG1.5 induces a conformational rearrangement of the binding pocket residues, which could contribute to SMO activation.  Collectively, these studies reveal the structural basis for the modulation of SMO by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9pbk2DLpA7LVg90H21EOLACvtfcHk0liHBOv967tfcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVert7g%253D&md5=5c7893dd6fd6ee3626a6e9483646c7bd</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fncomms5355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5355%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DEvron%26aufirst%3DT.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DMangano%26aufirst%3DT.%2BJ.%26aulast%3DUrban%26aufirst%3DD.%2BJ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520basis%2520for%2520Smoothened%2520receptor%2520modulation%2520and%2520chemoresistance%2520to%2520anticancer%2520drugs%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D4355%26doi%3D10.1038%2Fncomms5355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Miller-Moslin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peukert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEwan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llamas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusuff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourret, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamurthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, J. F.</span><span> </span><span class="NLM_article-title">III.1-Amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3954</span><span class="NLM_x">–</span> <span class="NLM_lpage">3968</span><span class="refDoi"> DOI: 10.1021/jm900309j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900309j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3954-3968&author=K.+Miller-Moslinauthor=S.+Peukertauthor=R.+K.+Jainauthor=M.+A.+McEwanauthor=R.+Karkiauthor=L.+Llamasauthor=N.+Yusuffauthor=F.+Heauthor=Y.+Liauthor=Y.+Sunauthor=M.+Daiauthor=L.+Perezauthor=W.+Michaelauthor=T.+Shengauthor=H.+Leiauthor=R.+Zhangauthor=J.+Williamsauthor=A.+Bourretauthor=A.+Ramamurthyauthor=J.+Yuanauthor=R.+Guoauthor=M.+Matsumotoauthor=A.+Vattayauthor=W.+Maniaraauthor=A.+Amaralauthor=M.+Dorschauthor=J.+F.+Kelleher&title=III.1-Amino-4-benzylphthalazines+as+orally+bioavailable+smoothened+antagonists+with+antitumor+activity&doi=10.1021%2Fjm900309j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm900309j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900309j%26sid%3Dliteratum%253Aachs%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DMcEwan%26aufirst%3DM.%2BA.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DLlamas%26aufirst%3DL.%26aulast%3DYusuff%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DMichael%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DBourret%26aufirst%3DA.%26aulast%3DRamamurthy%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DAmaral%26aufirst%3DA.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26atitle%3DIII.1-Amino-4-benzylphthalazines%2520as%2520orally%2520bioavailable%2520smoothened%2520antagonists%2520with%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3954%26epage%3D3968%26doi%3D10.1021%2Fjm900309j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Hipskind, P. A.; Patel, B. K.; Wilson, T.</span><span> </span><span class="NLM_article-title">Preparation of disubstituted phthalazine derivatives for use as hedgehog pathway antagonists and useful in treatment of cancer</span>. PCT Int. Appl. WO 2010147917 A1, Dec 23,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=P.+A.+Hipskind&author=B.+K.+Patel&author=T.+Wilson&title=Preparation+of+disubstituted+phthalazine+derivatives+for+use+as+hedgehog+pathway+antagonists+and+useful+in+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHipskind%26aufirst%3DP.%2BA.%26atitle%3DPreparation%2520of%2520disubstituted%2520phthalazine%2520derivatives%2520for%2520use%2520as%2520hedgehog%2520pathway%2520antagonists%2520and%2520useful%2520in%2520treatment%2520of%2520cancer%26jtitle%3DPCT%2520Int.%2520Appl.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structure of the human smoothened receptor bound to an antitumour agent</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">497</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span><span class="refDoi"> DOI: 10.1038/nature12167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fnature12167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=23636324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFylsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2013&pages=338-343&author=C.+Wangauthor=H.+Wuauthor=V.+Katritchauthor=G.+W.+Hanauthor=X.-P.+Huangauthor=W.+Liuauthor=F.+Y.+Siuauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+smoothened+receptor+bound+to+an+antitumour+agent&doi=10.1038%2Fnature12167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human smoothened receptor bound to an antitumour agent</span></div><div class="casAuthors">Wang, Chong; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Huang, Xi-Ping; Liu, Wei; Siu, Fai Yiu; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">497</span>
        (<span class="NLM_cas:issue">7449</span>),
    <span class="NLM_cas:pages">338-343</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The smoothened (SMO) receptor, a key signal transducer in the hedgehog signalling pathway, is responsible for the maintenance of normal embryonic development and is implicated in carcinogenesis.  It is classified as a class frizzled (class F) G-protein-coupled receptor (GPCR), although the canonical hedgehog signalling pathway involves the GLI transcription factors and the sequence similarity with class A GPCRs is less than 10%.  Here we report the crystal structure of the transmembrane domain of the human SMO receptor bound to the small-mol. antagonist LY2940680 at 2.5 Å resoln.  Although the SMO receptor shares the seven-transmembrane helical (7TM) fold, most of the conserved motifs for class A GPCRs are absent, and the structure reveals an unusually complex arrangement of long extracellular loops stabilized by four disulfide bonds.  The ligand binds at the extracellular end of the seven-transmembrane-helix bundle and forms extensive contacts with the loops.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmaIV6OXnzIrVg90H21EOLACvtfcHk0liahtVZY1kcmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFylsb0%253D&md5=fdd96ac77bcf93d5c8da46e5630795b2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature12167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12167%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSiu%26aufirst%3DF.%2BY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520smoothened%2520receptor%2520bound%2520to%2520an%2520antitumour%2520agent%26jtitle%3DNature%26date%3D2013%26volume%3D497%26spage%3D338%26epage%3D343%26doi%3D10.1038%2Fnature12167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Weierstall, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, J. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doak, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromme, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromme, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotjohann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatsepin, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messerschmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koglin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoeman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirian, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyerlein, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span> </span><span class="NLM_article-title">Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="refDoi"> DOI: 10.1038/ncomms4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fncomms4309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=24525480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A280%3ADC%252BC2cvltVeqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3309&author=U.+Weierstallauthor=D.+Jamesauthor=C.+Wangauthor=T.+A.+Whiteauthor=D.+Wangauthor=W.+Liuauthor=J.+C.+H.+Spenceauthor=R.+B.+Doakauthor=G.+Nelsonauthor=P.+Frommeauthor=R.+Frommeauthor=I.+Grotjohannauthor=C.+Kupitzauthor=N.+A.+Zatsepinauthor=H.+Liuauthor=S.+Basuauthor=D.+Wackerauthor=G.+W.+Hanauthor=V.+Katritchauthor=S.+Boutetauthor=M.+Messerschmidtauthor=G.+J.+Williamsauthor=J.+E.+Koglinauthor=M.+M.+Seibertauthor=M.+Klinkerauthor=C.+Gatiauthor=R.+L.+Shoemanauthor=A.+Bartyauthor=H.+N.+Chapmanauthor=R.+A.+Kirianauthor=K.+R.+Beyerleinauthor=R.+C.+Stevensauthor=D.+Liauthor=S.+T.+A.+Shahauthor=N.+Howeauthor=M.+Caffreyauthor=V.+Cherezov&title=Lipidic+cubic+phase+injector+facilitates+membrane+protein+serial+femtosecond+crystallography&doi=10.1038%2Fncomms4309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography</span></div><div class="casAuthors">Weierstall Uwe; James Daniel; Wang Dingjie; Spence John C H; Bruce Doak R; Nelson Garrett; Zatsepin Nadia A; Liu Haiguang; Wang Chong; Liu Wei; Wacker Daniel; Han Gye Won; Katritch Vsevolod; Stevens Raymond C; Cherezov Vadim; White Thomas A; Gati Cornelius; Barty Anton; Beyerlein Kenneth R; Fromme Petra; Fromme Raimund; Grotjohann Ingo; Kupitz Christopher; Basu Shibom; Boutet Sebastien; Messerschmidt Marc; Williams Garth J; Koglin Jason E; Marvin Seibert M; Klinker Markus; Shoeman Robert L; Chapman Henry N; Kirian Richard A; Li Dianfan; Shah Syed T A; Howe Nicole; Caffrey Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3309</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lipidic cubic phase (LCP) crystallization has proven successful for high-resolution structure determination of challenging membrane proteins.  Here we present a technique for extruding gel-like LCP with embedded membrane protein microcrystals, providing a continuously renewed source of material for serial femtosecond crystallography.  Data collected from sub-10-μm-sized crystals produced with less than 0.5 mg of purified protein yield structural insights regarding cyclopamine binding to the Smoothened receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDUg0uqQckxOWhZTslLrfffW6udTcc2eaFGGULgSaIerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvltVeqsA%253D%253D&md5=ce335fa0a5bfeb8990c836e7f425e2d2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fncomms4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4309%26sid%3Dliteratum%253Aachs%26aulast%3DWeierstall%26aufirst%3DU.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DT.%2BA.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSpence%26aufirst%3DJ.%2BC.%2BH.%26aulast%3DDoak%26aufirst%3DR.%2BB.%26aulast%3DNelson%26aufirst%3DG.%26aulast%3DFromme%26aufirst%3DP.%26aulast%3DFromme%26aufirst%3DR.%26aulast%3DGrotjohann%26aufirst%3DI.%26aulast%3DKupitz%26aufirst%3DC.%26aulast%3DZatsepin%26aufirst%3DN.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DBoutet%26aufirst%3DS.%26aulast%3DMesserschmidt%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DKoglin%26aufirst%3DJ.%2BE.%26aulast%3DSeibert%26aufirst%3DM.%2BM.%26aulast%3DKlinker%26aufirst%3DM.%26aulast%3DGati%26aufirst%3DC.%26aulast%3DShoeman%26aufirst%3DR.%2BL.%26aulast%3DBarty%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DH.%2BN.%26aulast%3DKirian%26aufirst%3DR.%2BA.%26aulast%3DBeyerlein%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DS.%2BT.%2BA.%26aulast%3DHowe%26aufirst%3DN.%26aulast%3DCaffrey%26aufirst%3DM.%26aulast%3DCherezov%26aufirst%3DV.%26atitle%3DLipidic%2520cubic%2520phase%2520injector%2520facilitates%2520membrane%2520protein%2520serial%2520femtosecond%2520crystallography%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D3309%26doi%3D10.1038%2Fncomms4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span>Maestro, <span class="NLM_edition">version 10</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.schrodinger.com/" class="extLink">http://www.schrodinger.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+10%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015%3B+http%3A%2F%2Fwww.schrodinger.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span>Epik, <span class="NLM_edition">version 2.2</span>; <span class="NLM_publisher-name">Schrodinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Epik%2C+version+2.2%3B+Schrodinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DEpik%26pub%3DSchrodinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span>LigPrep, <span class="NLM_edition">version 2.5</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2009&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2785</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span><span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lhILPfohmBb0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Sanner, M. F.</span><span> </span><span class="NLM_article-title">Python: a programming language for software integration and development</span> <span class="citation_source-journal">J. Mol. Graph. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10660911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=57-61&author=M.+F.+Sanner&title=Python%3A+a+programming+language+for+software+integration+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Python: a programming language for software integration and development</span></div><div class="casAuthors">Sanner, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The use of interpreted languages in biocomputing has been investigated to create a programmable, dynamic environment in which components can be tied together at a high level.  This work has demonstrated the benefits of such an approach and the features of the interpreted language that are key to successful component integration.  This involved Python, an interpreted, interactive, object-oriented programming language.  It provides high-level data structures such as list and associative arrays, dynamic typing and dynamic binding, modules, classes, exceptions, automatic memory management and others.  Python has been found to be instrumental in the mol. modeling research environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCFXA1JC8X7Vg90H21EOLACvtfcHk0li_0qTz_pvkLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D&md5=3bf94934548080055dda54f68468c656</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26atitle%3DPython%253A%2520a%2520programming%2520language%2520for%2520software%2520integration%2520and%2520development%26jtitle%3DJ.%2520Mol.%2520Graph.%2520Model.%26date%3D1999%26volume%3D17%26spage%3D57%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Pettersen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrin, T. E.</span><span> </span><span class="NLM_article-title">UCSF Chimera: a visualization system for exploratory research and analysis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera%3A+a+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0li_0qTz_pvkLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera%253A%2520a%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (pains) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28pains%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0li_0qTz_pvkLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528pains%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Castellone, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laukkanen, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alì, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutkind, J. S.</span><span> </span><span class="NLM_article-title">Cross talk between the bombesin neuropeptide receptor and sonic hedgehog pathways in small cell lung carcinoma</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1679</span><span class="NLM_x">–</span> <span class="NLM_lpage">1687</span><span class="refDoi"> DOI: 10.1038/onc.2014.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1038%2Fonc.2014.104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1679-1687&author=M.+D.+Castelloneauthor=M.+O.+Laukkanenauthor=H.+Teramotoauthor=R.+Bellelliauthor=G.+Al%C3%ACauthor=G.+Fontaniniauthor=M.+Santoroauthor=J.+S.+Gutkind&title=Cross+talk+between+the+bombesin+neuropeptide+receptor+and+sonic+hedgehog+pathways+in+small+cell+lung+carcinoma&doi=10.1038%2Fonc.2014.104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.104%26sid%3Dliteratum%253Aachs%26aulast%3DCastellone%26aufirst%3DM.%2BD.%26aulast%3DLaukkanen%26aufirst%3DM.%2BO.%26aulast%3DTeramoto%26aufirst%3DH.%26aulast%3DBellelli%26aufirst%3DR.%26aulast%3DAl%25C3%25AC%26aufirst%3DG.%26aulast%3DFontanini%26aufirst%3DG.%26aulast%3DSantoro%26aufirst%3DM.%26aulast%3DGutkind%26aufirst%3DJ.%2BS.%26atitle%3DCross%2520talk%2520between%2520the%2520bombesin%2520neuropeptide%2520receptor%2520and%2520sonic%2520hedgehog%2520pathways%2520in%2520small%2520cell%2520lung%2520carcinoma%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D1679%26epage%3D1687%26doi%3D10.1038%2Fonc.2014.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupont, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonfils, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ste-Croix, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoyne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakovic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeppel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeppel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannion, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroun, C.</span><span> </span><span class="NLM_article-title">Potent preclinical antitumor activity of MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor in phase II clinical development, in combination with an EGFR Inhibitor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">3612</span><span class="NLM_x">–</span> <span class="NLM_lpage">3612</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM10-3612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;key=10.1158%2F1538-7445.AM10-3612" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=3612-3612&author=M.+Fournelauthor=I.+Dupontauthor=C.+Bonfilsauthor=M.+Dubayauthor=H.+Ste-Croixauthor=C.+Beaulieuauthor=N.+Beaulieuauthor=C.+Lemoyneauthor=J.+Wangauthor=L.+Isakovicauthor=S.+Claridgeauthor=O.+Saavedraauthor=F.+Raeppelauthor=S.+Raeppelauthor=M.+Mannionauthor=A.+Vaisburgauthor=R.+E.+Martellauthor=J.+M.+Bestermanauthor=C.+Maroun&title=Potent+preclinical+antitumor+activity+of+MGCD265%2C+an+orally+active+Met%2FVEGFR+multitargeted+kinase+inhibitor+in+phase+II+clinical+development%2C+in+combination+with+an+EGFR+Inhibitor&doi=10.1158%2F1538-7445.AM10-3612"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM10-3612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM10-3612%26sid%3Dliteratum%253Aachs%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DDupont%26aufirst%3DI.%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DDubay%26aufirst%3DM.%26aulast%3DSte-Croix%26aufirst%3DH.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DBeaulieu%26aufirst%3DN.%26aulast%3DLemoyne%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DIsakovic%26aufirst%3DL.%26aulast%3DClaridge%26aufirst%3DS.%26aulast%3DSaavedra%26aufirst%3DO.%26aulast%3DRaeppel%26aufirst%3DF.%26aulast%3DRaeppel%26aufirst%3DS.%26aulast%3DMannion%26aufirst%3DM.%26aulast%3DVaisburg%26aufirst%3DA.%26aulast%3DMartell%26aufirst%3DR.%2BE.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DMaroun%26aufirst%3DC.%26atitle%3DPotent%2520preclinical%2520antitumor%2520activity%2520of%2520MGCD265%252C%2520an%2520orally%2520active%2520Met%252FVEGFR%2520multitargeted%2520kinase%2520inhibitor%2520in%2520phase%2520II%2520clinical%2520development%252C%2520in%2520combination%2520with%2520an%2520EGFR%2520Inhibitor%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D3612%26epage%3D3612%26doi%3D10.1158%2F1538-7445.AM10-3612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N4W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N4W','PDB','4N4W'); return false;">PDB: 4N4W</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4QIM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4QIM','PDB','4QIM'); return false;">PDB: 4QIM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKV','PDB','4JKV'); return false;">PDB: 4JKV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R','PDB','4O9R'); return false;">PDB: 4O9R</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00794">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47733"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00794">10.1021/acs.jmedchem.7b00794</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Binding affinities, Tanimoto similarity index, ligand interactions, and compound characterization (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_002.csv">CSV</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>3</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N4W">4N4W</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>5</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R">4O9R</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_004.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>6</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R">4O9R</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_005.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>7</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N4W">4N4W</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_006.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>8</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R">4O9R</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_007.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>11</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKV">4JKV</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_008.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>9</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKV">4JKV</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_009.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>12</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N4W">4N4W</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_010.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates of the calculated SMO/ligand complex of <b>10</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R">4O9R</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_011.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_001.pdf">jm7b00794_si_001.pdf (2.26 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_002.csv">jm7b00794_si_002.csv (0.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_003.pdb">jm7b00794_si_003.pdb (213.03 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_004.pdb">jm7b00794_si_004.pdb (274.65 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_005.pdb">jm7b00794_si_005.pdb (274.65 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_006.pdb">jm7b00794_si_006.pdb (213.95 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_007.pdb">jm7b00794_si_007.pdb (274.73 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_008.pdb">jm7b00794_si_008.pdb (213.1 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_009.pdb">jm7b00794_si_009.pdb (212.1 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_010.pdb">jm7b00794_si_010.pdb (213.18 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00794/suppl_file/jm7b00794_si_011.pdb">jm7b00794_si_011.pdb (274.11 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00794&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00794%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-17%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00794" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679956698b5f3de3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
